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1The importance of vitamin A for the immune system has been known for a long time from epidemiological studies in developing countries where a large number 
of people, mainly children, suffer from vitamin A deficiency. Vitamin A deficiency 
compromises proper mucosal immune responses, causing diarrhea, infections 
and early childhood mortality [1-3]. The exact role for vitamin A in maintaining 
immune homeostasis was not known, but since the discovery in 2004 by Iwata 
et al. [4], that the vitamin A metabolite retinoic acid directly imprints T cells with 
gut-homing capacity, the role of vitamin A in the intestinal immune system has 
gained considerable attention from research groups. 
The generic term “retinoids” covers hydrophobic, lipid-soluble and small sized 
molecules that include natural vitamin A (retinol) and all vitamin A metabolites, 
e.g. all-trans retinoic acid. 
1. Vitamin A metabolism
1.1 Absorption, metabolism and storage
Vertebrate animals need vitamin A for several life processes such as embryogenesis, 
vision, reproduction, intestinal barrier function, immune function and normal cell 
proliferation and differentiation. The ability for de novo synthesis of vitamin A 
molecules is limited to plants and microorganisms [5,6].  Vertebrate animals, 
however, must obtain vitamin A from their diet. Vitamin A (retinol) is a fat soluble 
vitamin and is absorbed from the gastrointestinal tract. The major sources 
of retinol in human diet are provitamin A carotenoids which can be obtained 
from fruits and vegetables, or retinyl esters (REs) found in animal source food 
[7]. Food with the highest concentration of REs in western countries are livers, 
fortified foods, milk, eggs or margarines. The highest concentration of provitamin 
A carotenoids can be found in carrots, pumpkin, spinach and kale [8]. In the 
intestinal lumen, carotenoids and REs are metabolized by endogenous enzymes 
secreted into the lumen to generate free retinol prior to absorption by enterocytes 
(subset of intestinal epithelial cells, Figure 1) [9-11]. Within enterocytes, retinol 
will be bound to cellular retinol binding protein 2 (CRBP2) [12]. The CRBP2-retinol 
complex serves as a substrate for the esterification process of retinol to REs by 
lecithin:retinol acyltransferase (LRAT) [13,14]. All formed REs are incorporated 
into chylomicrons or intestinal lipoproteins and then released into the lymphatic 
system [7,15,16] and the portal circulation [17] for transport to liver hepatocytes 
and stellate cells (Figure 1). The liver is the primary site of vitamin A storage, 
where vitamin A will be stored mainly in the form of REs in large cytoplasmic 
lipid droplets [18-22]. Liver stellate cells account for 80% of total body vitamin 
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A storage, while the remainder is stored in liver hepatocytes [18,23]. The liver 
regulates the availability of serum retinol to meet tissue requirements. Before 
REs are mobilized from their storage, REs are hydrolyzed into free retinol that 
will bind to serum retinol binding proteins (RBPs) for secretion from the liver, 
transport through the circulation and delivery to target cells (Figure 1) [24]. Since 
retinol is relatively hydrophobic, it requires protein binding to be effectively 
transported. Also, binding to RBPs prevents retinol from chemical and enzymatic 
degradation. In vitamin A sufficient animals, circulating levels of RBP-retinol are 
maintained at a constant level. These levels generally do not decline, except when 
hepatic stores of vitamin A are depleted. The levels also decrease in the setting 
of serious infections, however the regulation of serum retinol levels by the liver is 
not completely understood. 
Figure 1. Major pathway for vitamin A absorption and transport (adapted from [221]).
Dietary retinyl esters are hydrolyzed to retinol in the intestinal lumen. Retinol and carotenoids are absorbed by 
enterocytes and converted into retinyl esters to be packaged into chylomicrons. Chylomicrons are released into 
the lymph and subsequently reach the circulation. Chylomicrons are cleared from the blood by the liver, where 
retinyl esters are hydrolyzed to retinol in hepatocytes. Here retinol will be bound to retinol binding proteins for 
transfer to stellate cells where retinol can be stored in lipid droplets in the form of retinyl esters. Alternatively, 
retinol can be released into the circulation bound to retinol binding proteins for delivery of retinol to target 
cells. RE, retinyl ester; CM, chylomicron; RBP, retinol binding protein. 
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1.2 Retinol delivery to target cells
Target cells expressing a RBP receptor on the plasma membrane can recognize 
retinol-RBP complexes and mediate the cellular uptake of retinol from its complex. 
STRA6 is now described as a cell surface receptor for retinol-RBP complexes. 
STRA6 is a member of a large group of “stimulated by retinoic acid” (STRA) genes 
that encode transmembrane proteins and it specifically binds to retinol-RBP 
complexes to mediate retinol uptake from its complex into the cell (Figure 2) [25-
27]. RNAi knockdown of STRA6 in WiDr cells greatly diminished retinol uptake 
[25]. Consistent with the essential roles of vitamin A in human development, 
mutations in human STRA6 caused severe birth defects, reduced RBP binding and 
largely abolished vitamin A uptake activity [26,28,29]. STRA6 is widely expressed 
in the murine embryo and in the adult, yet STRA6 is undetectable (or is expressed 
at low levels) in some tissues that are highly responsive to retinoids like the skin 
or liver [29]. This suggests the existence of other RBP receptors that have yet to 
be discovered. 
1.3 Cellular retinoid binding proteins 
Various cellular retinoid binding proteins exist to solubilize and stabilize their 
hydrophobic and labile ligands in the aqueous milieu within cells. These binding 
proteins show high specificity and affinity for their specific retinoid ligands. 
In addition, cellular retinoid binding proteins have specific functions in the 
regulation of retinoid transport, metabolism and activity of retinoids [30] (Figure 
2). The cellular retinoid binding proteins include cellular retinol binding proteins 
(CRBPs) and cellular retinoic acid binding proteins (CRABPs) and belong to a family 
of cytosolic proteins binding small hydrophobic ligands [31,32]. In general, the 
cellular concentrations of CRBPs and CRABPs exceed the concentrations of their 
ligands. CRBPs are known to exist in 4 isoforms of which CRBP1 and CRBP2 are the 
most well-known retinol binding proteins. CRBP2 expression is almost exclusively 
restricted to adult intestines and is involved in absorption of retinol from the 
intestinal lumen [33-36]. CRBP1 is expressed in multiple extra-intestinal tissues 
and is involved in uptake of retinol from the circulation [30,37]. In addition, 
CRBPs are proposed to facilitate the metabolism of retinol, since enzymes like 
LRAT or alcohol dehydrogenases (ADHs) recognize the CRBP-retinol complex very 
efficiently, while the affinity of these enzymes for free retinol is much lower. CRBPs 
promote access of retinoids to some enzymes, while metabolism or catabolism by 
other enzymes is prevented. 
A second family of retinoid binding proteins is formed by the cytoplasmic cellular 
retinoic acid binding proteins (CRABPs). The general function of CRABPs is to allow 
access to enzymes for generation of retinoic acid and modulate the concentration 
of retinoic acid available to nuclear retinoid receptors [38]. Two isoforms, CRABP1 
and CRABP2, exist that are highly similar, displaying about 74% sequence identity, 
General introduction14
1
Figure 2. Intracellular vitamin A metabolic pathway.
Retinol is transported through the bloodstream by RBP. Cells expressing retinol-RBP binding receptors like 
STRA6 specifically bind RBP and mediate retinol uptake from the retinol-RBP complex into the cell. Within the 
cytoplasm, retinol forms a complex with CRBP and is subjected to conversion by ADH enzymes for metabolism 
of retinal. RALDH enzymes subsequently produce RA from the CRBP-retinal complex. RA is bound to either 
CRABP1 or CRABP2. CRABP1 functions by targeting RA to cytochrome P-450 CYP26 enzymes that degrade 
RA to inactive metabolites like 4-oxo-RA. CRABP2 undergoes rapid nuclear localization upon binding RA and 
delivers RA to its retinoic acid receptors (RARs and RXRs). These receptors bind to short DNA sequences in 
the vicinity of target genes known as RAREs. RA receptors act as transcription factors that will regulate the 
transcription of many target genes upon binding of RA. 
ADH, alcohol dehydrogenase; CRABP, cellular retinoic acid binding protein; CRBP, cellular retinol binding 
protein; RA, retinoic acid; RARE, retinoic acid response element; RALDH, retinaldehyde dehydrogenase;  RBP, 
retinol binding protein.
and are highly conserved between species. Yet, these isoforms display different 
patterns of expression across cells and have different specific functions. CRABP1 is 
almost ubiquitously expressed, while CRABP2 is more specific to certain cell types. 
CRABP1 is predominantly present in the cytoplasm and almost excluded from 
the nucleus. CRABP1 serves to target retinoic acid to cytochrome P-450 CYP26 
enzymes that degrade retinoic acid to inactive metabolites (Figure 2) [39,40]. 
Increased expression of CRABP1 leads to enhanced retinoic acid degradation rates 
[41]. CRABP1 binds retinoic acid with a 5-fold higher affinity than CRABP2 [38,42] 
and thus acts to decrease cellular retinoic acid concentrations and to diminish 
cellular responses to retinoic acid. CRABP2, a predominantly cytosolic protein, 
acts to deliver retinoic acid to the nucleus [43]. CRABP2 undergoes rapid nuclear 
localization upon retinoic acid binding and interacts with retinoic acid receptors 
(RARs) in a ligand-dependent fashion to deliver retinoic acid to its receptor for 
regulation of gene transcription (Figure 2) [44]. Overexpression of CRABP2, but not 
CRABP1, results in a marked stimulation of transcription of RAR-driven reporter 
genes [44-46]. Interestingly, cells that lack CRABP2 are not responsive to retinoic 
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acid [47,48], further corroborating that CRABP2, and not CRABP1, is responsible 
for delivery of retinoic acid to the nucleus. In conclusion, expression levels of 
CRBPs regulate retinol uptake and metabolism, while CRABPs control cellular 
retinoic acid concentrations and cellular responses to retinoic acid. Therefore, the 
expression levels of these binding proteins within cells are critically important for 
retinoid dependent signalling. 
1.4 Retinoic acid metabolism and catabolism
In order to fulfill its function vitamin A (retinol) must be metabolized to retinoic 
acid, the active form that can regulate gene expression by serving as a ligand 
for nuclear retinoic acid receptors. Retinol itself is inactive and does not bind to 
nuclear receptors. After cellular uptake, retinol, complexed with CRBP, is subjected 
to enzymatic metabolism. The major pathway of retinoic acid synthesis depends 
on two steps (Figure 2). In the first step, retinol is reversibly oxidized by alcohol 
dehydrogenases (ADH) to form retinaldehyde (retinal). Within the vertebrate ADH 
family, ADH1 and ADH4 have been demonstrated to metabolize retinol to retinal 
in both human and mouse [49-51]. In the second step, retinal is irreversibly 
metabolized to retinoic acid by retinaldehyde dehydrogenases (RALDH) [52-
54]. The vertebrate RALDH family consists of 16 distinct enzymes with RALDH1, 
RALDH2 and RALDH3 representing the three cytoplasmic enzymes producing 
retinoic acid from CRBP-retinal. RALDH1 through 3 are highly conserved between 
man and mouse. RALDH1 was the first enzyme found to oxidize retinal to retinoic 
acid in man, originally called ALDH1, as well as in mouse, originally called Ahd-2 
[55,56]. RALDH1 expression is found in a subset of retinoid-dependent embryonic 
tissues, as well as in many adult epithelia [57]. RALDH2 shares 72% sequence 
homology with RALDH1. The catalytic efficiency of RALDH2 for retinal oxidation 
is about 15-fold higher than that of RALDH1 [58,59]. RALDH2 expression occurs 
in many retinoid-dependent embryonic tissues and in adult reproductive organs 
[57]. RALDH3 was identified much later to be conserved between mouse and man 
and being able to metabolize retinoic acid from retinal [52]. All-trans retinoic 
acid is the most potent biologically active vitamin A metabolite produced by 
RALDH enzymes and can prevent and rescue the main defects caused by vitamin A 
deficiency in adult animals [60]. Other isoforms of retinoic acid are amongst others 
13-cis retinoic acid, specific for the eye, and 9-cis retinoic acid. The consideration 
of 9-cis retinoic acid as a natural bioactive metabolite remains controversial since 
9-cis retinoic acid has not been consistently detected in mammalian cells. 
Retinoic acid has a short half life in vivo and in vitro of about 6-7 hours [61,62]. 
Cytochrome P-450 enzymes are involved in the degradation of endogenous 
retinoic acid into inactive metabolites, like 4-oxo retinoic acid, to regulate cellular 
retinoic acid levels and to protect cells from excess retinoic acid [39,40,63,64]. 
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1.5 Transcriptional gene regulation by retinoic acid 
Once formed, the vitamin A metabolite retinoic acid serves as a ligand for nuclear 
retinoic acid receptors (RARs and RXRs) for regulation of target gene expression. 
Nuclear receptors are ligand-dependent transcription factors and regulate gene 
expression of specific subsets of genes by binding to short DNA sequences in 
the vicinity of target genes known as retinoic acid response elements (RAREs) 
[65]. Most identified RAREs have been found to be direct or inverted repeats 
of consensus sequence (A)GGTCA spaced by 1, 2 or 5 basepairs [66-69]. Three 
genes encoding highly related RARs have been identified in mouse and human, 
RARα [70,71], RARβ [72] and RARγ [73,74]. The RAR genes are mapped on 
different chromosomes [74]. All-trans retinoic acid as well as synthetic retinoic 
acid analogues are high-affinity ligands for these three RARs. Other retinoic 
acid isomers, like 9-cis retinoic acid, bind RARs with low affinity and specifically 
bind (with higher affinity) to RXRs. Three distinct RXR genes (RXRα, RXRβ, and 
RXRγ) have been found in mouse and man [75-77]. RARs and RXRs belong to two 
different groups of the nuclear receptor family, but both are involved in retinoid 
signalling. RARs have been studied intensively, but multiple questions about the 
actual biological role of RXRs have still to be answered.
At least one of the RARs has been found in every cell type examined, and sometimes 
two or three of the RARs are expressed in a given cell type. For high affinity 
binding to RARE sequences, RARs heterodimerize with RXRs, while homodimers of 
RARs can only bind RARE sequences at high protein concentration [78-80]. In the 
absence of RAR ligand, the RAR-RXR dimers recruit corepressor proteins (like NCoR, 
Figure 3. Schematic representation of retinoic acid receptor proteins (adapted from [79]).
Retinoic acid receptors (RARs and RXRs) have a well-defined domain organization and structure composed 
of six conserved regions, A to F. Regions C and E are the most conserved and important domains for 
transcriptional regulation of target genes. The C region contains the central DNA-binding domain (DBD) that 
recognizes retinoic acid response elements (RAREs) composed of (A)GGTCA repeats in the DNA of target genes. 
The E region contains the ligand-binding domain (LBD) for retinoic acid (RA). The ligand-binding pocket in the 
LBD contains hydrophobic residues and the shape of the ligand binding pocket matches the volume of the RA 
ligand. This maximizes hydrophobic contacts and contributes to the selectivity of ligand binding [222, 223]. 
The E region also contains a heterodimerization surface for pairing of RARs and RXRs and sites that interact 
with coregulators. The N-terminal domain (NTD) corresponds to regions A and B that interact with specific 
coregulators. The D region is considered to serve as a hinge between the DBD and the LBD, allowing rotation 
of the DBD. It also harbors nuclear localization signals. The F region, which is absent in RXRs, has multiple 
phosphorylation sites that might modulate RAR function, but the exact functions of this region remain poorly 
understood. NTD, N-terminal domain; DBD, DNA-binding domain; LBD, ligand-binding domain. 
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SMRT, HDACs) that lead to an inactive condensed chromatin structure, preventing 
transcription. When retinoic acid binds to RAR-RXR dimers, corepressors are 
released and coactivator complexes (amongst others histone acetyltransferases 
or methyl transferases) are recruited to activate gene transcription [81] (Figure 
3). RARs have a well-defined domain organization and structure, consisting of a 
central DNA binding domain linked to a C-terminal ligand-binding domain (LBD) 
and an N-terminal domain, which interacts with specific coregulators [82] (Figure 
3). Degradation of RARs by the ubiquitin-proteasome controls the magnitude and 
duration of the retinoid response [83-85]. 
A large number of the retinoic acid-responsive genes encodes proteins that 
participate in the metabolic pathway of vitamin A. For instance, all three RAR 
genes contain a RARE site in their promoters [67,86-88]. Retinoic acid also 
regulates expression levels of CRBP1 and CRBP2 [89,90], LRAT [91,92] as well 
as CRABP2 [68,93]. We and others have demonstrated that the RALDH2 gene is 
also responsive to retinoic acid [58,94,95] (see chapter 4). Furthermore, retinoic 
acid induces its own catabolism by inducing CYP26 transcription [96]. In this 
way cellular retinol uptake is maintained by inducing CRBP, but retinoic acid 
concentrations are limited by accelerating its catabolism and preventing cellular 
retinoic acid toxicity. retinoic acid itself therefore functions as a regulator of its 
own synthesis and catabolism creating an autoregulatory loop.
Table 1. Players in retinoic acid-dependent signalling
Functions
Ligand All-trans retinoic acid Active vitamin A metabolite
Receptor specificity
Cell-specific synthesis
Binding proteins RBP Transport, Metabolism, Sequestration
CRBP1 and CRBP2
CRABP1 and CRABP2
Nuclear receptors RARα, RARβ, RARγ Transcription factors
RXRα, RXRβ, RXRγ DNA-binding
Ligand, cell and promoter specific 
activity
Receptor dimers RAR/RXR Combinatorial diversity
Response elements RARE and RXRE Regulation gene transcription
Direct or inverted Activation or repression
repeats of (A)GGTCA
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2. Global prevalence and intervention of vitamin A deficiency
The importance of vitamin A can clearly be inferred from situations of vitamin A 
deficiency where epithelial integrity, growth and immunity are impaired. Vitamin 
A deficiency weakens the host defense against infection, causing increases in the 
incidence and severity of infections and ultimately elevates the risk of mortality in 
early childhood [97,98]. Vitamin A deficiency contributes to the deaths of over a 
million children each year, especially from measles, diarrhea and malaria [99,100]. 
The most recent estimates from the World Health Organization report that in 
developing countries about 190 million preschool children (~32%) and nearly 20 
million pregnant mothers (~10%) are vitamin A deficient (Figure 4) [3]. Improving 
the vitamin A status of young children in developing countries has been shown to 
reduce child death rates by 20–50%, which suggests that a substantial portion of 
their mortality is attributable to vitamin A deficiency [101].
Vitamin A deficiency is defined when liver stores of vitamin A fall below 20 µg/g 
(0.07 µmol/g) and serum retinol levels below 20 µg/dL (0.70 µmol/L)  [102,103]. 
Under normal conditions, serum retinol levels are 1-3 µmol/L. As vitamin A 
status declines physiological functions become impaired. Initially, the integrity of 
epithelial barriers (surface linings of the gastrointestinal, respiratory, excretory 
and reproductive systems) is disturbed and the immune system becomes 
compromised, followed by impairment of the visual system. Consequently, 
there is progression to total blindness, increased severity of infections and an 
increased risk of death, especially among children. Other clinical signs of vitamin 
A deficiency include growth retardation and anemia [100,104].
The underlying cause of vitamin A deficiency is inadequate consumption of 
vitamin A rich foods which is related to poverty. In general, young children in 
industrialized countries receive most of their vitamin A from animal source 
food, whereas provitamin A in fruits and vegetables is the primary source of 
dietary vitamin A for children in underdeveloped countries [101,105]. Due to 
poverty, people turn to low priced food of lower quality and variety, which limits 
consumption of vitamin A rich foods [3]. This becomes evident when physiological 
needs are greatest, namely during early childhood, pregnancy, and lactation. 
Vitamin A deficiency in children is initially caused by the fact that their mothers 
are deficient and produce breast milk with very low concentrations of vitamin A 
[101]. Generally, all newborn children are physiologically vitamin A “depleted” at 
birth and need to build up adequate vitamin A stores in their livers. Breast fed 
babies of vitamin A-deficient women therefore remain depleted. Furthermore, 
if these children receive food after breast feeding that is also low in vitamin A, 
the child’s risk for developing vitamin A deficiency further increases when breast 
feeding stops. A third contributing factor is that they spend a substantial part 
of childhood being sick, suffering from diarrhea and infections. These illnesses 
involve loss of appetite and malabsorption of nutrients, which further deteriorate 
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their vitamin A status [101]. 
Young children in developing countries cannot build up adequate liver vitamin 
A stores in the liver from plant diets alone, since dietary intake is too low. The 
efficiency with which plant-derived provitamin A can be converted into vitamin A 
is much lower than that for preformed vitamin A in animal source foods [105]. To 
overcome or prevent vitamin A deficiency, consuming modest amounts of animal 
or fortified food sources of preformed vitamin A or vitamin A supplementation is 
required. The first randomized trial of vitamin A supplementation was started in 
1986 in Indonesia, after which it was repeated in other populations in the late 80s 
and early 90s [2]. These trials demonstrated a clinically and statistically significant 
reduction (~29-54%) in mortality among children from 6 months to 5 years of 
age [2]. By 1992, consensus was reached that vitamin A deficiency increased 
overall mortality and improving vitamin A status would reduce this. Vitamin A 
supplementation is a very effective approach to increase vitamin A intake and 
is being developed to correct vitamin A deficiency worldwide. The World Health 
Organization (WHO) recommends children to receive a defined dose of vitamin A 
once every four to six months. The great majority (78%) of countries where vitamin 
A deficiency is known to be a major public health problem have adopted this 
policy and vitamin A supplementation of children has been successfully integrated 
into routine maternal child health visits, or is often linked to community-based 
nutrition improvement programs like National Immunization Days or Vitamin 
A week [2]. Other effective means to control and prevent widespread vitamin A 
deficiency are fortification of foods with vitamin A and supplementing pregnant 
Figure 4. Global prevalence of vitamin A deficiency 
This map displays the prevalence of vitamin A deficiency (VAD) worldwide (from WHO Global database on 
vitamin A deficiency). Mainly in underdeveloped countries, vitamin A deficiency poses a major public health 
problem. Vitamin A deficiency is categorized in clinical (red) to severe (orange), moderate (yellow,) and mild 
(light green) subclinical symptoms in individuals. Vitamin A deficiency is under control  in western countries 
(green). 
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mothers with vitamin A resulting in improved health of the mothers and increased 
vitamin A levels in breast milk. This subsequently will reduce childhood mortality 
[100,106-108]. 
In conclusion, the prevention of vitamin A deficiency remains a global public health 
priority. With the continuation of present supplementation programs, clinical 
vitamin A deficiency may be eliminated in many parts of the world in the coming 
years. Nevertheless, many children will remain affected by sub-clinical vitamin 
A deficiency. Therefore, it will be necessary to pursue intervention programs to 
allow long-term control of vitamin A deficiency and improve health and nutritional 
status in developing countries. Although vitamin A supplementation has taken its 
place as a major health intervention, it is still not precisely known how it improves 
health and the immune system and increases resistance to infection. Research has 
now focused on the protective mechanisms of vitamin A to provide more insights 
into the role of vitamin A in immune function. 
Box 1. Hypervitaminosis 
Worldwide the incidence of vitamin A excess, or hypervitaminosis A, is a very minor problem 
compared with the incidence of vitamin A deficiency. A few hundred cases of hypervitaminosis 
A occur annually whereas an estimated 1 million people develop vitamin A deficiency each 
year. However, vitamin A toxicity may be a growing concern because intake from preformed 
sources of vitamin A often exceeds the recommended dietary allowances (RDA) [109]. 
Assessing vitamin A status in persons with vitamin A toxicity is difficult since serum retinol 
levels are tightly regulated and are therefore inadequate indicators of liver vitamin A stores 
[109]. Hypervitaminosis A may result from excessive consumption of animal source food or 
overconsumption of vitamin A supplements and can be divided into two categories: acute, 
resulting from ingestion of a very high dose over a short period of time, and chronic, resulting 
from continued ingestion of high doses for months or even years. 
Typical symptoms of acute hypervitaminosis A include bulging fontanels in infants, headache 
due to increased intracranial pressure in adults, nausea, vomiting, fever, vertigo, hemorrhages, 
joint pains, and visual disorientation [110-112]. The symptoms are generally transient and do 
not lead to permanent adverse effects. 
Chronic hypervitaminosis A is more common than acute hypervitaminosis A. Its symptoms 
are highly variable but anorexia, skin problems, loss of hair, increased intracranial pressure, 
and hepatomegaly are among the most common symptoms [110-112]. Osteoporosis and 
hip fractures have now also been associated with chronic overcomsumption of vitamin A of 
only twice the RDA [113-115]. This involves hypercalcemia, increased bone resorption and 
decreased bone formation [116-118]. Moreover, excessive intake of vitamin A by pregnant 
women can cause abnormal morphological development and birth defects in the newborn 
child [111,119].
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3. The mucosal immune system 
The intestinal immune system has to be non-responsive and be able to induce 
tolerance towards harmless food antigens and the commensal microflora, while 
robust immune responses are needed towards harmful pathogens. Maintenance 
of this critical balance is attributed to mucosal dendritic cells (DCs) residing 
in gut-associated lymphoid tissues, like Peyers’ Patches (PPs) and mesenteric 
lymph nodes (MLNs), and in the subepithelial lamina propria of the intestines. 
Dysregulation of this balance results in uncontrolled inflammatory disorders 
such as inflammatory bowel diseases in humans. Many studies have shown the 
beneficial effect of vitamin A on the mucosal immune system and research now 
concentrates on the mechanisms by which vitamin A and its metabolite retinoic 
acid maintain intestinal homeostasis.
3.1 Lymphocyte subsets and retinoic acid
Th1 versus Th2 cells
Naïve CD4+ T cells, produced in the thymus, can become Th1, Th2 or Th17 cells, 
which act as effector/memory cells to stimulate the immune system to clear 
pathogens and tumor cells, or can become regulatory T cells which function 
to suppress the immune system. The subset of T cells termed Th1 cells, which 
produce interleukin-2 (IL-2), interferon-γ (IFNγ) and lymphotoxin, are in particular 
important for immunity against intracellular pathogens, such as Leishmania Major. 
By their production of IFNγ, they deliver assistance to macrophages for enhanced 
pathogen clearance. In contrast, Th2 cells produce IL-4, IL-5, IL-10 and IL-13, which 
contributes to the direct enhancement of antibody-mediated immunity against 
extracellular pathogens. Dietary vitamin A has been shown to affect Th1 and Th2 
development as vitamin A deficiency causes IFNγ overproduction and shifts the 
immune response toward a Th1-type response and impairs the development of 
a Th2-type response [120,121]. On the other hand, high-level dietary vitamin A 
enhances Th2 cytokine and decreases Th1 cytokine production [122]. Moreover, 
it was shown that the vitamin A metabolite retinoic acid directly skews T cells 
upon their activation towards the Th2-type profile, while inhibiting Th1 cytokine 
production [123,124]. Via RAR signalling, retinoic acid can directly suppress IFNγ 
production and enhance IL-4 production in stimulated T cells in vitro. Specific 
blockade of RAR, and not RXR, further confirmed the crucial involvement of RAR 
signalling in retinoic acid-mediated Th2 skewing [124]. Therefore, the balance of 
Th1 and Th2 responses is highly dependent on vitamin A status.
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FoxP3 expressing regulatory T cells
In addition to Th1 and Th2 cells, regulatory T cell (Treg cells), identified by FoxP3 
expression, are an essential component of the immune system. Treg cells function 
to induce tolerance to harmless food antigens or commensal bacteria and prevent 
escalation of immune responses. FoxP3+ Treg cells are made in the thymus from 
progenitors. In addition, immunization through the oral route results in the 
induction of Treg cells from naïve CD4+ T cells in peripheral lymphoid organs 
[125-128]. 
The cytokine milieu is very important in the induction of FoxP3+ Treg cells. TGFβ 
and IL-2 are well known for their role in the induction and maintenance of FoxP3+ 
Treg cells [129-131]. More recently, retinoic acid was identified as a cofactor that 
controls peripheral induction of FoxP3+ Treg cells in mice [123,132-138]. Retinoic 
acid, in combination with TGFβ, is very effective in inducing FoxP3 expression in 
murine CD4+ as well as murine CD8+ T cells, while this induction could be blocked 
with RAR antagonists or neutralizing anti-TGFβ antibodies [135-138]. In contrast 
to the induction of Treg cells in mice, TGFβ is dispensable for human Treg cell 
conversion. Retinoic acid alone was shown to be sufficient to convert human naïve 
T cells into FoxP3+ Treg cells [135]. 
The mechanism by which retinoic acid regulates human naïve T cells to convert 
to Treg cells occurs at multiple levels. By binding to the RARE site in the promoter 
region of Foxp3, retinoic acid induces histone acetylation in the human FoxP3 
promoter [135,139], which is thought to open the promoter for enhanced 
transcription of the FoxP3 gene. In addition, retinoic acid enhances FoxP3 
induction indirectly by relieving inhibition from CD4+ CD44+ effector/memory 
T cells [134], through reducing the production of inflammatory cytokines [134]. 
Further proof for the role of retinoic acid in the generation of FoxP3+ Treg cells in 
mice has come from studies in which either retinoic acid or RAR antagonists were 
administered [135,136]. While administration of retinoic acid during antigenic 
stimulation resulted in an increase in Treg conversion [135,136], blockade of RAR 
signalling decreased the generation of FoxP3+ Treg cells [136]. 
Th17 cells
More recently, a subset of inflammatory T cells named Th17 has been identified 
[140-142]. Th17 cells secrete IL-17, IL-21, and IL-22 [143-145] and have an 
important role in protecting the host from bacterial and fungal infections, 
particularly at mucosal surfaces. IL-23, IL-6 and TGFβ promote the differentiation 
of naïve T cells into Th17 cells [146-149] and are under the control of the 
transcription factor RORγt [150]. Since both Th17 and Treg cells are dependent 
on TGF-β as an inductive cytokine controlling their development, the levels 
of IL-6 become important. It has been shown that retinoic acid can directly 
counteract the IL-6 effect in a dose-dependent manner and that it reduces the 
expression of RORγt in T cells activated under Th17 culture conditions [136]. 
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B lymphocytes
Retinoic acid is also physiologically important for immunoglobulin secretion by B 
cells. IgA is the most abundant immunoglobulin isotype produced in the body and 
serves to protect the host against the vast array of microbes constantly present 
in the intestinal lumen. Mice with defective or impaired IgA production are more 
susceptible for intestinal pathogens [153]. 
PPs and MLNs are the main secondary lymphoid tissues where naïve B cells will 
differentiate into IgA secreting plasma cells. Subsequently, these IgA producing B 
cells will migrate from MLNs and PPs to the lamina propria of the intestine where 
IgA is secreted into the lumen as part of the antimicrobial defense [154,155]. It has 
been shown that DCs from PPs, but not from spleen, promoted immunoglobulin 
class switching to the IgA isotype in activated B cells [156]. Furthermore, in the 
presence of retinoic acid, B cells displayed increased class switching to the IgA 
isotype [157] and IgA class switching induced by PP-DCs, MLN-DCs or lamina 
Figure 5. Retinoic acid synthesis 
by dendritic cells and its effects on 
lymphocytes.
Through the expression of ADH and 
RALDH enzymes, mucosal dendritic cells 
can produce retinoic acid from vitamin A. 
Retinoic acid acts on T cells and B cells by 
inducing the mucosal homing receptors 
a4b7 and CCR9. Moreover, retinoic 
acid in the presence of TGFb promotes 
the conversion of naïve T cells into 
Foxp3+ regulatory T cells and inhibits the 
differentiation of Th17 cells. In addition, 
retinoic acid synergizes with IL-6 and IL-5 
and promotes class switching to IgA in B 
cells. 
Whether inflammatory Th17 cells or suppressive FoxP3+ T cells are generated 
largely depends on the local cytokine milieu formed by IL-6, TGFβ and retinoic 
acid (Figure 5). Under physiological conditions, the retinoic acid-driven, TGFβ-
dependent Treg cell conversion might overrule the IL-6–driven TGFβ-dependent 
Th17 cell differentiation [136], while appropriate concentrations of TGF-β and IL-
6, IL-21, and IL-23 might skew T cells towards Th17 development [146,151,152]. 
It is now well established that retinoic acid is very important for the generation of 
these T cell subsets, either by promoting or blocking the differentiation of naïve 
T cells into Th1, Th2, Th17 or Treg cells. 
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propria DCs was diminished in the presence of RAR inhibitors [158-160]. 
Consistently, animals depleted of vitamin A show decreased IgA secretion and 
decreased mucosal antigen-specific IgA responses [159,161,162], while studies 
with high dietary vitamin A showed that IgA responses and IL-10 production were 
significantly enhanced [122]. Thus, retinoic acid has a direct IgA promoting effect 
on B cells which seems to be disturbed during vitamin A deficiency.
3.2 Immunomodulatory role of retinoic acid
Tissue-specific lymphocyte migration
It is well recognized that DCs play a central role in the priming and differentiation 
of naïve T cells into Th1, Th2, Th17 or regulatory T cells. Also, DCs can imprint 
trafficking programs in T cells that target their migration to specific peripheral 
tissues by the induction of specific combinations of adhesion molecules and 
chemokine receptors. Within the periphery, DCs acquire antigens from their 
surroundings, process it, and display the processed antigen on their surfaces 
using major histocompatibility class I or II molecules. When DCs arrive at the gut-
draining MLN, they expose naive T cells to antigen and initiate T cell activation and 
proliferation, either inducing effector/memory T cells or tolerogenic regulatory T 
cells depending on the nature of the antigen. Upon activation by DCs, T cells 
are induced to express adhesion molecules and chemokine receptors to ensure 
that activated T cells will preferentially migrate to the site where DCs initially 
encountered the antigen [163-167]. 
The induction of tissue-specific homing mlecules upon lymphocyte activation 
within the draining lymph nodes enhances the efficiency by which effector 
lymphocytes will arrive at the site where their action is needed. Studies have 
shown that DCs from gut-associated lymphoid tissue (GALT), like MLN-DCs, PP-
DCs or lamina propria DCs, have a selective ability to induce homing receptors 
on activated T cells specific for migration to the intestines, i.e. integrin α4β7 and 
chemokine receptor CCR9 [166,168-172]. Homing of IgA secreting plasma cells 
to the intestinal lamina propria is also mediated by α4β7 and CCR9 molecules 
[154,173,174]. 
The ligand for α4β7, mucosal addressin cell adhesion molecule-1 (MAdCAM-1), 
is expressed on endothelial cells in the lamina propria of the colon and small 
intestine [175-177], while CCL25, the ligand for CCR9, is produced by epithelial 
cells of the small intestine [178-183]. DCs in skin-draining lymph nodes or splenic 
DCs are unable to imprint gut homing molecules but instead induce skin-homing 
molecules on responding T cells. This imprinting results in the expression of 
the skin-homing molecules E- and P-selectin ligands as well as the chemokine 
receptors CCR4 and CCR10 on activated T cells [163,165,166,184-186]. 
Expression of these two chemokine receptors enables T cells to respond to CCL17 
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and CCL27 expressed by keratinocytes in the skin [187]. By expression of tissue-
specific homing molecules, migration of effector/memory T cells and B cells to 
peripheral tissues is ensured. 
Retinoic acid-dependent imprinting of gut-homing molecules
In 2004, it was discovered by Iwata et al. that the vitamin A metabolite retinoic 
acid directly affects gut-homing molecule expression on T cells. Gut-homing 
molecules α4β7 and CCR9 could easily be induced on both CD4
+ and CD8+ T 
cells in vitro when they were activated in the presence of  retinoic acid [4]. Upon 
activation in the absence of retinoic acid, T cells expressed skin-specific homing 
molecules E- and P-selectin ligands, which were downregulated when retinoic 
acid was present [4]. In addition, the induction of α4β7 and CCR9 expression by 
activated B cells also requires retinoic acid [159]. Experiments with transgenic 
T cells from luciferase reporter mice, in which luciferase activity is under the 
control of a promoter with RARE sites, furthermore showed that the induction of 
CCR9 required signalling of retinoic acid through its nuclear receptors and CCR9 
induction was indeed blocked by the presence of a pan-RAR antagonist [188]. 
Further proof for the importance of vitamin A in the imprinting of lymphocytes 
with gut tropism came from studies with vitamin A deficient mice, in which 
secondary lymphoid organs as well as the intestinal lamina propria were depleted 
of α4β7
+ CD4+ T cells and α4β7
+ B cells [4,159]. Thus, the vitamin A metabolite 
retinoic acid appears to be a key molecules for controlling lymphocyte homing to 
the intestines. 
Mucosal dendritic cells
Expression of α4β7 and CCR9 molecules on activated T cells is specifically induced 
by MLN-DCs, PP-DCs or lamina propria DCs, but not by PLN-DCs or splenic DCs 
[168,169,189]. Additionally, these GALT-DCs are very efficient at inducing FoxP3+ 
Treg cells, while splenic DCs are unable to induce Treg cells [133,135,138]. As 
described above, induction of gut-homing molecules and FoxP3+ expressing Treg 
cells requires retinoic acid and thus DCs associated with the mucosal immune 
system must be especially well equipped to steer these processes. Indeed, GALT-
DCs were shown to express vitamin A metabolizing RALDH enzymes [4] and 
are thus able to produce retinoic acid (Figure 5). The enzyme RALDH2 has been 
described to be the most abundantly expressed vitamin A converting enzyme in 
MLN-DCs [133,190], while PP-DCs highly express RALDH1[4]. And since splenic 
and PLN-DCs only display very low expression levels of these enzymes [4,133,191], 
RALDH expression seems to be a special feature of DCs that are associated with 
the mucosal immune system. 
To identify which DC subset within gut-associated lymphoid tissues is responsible 
for regulation of gut-tropic T cells, DCs were sorted from PP and MLN based on 
the expression of conventional DC markers CD8, B220 and CD11b. Yet all DC 
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subsets were found to induce gut-homing molecules α4β7 and CCR9 on T cells 
[168,185]. This would suggest that all DCs within gut-associated lymphoid 
tissues are equally efficient at generating gut-tropic T cells. However, recently a 
distinct subset of DCs, based on the expression of CD103, has been identified 
in murine MLNs that represent ~50% of total MLN-DCs and are more efficient 
at inducing gut-tropic T cells compared to their CD103- counterparts [192,193]. 
These DCs express RALDH enzymes at higher levels when compared to CD103- 
MLN-DCs and are better at inducing retinoic acid receptor-dependent signalling 
in T cells [133,188]. Consequently, induction of gut-homing molecule expression 
on activated T cells and FoxP3+ Treg cell differentiation by CD103+ MLN-DCs is 
enhanced when compared to T cell priming by CD103- MLN-DCs [133,192,193]. A 
CD103+ DC subset with similar characteristics has also been identified in human 
MLNs [194,195]. 
Also a CD103+ DC subset resides within the small intestinal lamina propria that 
displays similar properties as the CD103+ DCs in MLNs [138]. This suggests that 
the CD103+ MLN-DCs represent a population of migratory DCs derived from the 
intestinal lamina propria. Studies have shown that indeed CD103+ DCs can be 
detected in lymph vessels draining the mesenteries [196] and can transport orally 
derived antigen from the intestine to the draining MLN. Within these LNs, CD103+ 
DCs will induce gut-tropic T cells and regulatory T cells upon their activation 
[138,193,195]. That indeed CD103+ MLN-DCs are derived from the intestinal 
lamina propria was shown in CCR7–/– mice [193]. CCR7 is required for DC migration 
from tissues to draining LNs and in the absence of CCR7, the numbers of CD103+ 
DCs were strongly reduced in the MLN.
Within the mucosal immune system additional cells express RALDH enzymes. 
Intestinal epithelial cells lining the gut are known to highly express RALDH1 [4,197] 
and these cells have been shown to produce retinoic acid from dietary vitamin A 
in vitro [198-200]. Furthermore, stromal cells from MLNs express retinoic acid 
metabolizing enzymes, and in vitro cultured MLN stromal cells can directly induce 
gut-homing molecule expression on activated T cells [191,201]. Thus, within the 
intestines and GALT, multiple cell types exist that express vitamin A metabolizing 
enzymes and thus produce retinoic acid, which is crucial for the maintenance and 
functioning of the mucosal microenvironment.
3.3 Differentiation of mucosal DCs
As described above, GALT-DCs, in particular the CD103+ subset, are able 
to produce retinoic acid, which enables them to preferentially promote Th2 
differentiation [202-204], gut-homing molecule expression and Treg cell 
conversion [133,135,138,168,189,194]. Therefore, RALDH expression by 
GALT-DCs is crucial for their retinoic acid producing capacity. The differential 
expression of RALDH enzymes by GALT-DCs, and not by splenic or PLN-DCs, 
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suggests a role for the mucosal environment in the induction and regulation of 
RALDH enzyme expression by DCs. Epithelial cells (ECs) are ideal candidates to 
educate mucosal DCs. Intestinal epithelial cells express E-cadherin, which is the 
ligand for CD103, on the basolateral surface of the cell [205,206]. This may allow 
cell-cell contact between intestinal DCs and the epithelial cells (Figure 6). In fact, 
CD103 has been reported to be induced under the influence of TGFβ, which can be 
produced by epithelial cells [207,208]. And thus, CD103 expression by DCs in the 
intestinal lamina propria could therefore be seen as a signature of their interaction 
Figure 6. DC conditioning by the mucosal microenvironment.
The functional properties of intestinal dendritic cells (DCs) are imprinted within the intestinal environment. 
Epithelial cells (ECs) are ideal candidates to condition mucosal DCs. These cells express E-cadherin on the 
basolateral surface of the cell [205, 206], which is the ligand for CD103 expressed by most mucosal DCs. 
Expression of these molecules allows cell-cell contact between mucosal DCs and intestinal epithelial cells. 
Intestinal epithelial cells, but possibly also other cell types present within the intestines, produce imprinting 
factors for the differentiation of mucosal DCs from blood-derived precursors. Retinoic acid (RA), transforming 
growth factor-b (TGFb), thymic stromal lymphopoietin (TSLP), IL-10, as well as GM-CSF, IL-13, and IL-4 are 
imprinting factors involved in conditioning of these DCs. These factors condition DCs to express RALDH2 
enzymes. Conditioned DCs downregulate IL-12 and IL-23 production and enhance production of RA, IL-10 and 
TGFb. In addition, signals through PRRs expressed by DCs and intestinal epithelial cells possibly contribute 
to mucosal imprinting of CD103+ lamina propria DCs by inducing RALDH enzyme expression in mucosal DCs 
or the production of imprinting factors by intestinal epithelial cells. Conditioned CD103+ lamina propria DCs 
preferentially drive Th2-type and regulatory T cell responses and efficiently induce gut-homing molecules on 
lymphocytes.
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with intestinal epithelial cells. Furthermore, in vitro experiments showed that 
contact with gut epithelial cells induces CD103 expression and RALDH enzyme 
expression in bone marrow- and monocyte-derived DCs. In addition, intestinal 
epithelial cells educated DCs to induce Th2 cell polarization as well as gut-homing 
molecule expression on activated T cells [94,194,204,209]. Also, conditioning 
by intestinal epithelial cells promoted DCs to drive the development of Foxp3+ 
Treg cells [94,194]. Factors that have been described to influence mucosal DC 
differentiation and that might be produced by intestinal epithelial cells, but 
possibly also by other cell types present within the intestines, are retinoic acid, 
TGFb, thymic stromal lymphopoietin (TSLP), IL-10, as well as GM-CSF, IL-13, and 
IL-4. Of these factors, retinoic acid and GM-CSF plus IL-4 have been shown to 
induce RALDH expression in DCs (Figure 6).  
A similar tissue-specific imprinting mechanism by peripheral tissue cells was 
shown for the skin. In coculture with dermal fibroblasts, DCs were imprinted to 
induce the expression of the skin-specific homing molecule E-selectin ligand on 
activated T cells [209]. Thus, it is thought that tissue-derived DCs, which develop 
from circulating DC precursors, acquire their tissue-specific imprinting capacity 
after having entered the tissue microenvironment. 
In addition to the exposure to intestinal imprinting factors, DCs come in contact 
with pathogens present within the intestinal lumen via their pattern recognition 
receptors (PRRs). This interaction may additionally influence the mucosal phenotype 
of DCs in the intestinal lamina propria. It has been shown with in vitro stimulated 
bone marrow-derived DCs that RALDH2 mRNA expression increases upon TLR5 
stimulation with flagellin or upon TLR2 stimulation with zymosan [160,210]. It 
is therefore possible that in the intestine also TLR-mediated signals or signals 
through other PPRs contribute to mucosal imprinting and RALDH expression in 
CD103+ lamina propria DCs. The literature indicates, however, that DCs, which 
are exposed to intestinal factors, express lower TLR levels and are thus less well 
able to respond to TLR ligands [133,211-213].
3.4 Retinoic acid in lymph node development
It has been known for a long time that retinoic acid is an important player in 
embryonic organogenesis (reviewed in [214]). Recently, it has been demonstrated 
that retinoic acid also plays a role in lymph node development [215]. 
Development of secondary lymphoid organs like PPs and MLNs involves clustering 
of hematopoietic lymphoid tissue–inducer (LTi) cells, characterized as CD4+ CD3- 
IL-7Rα+, with VCAM+ stromal organizer cells [216-218]. Subsequently, triggering 
of the lymphotoxin-β receptor (LTβR) on stromal organizer cells by lymphotoxin-αβ 
(LTαβ) on LTi cells [219] causes stromal organizer cells to synthesize chemokines 
and adhesion molecules that attract and retain more LTi cells [220]. This initiates 
a chain of events that involves further accumulation and signalling of LTi cells and 
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the organization of cell clusters to the complete development of the LN. Recently 
it was shown that the very first clustering of LTi cells and stromal organizer cells is 
controlled by the production of CXCL13 [215]. Retinoic acid was shown to be the 
inducing factor for CXCL13 expression in stromal cells and neurons adjacent to 
the location of lymph node development most likely are the providers of retinoic 
acid during LN development, because of their expression of RALDH enzymes 
[215]. These studies demonstrate that not only retinoic acid is crucial for mucosal 
immune homeostasis in adults, but also that retinoic acid is essential for the 
formation of the immune system during embryonic development. 
The mucosal immune system must remain silent to harmless antigens while allowing 
vigorous immune responses towards harmful pathogens. It is now becoming clear 
that vitamin A plays a crucial role in maintaining immune homeostasis since the 
vitamin A metabolite retinoic acid is essential in multiple immunological process 
like the balance of Treg cells versus Th17 cells, epithelial barrier function, mucosal 
DC differention and gut-homing of T cells and IgA+ B cells. In order to maintain the 
mucosal microenvironment and its immune balance, it is therefore of importance 
to learn how RALDH levels within the mucosal immune system are regulated and 
may be manipulated to correct dysregulation of immune homeostasis.
4. Thesis outline
Vitamin A plays an important role in maintaining mucosal immune homeostasis. 
Dysregulation of this balance, for instance by impaired vitamin A metabolism 
or vitamin A deficiency results in the development uncontrolled inflammatory 
conditions. The studies described in this thesis focus on the different cell types 
involved in maintainance of the mucosal microenvironment and immune balance. 
Furthermore, the effects of vitamin A deficiency and differences in vitamin A 
metabolism on the mucosal immune system in health and disease were addressed.
Chapter 2 describes the role of the LN microenvironment in providing signals for 
T cell tropism. Gut or skin draining LNs were transplanted into the popliteal fossa, 
so that DCs entering these LNs are bringing in antigen from the same peripheral 
site. These transplantations show that the microenvironment of mucosal MLNs 
and not peripheral LNs (PLNs), supports the induction of α4β7, but not CCR9, on T 
cells upon their activation. Furthermore, MLN stromal cells showed expression of 
vitamin A converting enzymes allowing production of retinoic acid by these cells. 
While in vitro cultured MLN stromal cells were able to induce gut-homing tropism 
on activated T cells directly, addition of RALDH-low unpulsed bone marrow-
derived DCs (BM-DCs) strongly enhanced the expression of gut-homing molecules 
α4β7 and CCR9. These results demonstrate a crucial role for MLN stromal cells 
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in creating an instructive mucosal microenvironment in lymph nodes and that 
stromal cells, DCs and lymphocytes cooperate for efficient differential imprinting 
of tissue tropism. 
Chapter 3 deals with the capacity of the peripheral tissue microenvironment to 
imprint DCs in such a way that they can induce skin and small intestine homing 
receptors on activated T cells. Upon activation by antigen-pulsed BM-DCs, CD8+ 
T cells up-regulated the skin homing receptor E-selectin ligand when co-cultured 
with dermal fibroblasts and gut homing receptors CCR9 and α4β7 when co-cultured 
with small intestinal epithelial cells. Soluble factors, such as retinoic acid, as 
well as cell-cell contact were essential for the induced tissue tropism imprinting 
capacity of DCs. This shows that peripheral tissue stromal and epithelial cells 
produce factors that license DC to induce tissue-specific homing receptors and 
thereby transmit information about their tissue of origin and the site of antigen 
capture to T cells. 
In chapter 4, we have investigated how the expression of RALDH enzymes in MLN-
DCs and MLN stromal cells is regulated postnatally. Studies with Trif mutant and 
MyD88-/- animals demonstrated that expression and activity of RALDH enzymes 
in MLN-DCs is independent of TLR signalling. On the contrary, dietary vitamin A 
appeared to be crucial for RALDH expression in MLN-DCs and MLN stromal cells. 
Furthermore, retinoic acid directly regulated the level of RALDH expression in BM-
DCs as well as lymph node stromal cells, thereby regulating RALDH expression 
within the mucosal immune system and consequently maintaining mucosal 
immune homeostasis. These data establish that dietary vitamin A plays a crucial 
role in proper functioning of the mucosal immune system. 
C57BL/6 and BALB/c mice are known as prototypical Th1- and Th2-type mice 
respectively, and retinoic acid has been described to skew T cells upon their 
activation towards the Th2-type profile. In chapter 5 of this thesis, we therefore 
investigated whether C57BL/6 and BALB/c mice differ in their capacity to 
produce retinoic acid. We demonstrated that BALB/c mice expressed higher 
levels of RALDH enzymes and had more retinoic acid-mediated signalling in the 
intestines. Consequently, MLN-DCs displayed higher RALDH activity, which led 
to increased induction of gut-homing molecule expression on CD4+ T cells and 
FoxP3+ regulatory T cells. The enhanced capacity to induce gut-homing molecules 
correlated with an increased accumulation of T cells and B cells in BALB/c small 
intestines when compared to C57BL/6 small intestines. Also, secretion of IgA into 
the lumen of the small intestines was higher in BALB/c mice when compared to 
C57BL/6 mice. Thus, these studies showed that the enhanced ability to convert 
vitamin A results in a better developed mucosal immune system.
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In chapter 6, we investigated whether the differences in retinoic acid production 
and retinoic acid receptor signalling observed in BALB/c and C57BL/6 mice could 
be correlated with the severity of inflammatory disease such as colitis. BALB/c 
mice suffered from less severe DSS colitis compared to C57BL/6 mice and 
recovered more quickly. During colitis, BALB/c mice showed an increased ability 
to form tertiary lymphoid tissue, which could contribute to IgA production and 
increased numbers of regulatory T cells. Retinoic acid has numerous beneficial 
effects on the mucosal immune system implicating that an increase in retinoic 
acid signalling could potentially improve the outcome of inflammatory disease 
and recovery from inflammation in BALB/c mice compared to C57BL/6 mice. 
Chapter 7 describes the investigation of LTi differentiation during LN development. 
We hypothesized that retinoic acid affects hematopoietic LTi differentiation in the 
embryo and demonstrated that oral supplementation of pregnant mothers with 
retinoic acid skewed the differentiation of hematopoietic precursors towards the 
final LTi phenotype. Consistently, administration of a vitamin A deficient diet to 
pregnant mothers led to a significant decrease of the LTi differentiation state 
in the developing LN of the embryo. Also, embryos from BALB/c mice, which 
displayed enhanced vitamin A metabolism when compared to C57BL/6 mice, 
had more mature LTi cells in their MLNs and adult BALB/c mice displayed larger 
mucosal lymphoid organs. Thus, retinoic acid is involved in local differentiation 
of LTi cells during LN development and we propose that vitamin A levels in the 
mother have a significant effect on the amount of LTi cells and the formation of 
LNs in the embryo. 
Finally, in chapter 8, the findings described in this thesis are summarized and 
discussed in the context of recent developments in the research on vitamin A and 
the mucosal immune system. Potential future research directions are indicated, 
which may resolve unanswered questions. This will give further insight in the 
mechanism of how the mucosal immune system operates and how it can be 
influenced.
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Abstract
T cells are imprinted to express tissue-specific homing receptors upon activation 
in tissue-draining lymph nodes, resulting in their migration to the site of antigen 
entry. Expression of gut-homing molecules a4b7 and CCR9 is induced by retinoic 
acid, a vitamin A metabolite produced by retinal dehydrogenases, which are 
specifically expressed in dendritic cells as well as stromal cells in mucosa-draining 
lymph nodes. Here, we demonstrate that mesenteric lymph node (MLN) stromal 
cell-derived retinoic acid can directly induce the expression of gut-homing 
molecules on proliferating T cells, a process strongly enhanced by DCs. Therefore, 
cooporation of sessile LN stromal cells with mobile dendritic cells warrants the 
imprinting of tissue specific homing receptors on activated T cells.
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Introduction
Upon activation by dendritic cells (DCs), coming from either peripheral or mucosal 
sites, T cells are induced to express adhesion molecules and chemokine receptors 
to ensure that activated T cells will preferentially migrate to the site where DCs 
initially encountered the antigen [1-5]. For migration to the intestines, T cells 
require expression of integrin a4b7 and chemokine receptor CCR9, although the 
requirement for CCR9 may not be absolute [6-11]. The ligand for a4b7, mucosal 
addressin cell adhesion molecule-1 (MAdCAM-1), is expressed in the lamina 
propria of the colon and small intestine [12-14], while CCL25, the ligand for CCR9, 
is mainly produced by epithelial cells of the small intestine [15-20]. 
In recent years more insight into the mechanisms by which homing receptors are 
induced has been obtained and an important role for the vitamin A metabolite 
retinoic acid (RA) in the upregulation of a4b7 and CCR9 on activated T and B 
cells has been described [6,21]. Vitamin A (retinol) is first reversibly oxidized by 
alcohol dehydrogenases to form retinal, which in turn is irreversibly metabolized 
to RA by three members of the aldehyde dehydrogenase gene family, the 
retinal dehydrogenases 1-3 (RALDH1-3) [22,23]. In mice, RALDH1 through 3 are 
differentially expressed in DCs from gut-draining lymphoid tissues, forming the 
basis for the RA-induced gut tropism [6]. This differential expression suggests 
a role for the mucosal environment in the induction of RALDH enzymes. This 
regulation could occur at the site where antigen is initially captured by DCs, for 
example the intestinal epithelium and lamina propria, as suggested by several 
reports [4,24-26]. In addition, it can be envisaged that the microenvironment of 
the draining mucosal LNs, where the interaction and activation of lymphocytes 
takes place, also provides the appropriate signals for induction of T cell tropism, 
as shown in a recent paper by Hammerschmidt et al. [27]. Such a role can further 
be inferred from our earlier experiments in which we showed with transplantation 
studies that mucosa-draining cervical LNs (CLNs) are unique in their capability 
to induce mucosa-associated immune tolerance, as peripheral, non-mucosal, LNs 
(PLNs) transplanted to the site of CLNs were not able to induce immune tolerance 
[28]. 
To elucidate the role of the LN microenvironment in providing signals for T cell 
tropism, either gut or skin draining LNs were transplanted into a peripheral site, 
the popliteal fossa, so that DCs entering these LNs are bringing in antigen from 
the periphery. These transplantations show that the microenvironment of mucosal 
mesenteric LNs (MLNs) and not peripheral LNs (PLNs), supports the induction of 
a4b7, but not CCR9, on T cells upon their activation. Furthermore, MLN stromal 
cells showed expression of vitamin A converting enzymes allowing production of 
RA by these cells. While in vitro cultured MLN stromal cells were able to induce 
gut-homing tropism on activated T cells directly, addition of RALDH-low unpulsed 
bone marrow-derived DCs (BM-DCs) strongly enhanced the expression of gut-
homing molecules a4b7 and CCR9. Altogether, our data demonstrates a crucial 
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role for MLN stromal cells in creating an instructive mucosal microenvironment in 
which three obligatory parties, the stromal cells, DCs and lymphocytes cooperate 
for efficient differential imprinting of tissue tropism. 
Materials and Methods
Mice
BALB/c and C57BL/6 mice aged 8 to 12 weeks were purchased from Charles River 
(Sulzfeld, Germany) and DO11.10, b-actin-GFP/C57BL/6, MHC-II-/-, OT-I, and OT-II 
transgenic mice and C57BL/6-CD45.1 and C57BL/6-CD45.2 congenic mice aged 
6 to 8 weeks were bred at our own facilities. The Animal Experiments Committee 
of the VU Medical Center approved all of the experiments described in this study.
Transplantation of LNs to the popliteal site
Transplantation of donor MLNs (mesenteric) or PLNs (from axial, brachial or 
inguinal sites) to the popliteal fossa was performed as described before [29]. 
T cell enrichment, CFSE labelling, transfer and antigenic stimulation
Spleens and LNs from DO11.10, OT-I, OT-II or C57BL/6 mice were minced through 
a 100-mm gauze to obtain single cell suspensions. To deplete erythrocytes from 
spleen cell suspension, cells were incubated for 2 minutes on ice in lysis buffer 
(150 mM NH4, 1 mM NaHCO3, pH 7.4). CD4
+ or CD8+ T cells were enriched to 
at least 60% and 85% respectively, using the CD4 or CD8 negative selection kit 
(Dynal, Oslo, Norway). Cells were labelled with 5 mM of 5,6-carboxy-succinimidyl-
fluoresceine-ester (CFSE, Molecular Probes, Invitrogen, Breda, The Netherlands) 
at 3x107 cells/ml for 10 min at 37˚ C. Cells were used for in vitro cultures with 
stromal cells and/or DCs or used for in vivo intravenous injections. Transplanted 
and control BALB/c or C57BL/6 mice were injected with approximately 107 OVA-
specific T cells and were subsequently stimulated 24 hours later by intramuscular 
(i.m.) or intragastric (i.g.) administration of 200 mg OVA in 10 ml saline or 50 mg 
OVA in 200 ml saline, respectively. After antigenic stimulation, transplanted LNs 
were isolated and used as single cell suspensions for FACS analysis. 
Immunofluorescence and flow cytometry
Single cell suspensions were made by cutting LNs with scissors, followed by 
digestion at 37ºC for 20 min, using Blendzyme 2 (Roche, Penzberg, Germany) 
and 100 U/ml DNAse I (Roche). Antibodies used were anti-ERTR7 (affinity purified 
from hybridoma cell culture supernatant), anti-CD4 (clone GK1.5, BD Pharmingen, 
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Woerden, The Netherlands), biotinylated anti-mouse DO11.10 TCR (KJ1-26, Caltag 
Laboratories, Burlingame, CA), PE-Cy7 conjugated anti-CD8 (eBiosciences), PE-Cy7 
conjugated anti-CD4 (eBiosciences), PE conjugated anti-mouse OT-I/OT-II TCR 
(Va2, eBiosciences), anti-a4b7 integrin (clone DATK32, kindly provided by Dr. 
Alf Hamann, Charité Universitätsmedizin Berlin, Germany), rat anti-mouse CCR9 
(clone 7E7), rat anti-mouse PNAd (clone Meca-79, kindly provided by Dr. E.C. 
Butcher, Stanford University), anti-B220 (clone 6B2), PE conjugated anti-CD11c 
(clone N418, eBioscience), anti-CD3 (clone KT3), Alexa Fluor 647 conjugated CD45 
(clone MP33), biotin conjugated anti-MHC-II (clone M5/114) and 7-AAD (Molecular 
Probes, Invitrogen) or Sytox Blue (Invitrogen) to discriminate live versus dead 
cells. Secondary antibodies were Alexa conjugated goat anti-rat-IgG and Alexa 
conjugated streptavidin (Molecular Probes, Invitrogen). 
Cells were analyzed with a FACScalibur (BD Biosciences, Breda, The Netherlands) 
or with a Cyan Advanced Digital Processing High-Performance Research flow 
cytometer (Beckman Coulter, Mijdrecht, The Netherlands). Cells were sorted 
using a MoFlo sorter (DakoCytomation, Glostrup, Denmark). Tissue stainings 
were analyzed on a Leica TCS-SP2-AOBS confocal laser-scanning microscope (Leica 
Microsystems Nederland BV, The Netherlands) and images were obtained with 
Leica confocal software.
In vitro experiments
To obtain stromal cells for in vitro cultures, MLNs and PLNs from C57BL/6 mice 
were dissociated with Blendzyme 2 as described above. 1x106 or 4x106 LN cells 
were grown per well of 96-wells or 24-wells flat bottom plates, respectively 
(Greiner Bio One, Alphen a/d Rijn, The Netherlands) in IMDM medium (Iscove’s 
Modified Dulbecco’s Medium from Gibco, N.Y USA) containing 10% fetal calf 
serum (FCS, Hyclone, Utah, USA), 50 µM b-mercaptoethanol (Merck, Darmstadt, 
Germany), 1% L-glutamine and 1% Penicillin-Streptomycin (Biowhittaker Europe, 
Verviers, Belgium) for 24 hours. Subsequently, nonadherent cells were removed, 
fresh medium was added and the culture was continued for one week. 
Bone marrow was isolated from the femur and tibia using a mortar and cultured 
for one week in IMDM medium with 20 ng/ml GM-CSF to obtain BM-DCs. 1x105 
BM-DCs were cultured on stromal cells for 48 hours in a volume of 200 µl IMDM 
complete medium with 50 nM retinol (Fluka, Sigma-Aldrich, Zwijndrecht, The 
Netherlands). Subsequently, cells were FACS-sorted into MHC-II+ CD11c+ DCs and 
CD45- MHC-II- CD11c- stromal cells for RNA isolation.
5x104 purified C57BL/6 CD8+ T cells were cultured on a layer of stromal cells 
with 50 nM retinol (Sigma-Aldrich), 10 µM citral (RALDH enzyme inhibitor, Sigma-
Aldrich), 10 nM all-trans retinoic acid (RA, Sigma Aldrich), 1 µM LE135 (RA receptor 
inhibitor, Tocris Bioscience, Bristol, United Kingdom), and 1 µM LE540 (RA receptor 
inhibitor, Wako Chemicals, Neuss, Germany) as indicated and activated with 5x104 
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CD3/CD28 T cell expander Dynabeads (Dynal, Invitrogen, Breda, The Netherlands) 
in presence or absence of 1x104 unpulsed BM-DCs. 
In all T cell activation assays, responding T cells were analyzed with flow cytometry 
after 96 hours.
RNA isolation, cDNA synthesis and real time PCR
Sorted MHC-II+ CD11c+ DCs, CD45- MHC-II- CD11c- LN stromal cells, and stromal 
cells after 7 days of culture were lysed in Trizol (Gibco BRL, Breda, The Netherlands) 
or RLT buffer (Qiagen Benelux, Venlo, The Netherlands). RNA was isolated by 
precipitation with isopropanol or by using the RNeasy kit (Qiagen Benelux) according 
to the manufacturer’s protocol and cDNA was synthesized from total RNA using 
RevertAid First Strand cDNA Synthesis Kit (Fermentas Life Sciences, Burlington, 
Canada) according to the manufacturer’s protocol. RALDH1 (Aldh1A1), RALDH2 
(Aldh1A2), and RALDH3 (Aldh1A3) specific primers and primers for housekeeping 
genes b-actin, Ubiquitin C, HPRT and GAPDH were designed across exon-intron 
boundaries using Primer Express software (PE Applied Biosystems, Foster City, 
CA). Real time PCR was performed on an ABI Prism 7900HT Sequence Detection 
System (PE Applied Biosystems). Total volume of the reaction mixture was 10 ml, 
containing cDNA, 300 nM of each primer and SYBR Green Mastermix (PE Applied 
Biosystems). To correct for primer efficiency, a standard curve was generated for 
each primer set with cDNA from a pool of non-activated LNs. Expression levels 
of transcripts obtained with real time PCR were analyzed and normalized with 
geNORM v.3.4 software [30]. 
Statistics
Statistical analysis was conducted using 2 tailed Student’s t-test for differences in 
mean fluorescence intensity (MFI), ratio of a4b7 or CCR9
 expression on activated T 
cells in LNs or cocultures, or differences in relative RALDH1, RALDH2, or RALDH3 
mRNA expression levels in sorted DCs and stromal cells. Differences were 
considered significant when p<0.05 or p<0.02 as indicated. 
Results
Donor-derived cells in transplanted LNs are stromal cells.
In earlier studies we showed by transplantation of LNs that differences exist 
between LNs with respect to their ability to allow the induction of mucosal 
tolerance [28]. Since DCs as well as lymphocytes are mobile cells that are likely to 
be replaced rapidly after transplantation these results suggested that the specific 
features that make up the differences between MLNs and PLNs reside within 
the stromal elements of the LN. To investigate this we transplanted MLNs from 
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b-actin-GFP/C57BL/6 mice into the popliteal fossa of C57BL/6 mice and addressed 
which cells were donor-derived at 12 weeks after transplantation. By staining for 
podoplanin (gp38) expressed on fibroblastic reticular cells (FRCs) and pericytes 
and for ERTR7, an extracellular matrix (ECM) glycoprotein produced by these 
cells, we could demonstrate that most podoplanin+ cells which co-localized with 
ERTR7+ ECM structures were GFP expressing donor-derived cells (Figure 1A, B), 
thus confirming that FRCs were donor-derived as reported for LN transplantations 
into gut mesenteries [27]. The majority of the high endothelial venules (HEVs) 
expressing PNAd (detected with MECA79) were of donor origin as well (Figure 
1C). Staining for haematopoietic cells revealed that CD4+ and CD8+ T cells, B 
cells, as well as DCs were lacking GFP expression and thus were host derived 
Figure 1. Non-haematopoietic cells remain in transplanted LNs, while all donor-derived 
haematopoietic cells disappear. 
A-D,  MLNs or PLNs from b-actin-GFP/C57BL/6 mice were transplanted into the popliteal fossa after removal 
of the popliteal LNs. Twelve weeks later, LNs were collected and stromal cells and haematopoietic cells in the 
transplanted LNs were analyzed with immunofluorescence for expression of (A) podoplanin (gp38, red), (B) 
ERTR7 (extracellular matrix marker, red), (C) PNAd (HEV marker, red), and (D) CD11c (DCs, red), while GFP+ 
donor-derived cells appear in green in all pictures. Results shown are representative for 6 LNs transplanted for 
each group. E, MLNs from C57BL/6-CD45.1 mice were transplanted into the popliteal fossa of C57BL/6-CD45.2 
recipients and collected after 5 weeks for FACS analysis of haematopoietic cells present in the transplanted 
MLN (tLN) or orthotopic PLN (coLN). The expression of B220, CD3 and CD11c on CD45.1+ cells and all (total) 
haematopoietic cells is shown for transplanted MLN (tLN). Results were comparable to transplanted PLN. 
Results shown are representative for 5 LNs transplanted for each group.
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(Figure 1D and data not shown). To further prove that indeed haematopoietic cells 
were derived from the host, we transplanted LNs from CD45.1 mice into CD45.2 
congenic hosts and observed that 5 weeks after transplantation very few donor-
derived hematopoietic CD45.1+ cells, predominantly B cells, could be detected in 
the transplanted LNs (Figure 1E). 
In conclusion, we established that after transplantation of lymph nodes virtually 
all haematopoietic cells were derived from the host, while the stromal cells were 
donor-derived.
Activation of T cells in transplanted MLNs results in increased expression of 
a4b7 but not CCR9.
To study the mechanism of tissue tropism induction guided by stromal cells in vivo, 
independent of mucosal tissue drainage, MLNs and PLNs were transplanted to the 
popliteal fossa of C57BL/6 mice. At twelve weeks after transplantation, C57BL/6 
mice were injected with CFSE-labelled ovalbumin (OVA) specific transgenic CD8+ 
Va2+ T cells (OT-I cells) and immunized with OVA in the sural muscle 24 hours 
later. At 72 hours after antigen administration, expression of mucosal homing 
molecules a4b7 and CCR9 was analyzed on proliferating OT-I cells by flow cytometry. 
We observed a significant difference between expression of a4b7 on OT-I cells 
activated in transplanted MLNs (tMLNs) versus transplanted  PLNs (tPLNs) (Figure 
2A). Induced expression in tMLN was comparable to levels on activated OT-I cells in 
the orthotopic MLNs (coMLN) upon intragastric administration of OVA (Figure 2A). 
No difference in a4b7 expression was visible on the CFSE-labelled non-proliferating 
T cell populations in tMLN versus tPLN, indicative of a uniform entry of injected 
cells in both types of transplanted LNs and the necessity of T cell activation for 
indcution of this gut-homing molecule. Remarkably, the mucosal homing receptor 
CCR9 was not induced on proliferating OT-I cells in tMLNs, while its expression 
was readily induced in the orthotopic MLNs upon intragastric administration of 
OVA (Figure 2B). Identical results were obtained when transplanted mice were 
injected with CFSE-labelled OVA specific CD4+ Va2+ T cells (OT-II cells). To rule 
out strain-specific effects the transplantations were also performed in the BALB/c 
mouse strain in combination with the DO11.10 transgenic T cells, giving similar 
results on the induction of a4b7 expression (not shown). To exclude the possibility 
that donor-derived mucosal DCs might still be present after transplantation and 
interfere with T cell activation in the transplanted LNs, LNs from MHC-II deficient 
mice were transplanted to the popliteal fossa of C57BL/6 mice. These experiments 
showed similar induction of a4b7 integrin on activated OT-II cells as observed in 
wild-type transplanted LNs (Figure 2A). Together, these results indicate that the 
mucosal microenvironment in the transplanted MLNs is partially preserved and 
allows for the induction of the gut-homing molecule a4b7, but not CCR9, by host-
derived DCs on antigen-specific T cells. For the induction of CCR9 on activated T 
cells additional factors might be required, presumably derived from the intestines 
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and present within the intestinal lamina propria as well as in the lymph draining 
from the gut into the MLNs. 
RALDH enzymes are expressed in mucosal DCs and MLN stromal cells.
Since the induction of gut-homing molecules on T cells has been described to 
be dependent on RA [6], we analyzed mRNA expression levels of RA producing 
RALDH enzymes in sorted CD45+ MHC-II+ CD11c+ DCs versus CD45- stromal cells. 
As expected, sorted DCs from MLN (MLN-DCs) expressed high levels of RALDH2 
as well as RALDH3, as shown before [6], while PLN-DCs expressed RALDH2 at 
much lower levels (Figure 3A). Notably, RALDH2 and RALDH3 were found to 
be expressed by freshly sorted CD45- stromal cells from MLNs, but not by PLN 
stromal cells (Figure 3C). Expression of RALDH1 was barely detectable in both PLN 
Figure 2. Transplanted MLNs provide a microenvironment for induction of  a4b7 integrin on 
stimulated antigen-specific T cells. 
A and B, C57BL/6 mice were transplanted with PLN (tPLN) or MLN (tMLN) from C57BL/6 (WT) or MHCII-/- donor 
mice and received CFSE-labelled OVA-specific CD8+ OT-I cells or CD4+ OT-II cells respectively at 12 weeks after 
transplantation. Activated OT-I cells or OT-II cells in tMLNs, tPLNs, and orthotopic PLNs (coPLN) were analyzed 
by flow cytometry 3 days after immunization with OVA antigen in the sural muscle and activated OT-I or 
OT-II cells in orthotopic MLNs (coMLN) were analyzed after intragastric OVA immunization. Shown are flow 
cytometry plots of cell proliferation and expression of a4b7 (A, top) and CCR9 (B, top) by proliferating OT-I 
cells in coLNs and WT tLNs. Data represent MFI ± SD of a4b7 expression (A, bottom) and CCR9 expression (B, 
bottom) on activated OT-I cells in WT tLN and activated OT-II cells in MHCII-/- tLN. For each transplanted group 
3 LNs were analyzed, while in each experiment one MLN and two popliteal LNs served as controls. Experiments 
were performed three times. Significant differences between tMLN and tPLN (p<0.02) are indicated by *. 
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Figure 3. RALDH enzymes are expressed in MLN stromal cells and MLN DCs. 
RNA was isolated from indicated cell types. Relative expression levels of RALDH1, RALDH2, and RALDH3 
enzymes were measured by real time PCR. Expression of transcripts was normalized to endogenous references 
genes using geNORM v.3.4 software. Relative expression levels in PLN-DCs (A) and PLN stroma (B, C) was set at 
1,0. Significant differences (p<0.02) are indicated by *. A, CD11c+ MHC-II+ DCs were FACS-sorted from PLNs and 
MLNs from 6 C57BL/6 mice of age 5-9 weeks, analyzed for RALDH1, RALDH2, and RALDH3 mRNA expression 
levels and normalized to GAPDH and HPRT. RALDH1 and RALDH3 expression were not detectable in these cells. 
The experiment was performed three times. B, 7 days cultured MLN stromal cells and PLN stromal cells were 
analyzed for relative expression levels of RALDH1, RALDH2, and RALDH3 enzymes and normalized to GAPDH 
and HPRT. The experiment was performed seven times. C, CD45- MLN stromal cells and PLN stromal cells, FACS 
sorted from freshly isolated MLN and PLN, were analyzed for relative expression levels of RALDH1, RALDH2, 
and RALDH3 enzymes and normalized to GAPDH and Ubiquitin C. RALDH1 expression was not detectable in 
these cells. RALDH2 was not detectable in PLN stroma. The experiment was performed three times. D, After 
7 days of culture, LN stromal cells were trypsinized and analyzed with flow cytometry for expression of CD45, 
CD11c, CD11b, CD4, CD8 and 6B2. Shown are percentages of the total cell suspension. 3 wells were pooled for 
analysis and experiment was performed 4 times.
and MLN stroma (not shown). Therefore, MLN stromal cells may contribute to the 
generation of gut-homing T cells by producing RA, either by directly influencing 
T cells as suggested before [27], through instruction of DCs or by affecting both. 
Gut-homing molecules are induced on activated T cells in the presence of 
MLN stromal cells and BM-DCs in vitro.
To see whether indeed stromal cells are instrumental to an instructive environment 
for induction of T cell tropism, we set up an in vitro assay to address this 
question. Since the low number of freshly sorted stromal cells would limit such 
in vitro studies, we addressed whether MLN stromal cells maintained RALDH 
levels after 7 days of culture. Indeed, RALDH1, RALDH2 and RALDH3 expression 
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was detected in cultured MLN stromal cells, and at very low levels in cultured 
PLN stromal cells (Figure 3B). Flow cytometric analysis of these stromal cultures 
showed that the majority of the cells were CD45-negative. Only a small percentage 
of haematopoietic cells was present after 7 days of culture (Figure 3D). 
To investigate the effect of LN stromal cells on the induction of T cell tropism, 
stromal cells from PLNs versus MLNs were cultured for 7 days, after which OVA 
peptide-loaded BM-DCs and CFSE-labelled OT-I cells were added. Although all our 
cultures were performed in the presence of 10% FCS, which should account for 
approximately 40 nM retinol, experiments were carried out in the presence or 
absence of additional retinol to circumvent potential loss of bioactivity of FCS-
derived retinol. After 96 hours, expression of mucosal homing molecules a4b7 
and CCR9 on proliferating antigen-specific T cells was analyzed by flow cytometry. 
When OT-I cells were stimulated in the presence of MLN stromal cells, the ratio 
of a4b7
+ to a4b7
- T cells increased with each cell division upon addition of retinol, 
suggesting that RA production from retinol was involved in the induction of a4b7 
expression (Figure 4A). This effect was not seen with stromal cells from PLNs, 
where a stable ratio of a4b7
+ to a4b7
- T cells was found. Similar results were found 
for the induction of CCR9. Only in the presence of MLN stromal cells and retinol, 
a robust expression of CCR9 on dividing T cells was seen (Figure 4B). Addition 
of retinol to the PLN stromal cell cultures allowed a slight induction of CCR9 
on activated T cells, however not to the levels seen on T cells activated on MLN 
stromal cells. These results suggest that only in the presence of MLN stromal cells, 
but not PLN stromal cells, peptide-pulsed BM-DCs can strongly induce a4b7 and 
CCR9 expression on activated T cells and that this process requires the addition 
of retinol, which is converted to RA by RALDH enzymes.
BM-DCs are not induced to express RALDH enzymes in vitro.
Since we have observed that BM-DCs, which were cultured together with small 
intestinal epithelial cells, were induced to express RALDH enzymes [25], we 
reasoned that a similar instruction could be mediated by MLN stromal cells. 
Therefore BM-DCs were co-cultured with MLN stromal cells or PLN stromal cells 
for 48 hours, after which stromal cells and DCs were sorted and analyzed for 
RALDH2 mRNA expression levels. BM-DCs cultured with PLN stromal cells express 
very low levels of RALDH2 mRNA, either in the presence or absence of added 
retinol. Moreover, MLN stromal cells were unable to further induce RALDH2 mRNA 
levels in BM-DCs, while MLN stromal cells expressed high levels of RALDH2 (Figure 
4C). Therefore, in the in vitro cultures that allow the induction of gut-homing 
molecules on activated T cells, MLN stromal cells are the main source of RALDH 
enzymes, which are needed to convert retinol into RA.
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Figure 4. MLN stromal cells support induction of gut-homing molecules on activated CD8+ T 
cells, which is greatly enhanced by the presence of BM-DCs. 
A and B, 1x105 CFSE-labelled OT-I cells were cultured in vitro with 5x104 OVA peptide-pulsed BM-DCs on a 
layer of MLN or PLN stromal cells in absence or presence of 50 nM retinol. After 96 hours, activated OT-I cells 
were analyzed by FACS for the expression of gut-homing molecules α
4
β
7
 (A) and CCR9 (B). Representative 
FACS plots are shown. Boxes indicate percentage of α
4
β
7
 or CCR9 expressing dividing T cells of total cell 
suspension. Experiment was performed two times. Data are calculated as the ratio of α
4
β
7
+ to α
4
β
7
- (A, right 
column) and CCR9+ to CCR9- (B, right column) activated antigen-specific T cells upon cell division on MLN or 
PLN stroma in absence (grey dots) or presence (black dots) of 50 nM retinol. C, 1x105 BM-DCs per well were 
cultured on a layer of MLN stromal cells or PLN stromal cells in presence of 50 nM retinol for 48 hours. Per 
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RALDH-low BM-DCs greatly enhance induction of gut-homing molecules by 
MLN stromal cells. 
To address whether indeed stromal cells alone are sufficient for the induction 
of gut-homing molecules on T cells, CD8+ T cells were activated with anti-CD3 
and anti-CD28 coated beads on LN stromal cells in the absence or presence of 
BM-DCs. Retinol was either added as a substrate for RA production by stromal 
cells or omitted from the cultures. After 96 hours, a4b7 and CCR9 expression on 
activated CD8+ T cells was determined. When CD8+ T cells were stimulated on MLN 
stromal cells in the absence of BM-DCs and retinol, the ratio of a4b7
+ to a4b7
- T 
cells was significantly higher when compared to T cells activated on PLN stromal 
cells. Addition of retinol slightly increased the ratio of a4b7
+ to a4b7
- T cells when 
activated on MLN stromal cells (Figure 4D). 
Notably, addition of unpulsed BM-DCs strongly increased the expression of 
a4b7 on bead-activated CD8
+ T cells in MLN stromal co-cultures. This increased 
expression was already observed when no retinol was added, suggesting that 
BM-DCs have a synergizing effect on the induction of gut-homing molecules on 
T cells (Figure 4D). Increased expression levels were not seen in PLN stromal 
cocultures, where a stable ratio of a4b7
+ to a4b7
- T cells was observed and thus did 
the low levels of RALDH in BM-DCs not contribute to this induction. Similarly, only 
in the presence of stromal cells from MLNs an increasing expression of CCR9 on 
activated T cells was seen upon addition of retinol, while this was not observed on 
PLN stromal cells. Also, addition of unpulsed BM-DCs increased the expression of 
CCR9 on activated T cells in presence of MLN stromal cells. Remarkably, the ratio 
of CCR9+ to CCR9- activated T cells was greatly increased upon addition of retinol 
(Figure 4E). These results show that MLN stromal cells can support the generation 
of gut-homing T cells directly, however the presence of DCs makes this process 
much more efficient.
condition 4 wells were pooled for FACS sorting. CD45+ CD11c+ MHC-II+ DCs and CD45- stromal cells were sorted 
from the co-cultures. Relative mRNA expression levels of RALDH2 were measured by real time PCR. Expression 
of transcripts was normalized to HPRT and Ubiquitin C using geNORM v.3.4 software. Relative expression in 
PLN stroma was set at 1,0. The experiment was performed five times. D and E, 5x104 CD8+ T cells were cultured 
in vitro with 5x104 T cell expander Dynabeads on a layer of MLN stromal cells (black bars) or PLN stromal cells 
(grey bars) in the absence or presence of unloaded BM-DCs as indicated. 50 nM retinol, 10 µM citral plus 1 µM 
of RA receptor β inhibitors LE540 and LE135 was added to the cultures as indicated. After 96 hours, activated 
CD8+ T cells were analyzed by flow cytometry for the expression of gut-homing molecules α
4
β
7
 and CCR9. Data 
represent the ratio of α
4
β
7
+ to α
4
β
7
- (D) and CCR9+ to CCR9- (E) of activated CD8+ T cells. Per condition 2 wells 
were pooled for analysis. The experiments have been performed three times. *, p<0.05, **, p<0.02. 
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Discussion
We have demonstrated here that stromal cells within MLNs mediate the induction 
of gut tropism by influencing proliferating T cells directly, a process strongly 
enhanced by DCs. We were able to show that, in spite of the fact that a MLN was 
transplanted to a site where it drains the skin rather than the intestine, MLN 
stromal cells can still provide the necessary microenvironment for the induction of 
gut-homing molecule a4b7 expression on T cells, regardless of antigen transport 
by DCs from the intestine. Our in vitro studies revealed that MLN stromal cells 
can directly induce expression of gut-homing molecules on T cells, supporting 
the recent publication by Hammerschmidt et al. [27]. However, our data extend 
their observation since we showed that in the presence of DCs the induction of 
these molecules was markedly increased, while these DCs failed to upregulate the 
expression of RALDH enzymes. 
Since an intimate interaction between LN stromal cells and DCs has been observed 
by immunofluorescence as well as by intravital microscopy [31-33], we propose 
that activation of T cells by DCs within organized lymphoid tissues also involves 
LN stromal cells. We therefore conclude that activation of lymphocytes within 
organized lymphoid tissues should no longer be viewed as an interaction between 
antigen presenting cells and lymphocytes, but rather as a response that involves 
three obligatory parties, namely stromal cells, DCs and lymphocytes. 
Within the MLNs, CD103+ DCs are able to induce the expression of both a4b7 and 
CCR9, while CD103- DCs are only capable of inducing a4b7 [34,35]. Since also 
a4b7
+ CCR9- cells were shown to migrate to the intestines, both DC subsets can 
induce gut-homing tropism [9]. It has been suggested that CD103+ DCs form the 
subset that constantly migrates from the intestinal lamina propria into the MLNs, 
while CD103- DCs enter the MLN via the blood [1,34-37]. In our experimental 
setting, the lamina propria-derived CD103+ DCs are absent from the transplanted 
MLNs, suggesting that the absence of CCR9 expression on OVA-specific T cells 
is due to absence of this DC subset. However, in our in vitro cultures, LN-derived 
stromal cells by themselves are able to induce both a4b7 and CCR9 expression on 
activated T cells, suggesting that stromal cells that have recently been removed 
from the intestinal environment are better equipped to induce gut-homing on T 
cells, possibly by producing higher amounts of RA. Although stromal cells within 
MLNs can directly induce gut-homing tropism on proliferating T cells, this process 
is markedly enhanced by DCs. And since DCs will initiate T cell activation by their 
presentation of antigen, we propose that stromal-derived RA might be transferred 
to and presented by DCs to T cells, perhaps through the immunological synapse 
formed between T cells and DCs during T cell activation. Compatible with this 
are the reported observations that uptake and presentation of RA to T cells can 
occur by DCs upon pre-incubation with RA. This process did not involve newly 
formed RA, since RALDH blockade did not affect induction of a4b7 and CCR9 
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expression on T cells [38]. Similarly, a cell-cell interaction between MLN stromal 
cells and mucosal DCs might be required for the transfer of RA to mucosal DCs. 
Alternatively, DCs may somehow increase, by their interaction with MLN stromal 
cells, RALDH activity within MLN stromal cells without augmenting mRNA levels, 
resulting in the enhanced induction of gut tropism in T cells. 
The stromal cells within LNs have been thought of as cells that simply provide a 
structure for immune cells to optimally interact with each other. However, recently 
it was shown that these stromal components also provide migratory guidance 
for T and B cells, while DCs have been reported to adhere to these cells [31,32]. 
In addition, stromal cells within the T cell area of LN, the fibroblastic reticular 
cells (FRCs), secrete extracellular matrix molecules as part of the conduit system, 
through which small size molecules can get rapid access to the LNs [33,39], while 
FRCs can mediate T cell survival through production of IL7 [40]. Furthermore, 
LN stromal cells can present endogenous antigen to T cells, hereby promoting 
peripheral tolerance induction [41,42]. Additionally, our studies have provided 
evidence that MLN stromal cells influence the final differentiation of T cells by 
differential expression of RALDH enzymes leading to the production of RA which 
creates an instructive mucosal microenvironment. Thus, our findings that unique 
stromal microenvironments exist in anatomically distinct LNs and that this may 
direct tissue-specific lymphocyte homing properties adds to the role stromal cells 
have in controlling immune responses. 
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Abstract
Tissue-specific homing of effector and memory T cells to skin and small intestine 
requires the imprinting of specific combinations of adhesion molecules and 
chemokine receptors by dendritic cells in the draining lymph nodes. Here, we 
demonstrate that CD8+ T cells activated by antigen-pulsed bone marrow-derived 
dendritic cells were induced to express the small intestine homing receptors 
a4b7 integrin and chemokine receptor CCR9 in co-culture with small intestinal 
epithelial cells. In contrast, in co-culture with dermal fibroblasts the skin homing 
receptor E-selectin ligand was induced. Interestingly, the imprinting of gut homing 
receptors on anti-CD3/anti-CD28 stimulated T cells was induced by soluble 
factors produced by small intestinal epithelial cells. Retinoic acid was identified as 
a crucial factor. These findings show that peripheral tissue cells directly produce 
homing receptor imprinting factors and suggest that dendritic cells can acquire 
their imprinting potential already in the peripheral tissue of origin.
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Introduction
Upon activation by dendritic cells (DC) in skin-draining lymph nodes, T cells 
up-regulate the skin homing receptors E- (E-lig) and P-selectin ligands (P-lig) as 
well as the chemokine receptors CCR4 and CCR10 [1-6]. Activation by DC from 
mesenteric lymph nodes (MLN) and Peyer’s patches (PP) results in the gut-homing 
receptors a4b7 integrin and CCR9 [4-9]. The role of lymph node resident DC 
versus DC that immigrated from peripheral tissues has not been addressed yet. 
DC from MLN and PP express retinal dehydrogenases (RALDH). They produce the 
vitamin A metabolite retinoic acid (RA) that induces up-regulation of a4b7 and 
CCR9 [10]. Lamina propria-derived CD103+ DC are responsible for the imprinting 
of gut homing receptors on T cells in PP and MLN [11,12]. Epidermal Langerhans 
cells (LC) were most efficient in the induction of skin homing receptors on CD8+ 
T cells in vitro as compared to DC from skin-draining lymph nodes [4,6]. These 
findings suggest that the DC immigrating into draining lymph nodes from 
peripheral tissues, rather than the lymph node resident DC, are responsible for 
homing receptor imprinting. In support of this view, two independent homing 
phenotypes can be induced on T cells in the same lymph node by DC immigrated 
from different peripheral sites [13]. Moreover, the majority of DC in skin draining 
lymph nodes consists of immigrants, i.e. Langerhans cells and dermal DC [14].
Here, we have studied the role of the peripheral tissue microenvironment in 
the imprinting of skin and small intestine homing receptors by DC in co-culture 
systems. CD8+ P14 T cells [15,16] upon activation with antigen-pulsed bone 
marrow-derived DC (BM-DC) up-regulated the skin homing receptor E-lig in co-
culture with dermal fibroblasts or the gut homing receptors CCR9 and a4b7 in 
co-culture with small intestinal epithelial cells (SIEC). Soluble factors such as RA 
induced the imprinting of the gut homing phenotype whereas cell-cell contact with 
dermal fibroblasts was important for the induction of E-lig on T cells. Our findings 
suggest that peripheral tissue stromal and epithelial cells produce factors that can 
directly induce homing receptors on T cells. These factors may license DC to also 
produce such factors and/or allow for the DC to shuttle these imprinting factors 
to the naive T cells in the regional draining lymph nodes.
Materials and Methods
Mice
C57BL/6 and TCR-transgenic Thy1.1 congenic P14 mice [15,16] were provided 
by the breeding facility of the University Medical Center Freiburg. All of the 
experimental procedures were in accordance with institutional, state and federal 
guidelines on animal welfare.
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Media and chemicals
BM-DC, P14 cells and dermal fibroblasts were cultured in RP-10 [4]. Small intestinal 
epithelial cells (m-ICc12) were cultured in m-IC medium as described [16].
The LCMV peptide GP33 (KAVYNFATM) was from Hermann GbR (Freiburg, 
Germany). All-trans RA was from Sigma-Aldrich (Munich, Germany). 9-cis RA and 
RA receptor antagonists (RAR, RXR26) were provided by Bernhard Homey. 
Antibodies and flow cytometry
All antibodies were from BD Biosciences (Heidelberg, Germany) unless stated 
otherwise and used as FITC, PE or biotin conjugates. Biotin conjugated antibodies 
were revealed with PE-Cy5 conjugated streptavidin. Antibodies used here: anti-
CD16/CD32 (FcγR II/III) (2.4G2), anti-CD90 (Thy1.1) (HIS51), anti-CD8a (53-6.7), 
anti-IAb (AF6-120.1), anti-CD11c (HL3), anti-CD103 (M290), anti-a4b7 (DATK32), 
E-selectin/human IgG-Fc-Chimera (R&D Systems, Wiesbaden, Germany), anti-
hu-IgG-FITC (DakoCytomation, Hamburg, Germany), rat anti-CCR9 [18], kindly 
provided by Reinhold Förster (Hannover, Germany), mouse anti-rat IgG (H+L) 
(Jackson ImmunoResearch, Newmarket, UK). FACS staining was done as 
described [4,6]. Data were acquired and analyzed on a FACScan instrument using 
CellQuestPro software (BD Biosciences). Anti-pan TGFβ was purchased from R&D 
systems (Wiesbaden, Germany).
Isolation and preparation of cells
BM-DC were prepared as described [4] but without IL-4. m-ICc12 cells were 
differentiated for 6 days on collagen in 24-well plates and cultured as described 
previously [17]. Primary SIEC were isolated as described [19]. Dermal fibroblasts 
were isolated from the skin of 2 day old mice with 5 U/ml dispase (Invitrogen, 
Karlsruhe, Germany) for 1 h at 37°C. The dermis was separated from the epidermis, 
washed in PBS and incubated in collagenase I (500 U/ML) (Worthington Biochemical 
Corporation, Lakewood, USA) for 45 min at 37°C. Cells were singularized, washed 
in PBS and resuspended in medium. Medium was changed after 24 h and cells 
were cultured until confluent. P14 spleen cells were prepared as described [4,6]. 
Total splenocytes were used (referred to as P14 cells) or CD8a (Ly-2) MicroBeads 
(Miltenyi Biotech, Bergisch Gladbach, Germany)-purified CD8+ P14 T cells were 
used in some experiments to exclude bystander cell effects. 
In vitro priming of T cells
BM-DC were harvested on day 7-9 and pulsed with 1 µM GP33 peptide (BM-DC-
GP33) [4,6] or used unpulsed. 1x105 BM-DC-GP33/well were incubated with P14 
splenocytes (2x105/well) with or without m-ICc12 in 24-well plates (Greiner bio-one, 
Frickenhausen, Germany) for 4 days in a volume of 2 ml RP-10/m-IC medium (1:1 
vol/vol). Retinoic acid receptor antagonists (8 µM RAR or 3 µM RXR) were added to 
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these co-cultures from the beginning. Co-cultures using BM-DC-GP33 (1x104/well) 
were incubated with 2x104 splenocytes and 1x104 dermal fibroblasts in round 
bottom 96-well plates (Corning Life Science, Wiesbaden, Germany) for 6 days in a 
total volume of 200 µl RP-10. Supernatants were collected at day 4 of co-culture 
and stored at –20°C. Cells were analysed by flow cytometry. Cell culture inserts 
(1 µm pore diameter; BD Falcon, Heidelberg, Germany) were used in transwell 
experiments. m-ICc12 or dermal fibroblasts were cultured at the bottom of 24-
well plates, BM-DC-GP33 and P14 splenocytes were co-cultured in the cell culture 
inserts. Cell numbers were as described above.
Antibody activated splenocytes (soluble anti-CD3ε (145-2C11, 3 µg/ml) and anti-
CD28 (37.51, 1.5 µg/ml) (BD Biosciences) were primed by addition of all-trans or 
9-cis RA (10 nM and 7.5 µM, respectively).
Isolation of RNA and real time-PCR
Total RNA was isolated from BM-DC, m-ICc12 and from BM-DC co-cultured with 
m-ICc12 for 4 days using RNeasy Mini Kit 50 (Qiagen, Hilden, Germany). DC were re-
isolated with CD11c MicroBeads using an AutoMACS following the manufacturer’s 
instructions or have been seperated from m-ICc12 by transwell culture inserts. 
cDNA was prepared from 1 µg template RNA using Qiagen Omniscript Reverse 
Transcription Kit (Qiagen, Hilden, Germany). RALDH-1,-2 and -3 specific primers 
and primers for housekeeping gene 18S RNA were designed using Roche www.
universalprobelibrary.com and were purchased from TIB Molbiol Syntheselabor 
GmbH (Berlin, Germany). The corresponding probes were obtained by Molecular 
Biochemicals (Mannheim, Germany). Real time PCR was performed on a Light 
Cycler 1.5 (Roche Molecular Biochemicals, Manheim, Germany) using LightCycler 
TaqMan Master (Roche Molecular Biochemicals, Mannheim, Germany). Total 
volume of reaction mixture was 20 µl, containing 1 µl cDNA, 4 µl Master Mix 
(TaqMan Master, see above) 1 µl of each primer (forward and reverse, end 
concentration 0.33 µM respectively), 1 µl probe in a final concentration of 0.1 µM 
and 12 µl RNase free water. A negative control was always included consisting of 
the same ingredients without any cDNA. The expression of transcripts was related 
to 18S RNA. CT values for 18S were subtracted from CT values for RALDH 1, 2 and 
3, respectively (∆CT) and normalized to values to ∆CT of DC alone (∆∆CT). Fold 
increase was calculated by 2-(∆∆CT).
Statistics and statistical analysis
Statistical analysis was conducted using Student’s t test or ANOVA (non parametric) 
for the PCR data. Differences were statistically significant at p<0.05.
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Figure 1: Induction of α
4
β
7
 and CCR9 on activated CD8+ T cells in the presence of small intestinal 
epithelial cells. 
(A) P14 splenocytes were cultured for 4 days alone (top), co-cultured with BM-DC-GP33 (second row), co-
cultured with BM-DC-GP33 and SIEC (m-IC
c12
) (third row) or co-cultured with BM-DC-GP33 and separated from 
m-IC
c12
 by using transwell culture inserts (bottom). Homing receptor induction on P14 cells was measured by 
flow cytometry. One representative of five independent experiments is shown. Gated on live Thy1.1+ cells. 
(B) Similar results were obtained with freshly isolated SIEC. Data are representative for three independent 
experiments. Gated on live Thy1.1+ cells. n.d.: not detected. (C) Supernatants from DC, P14 splenocytes, 
m-IC
c12
 or freshly isolated SIEC (co-)cultures were added as conditioned media (CM) to P14 cells activated with 
anti-CD3ε and anti-CD28. Live Thy1.1+ cells were analysed by FACS. Double positive cells (α
4
β
7
/CCR9) were 
normalized to double positive splenocytes cultured without supernatants. Data represents the mean of three 
independent experiments. * = significant difference to CM from P14 cultures (p<0.05). TW: transwell. n.d.: not 
detected.
Results and Discussion
Small intestinal epithelial cells induce a4b7 and CCR9 in T cell-BM-DC co-
cultures by soluble factors.
It is conceivable that the antigen-loaded DC immigrating from peripheral tissues 
confer the information about their tissue of origin to T cells in local draining lymph 
nodes. In order to analyse the role of the peripheral tissue microenvironment 
in homing receptor imprinting, TCR transgenic P14 splenocytes (P14 cells) as a 
source for GP33 specific CD8+ T cells were co-cultured with BM-DC-GP33 in the 
presence or absence of the SIEC line m-ICC12. Cells were analysed by flow cytometry 
on day 4 of co-culture (Figure 1A). Almost all CD8+ T cells expressed both a4b7 
integrin and CCR9 in the presence of m-ICc12 when compared to controls. A role 
for soluble factors was shown in transwell experiments separating co-cultures 
of P14 splenocytes and BM-DC-GP33 from m-ICc12 cells. The extent of homing 
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receptor up-regulation was comparable to the cultures without transwells (Figure 
1A, left column). E-lig was not detected (Figure 1A, right column). Similar results 
were obtained with freshly isolated primary SIEC (Figure 1B) using purified CD8+ 
P14 T cells instead of splenocytes (data not shown).
Supernatants from co-cultures were used as conditioned medium (CM). P14 cells 
activated by anti-CD3ε and anti-CD28, and incubated with CM from co-cultures 
that contained either m-ICc12 or primary SIEC significantly up-regulated a4b7 
integrin and CCR9 compared to CM from P14 cells only (Figure 1C). Interestingly, 
even CM from m-ICc12 cells alone and to a lesser extent from primary SIEC alone 
were able to induce gut homing receptor expression on CD8+ T cells (Figure 1C). 
These findings indicate that SIEC release soluble factors that can induce small 
intestine homing receptors on T cells. It remains to be determined whether the 
difference between primary SIEC alone and SIEC + DC (Figure 1C) is indicative of 
an imprinting of DC by SIEC.
Figure 2: Effects of RA-receptor antagonists on the expression of gut homing receptors and 
induction of a gut-associated phenotype of DC by m-IC
c12
. 
(A) P14 splenocytes were co-cultured with BM-DC-GP33 and m-IC
c12
 in the absence (top), or presence of RAR 
antagonist (middle), or RXR antagonist (bottom). Gated on live Thy1.1+ cells. (B) Total RNA was isolated on day 
4 of culture from BM-DC, mIC
c12
, BM-DC from transwell (TW) cultures with mIC
c12
 and from BM-DC previously 
co-cultured with m-IC
c12
 re-isolated using CD11c MACS separation. cDNA was prepared and real time-PCR 
for RALDH1, 2 and 3 and the housekeeping gene 18S was performed in triplicates. n.d.: not detected. (C) 
Expression of CD103 on DC after co-culture with m-IC
c12
. BM-DC were cultured in presence (shaded area) or 
absence of m-IC
c12
 (bold line)
,
 harvested and stained at day 4. Cells were gated on CD11c/IAb double positive 
cells. Histogram is representative for four independent experiments. Numbers indicate the mean fluorescence 
intensity (MFI).
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Retinoic acid is involved in homing receptor imprinting in SIEC co-cultures.
Both isoforms of the vitamin A metabolite retinoic acid (RA), all-trans and 9-cis RA, 
efficiently induced a4b7 integrin and CCR9 on P14 T cells activated with anti-CD3 
and anti-CD28 (data not shown) as previously reported [10]. All-trans RA binds 
to RA receptor (RAR) only whereas 9-cis RA binds to RAR and RX receptor (RXR). 
Both receptors mainly function as heterodimeric, ligand-inducible transcription 
factors [20].
To test a potential role of RA, m-ICc12 were co-cultured with P14 cells and BM-DC-
GP33 in the presence or absence of RA receptor antagonists. The upregulation of 
CCR9 was completely blocked in the co-cultures by both RAR and RXR antagonists 
whereas the expression level of a4b7 was only reduced in presence of RAR 
antagonist (Figure 2A). In contrast to the antagonists used here, inhibition of 
RALDH by citral or of RAR by the antagonist LE135 efficiently suppresses RA- or 
MLN-DC-induced a4b7 upregulation [10]. It has been reported that TGFβ is a potent 
regulator of a4b7 [21]. Neutralization of TGF-β in the presence or absence of RAR 
and RXR ntagonists had no effect on the expression of a4b7 in our co-cultures 
(supplementary figure S1). These results suggest that SIEC play an important role 
in the induction of gut homing receptors on T cells by production of imprinting 
factors such as RA. RA production by human intestinal epithelium has been 
reported [22] and seems to be crucial for gut homing receptor induction.
BM-DC show a gut-associated phenotype after co-culture with m-ICc12.
CD103+ DC isolated from MLN were the most potent in inducing a gut homing 
phenotype on T cells compared to CD103- MLN DC [11, 12]. They express RALDH 
enzymes and can produce the imprinting factor RA [10]. Furthermore, almost all 
lamina propria DC but only a subpopulation of DC from MLN express CD103 (aE 
chain of the integrin aEb7). These CD103
+ lamina propria DC produce RA [23]. 
To evaluate whether BM-DC adopt a gut DC phenotype in the presence of SIEC in 
vitro, BM-DC were stained for CD11c, I-Ab and CD103 before and after co-culture 
with m-ICc12. At day 4 of co-culture, only a slight, but reproducible upregulation 
of CD103 could be detected compared to BM-DC cultured alone (Figure 2C). We 
also observed the induction of RALDH1 in DC after co-culture with m-ICc12 (Figure 
2B). These data show a bias towards a gut-associated phenotype of the BM-DC 
induced by SIEC. This implies that DC may acquire the ability to produce RA 
in the tissue microenvironment of the lamina propria. Positive feedback loops 
for the production of RA have been defined [24,25]. Thus, interactions of DC 
with peripheral tissue cells may induce a differentiation program resulting in 
the tissue-specific phenotype of the DC [4-9]. It is also possible that DC shuttle 
soluble factors produced by peripheral tissue cells, in this case SIEC, to the lymph 
nodes as suggested for RA [21].
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BM-DC induce E-selectin ligands in the presence of dermal fibroblasts.
In order to test whether dermal fibroblasts from mouse skin have a similar impact 
on the imprinting of skin homing receptors on T cells, co-cultures with dermal 
fibroblasts, BM-DC-GP33 and P14 cells were set up and analyzed after 6 days. 
The skin homing receptor E-lig was induced in these co-cultures, in contrast to 
cultures without dermal fibroblasts (Figure 3, left column). Induction of skin 
homing receptors was not observed when cell culture inserts were used to 
separate DC and P14 cells from the fibroblasts (Figure 3, left bottom panel). These 
results suggest that cell-cell contact is necessary for the induction of skin homing 
receptors on T cells, although IL-12 can induce E-lig in vitro [26]. Most likely this 
cell interaction takes place between DC and skin cells as naive T cells do not have 
access to dermal fibroblasts before they are primed for skin homing in the lymph 
node in vivo. We did not see any effects on E-lig expression by the Vitamin D3 
metabolite calcitriol (data not shown) which helps to induce CCR10 expression 
on human T cells [27]. CCR4 was upregulated in an activation-dependent manner 
(data not shown) [4]. Similar results were obtained in all of these settings when 
purified CD8 T cells were used instead of splenocytes, excluding bystander effects 
of non-T cells. Expression of the gut homing receptors a4b7 integrin or CCR9 was 
not observed in these experiments (Figure 3, right column).
Our findings demonstrate an instructive role for peripheral tissue cells in the 
imprinting of skin and small intestine homing receptors on T cells. It has been 
Figure 3. Induction of E-selectin ligand on DC-activated CD8+ T cells in the presence of dermal 
fibroblasts. 
Expression levels of E-lig, a
4
b
7
 and CCR9 on P14 cells cultured with BM-DC-GP33 in the absence (top) or 
presence of dermal fibroblasts (middle). Dermal fibroblasts were separated from splenocytes co-cultured with 
BM-DC-GP33 by transwell culture inserts (TW, bottom). All plots are representative for three experiments. 
Gated on live Thy1.1+ cells.
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reported that stromal cells can influence DC differentiation [28-30] (reviewed in 
[31]). For Langerhans cells that differentiate in the skin from monocyte precursors 
[32, 33], a role for both contact-dependent mechanisms and soluble factors in 
the acquisition of tissue-specific characteristics has been described [34,35]. In 
summary, we suggest that the peripheral tissue microenvironment conditions DC 
to shuttle topographical information to the lymph node in a bimodal fashion. As 
reported, DC may themselves be induced to produce factors for homing receptor 
imprinting [10] and, in addition, may transport factors produced by peripheral 
tissue cells to the draining lymph nodes [21]. This would license the DC to induce 
tissue-specific homing receptors and thereby pass the information about their 
tissue of origin and the site of antigen entry on to the T cells.
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Supplemental data
Supplementary figure 1: Effect of TGF-β on homing receptor 
expression.
P14 splenocytes were co-cultured for 4 days with BM-DC-GP33 and 
m-IC
c12
 in the presence (bold line) or absence (shaded area) of 5 µg/
ml anti-pan TGF-β antibodies and the expression levels of CCR9, α
4
β
7
 
and E-lig were analysed on Thy1.1+ CD8+ T cells by flow cytometry. One 
representative of five independent experiments is shown.
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Abstract
The vitamin A metabolite retinoic acid (RA) plays a crucial role in mucosal 
immune responses. We demonstrate here that RA-producing RALDH enzymes are 
postnatally induced in mesenteric lymph node (MLN) dendritic cells (DCs) and 
MLN stromal cells. RALDH enzyme activity in migratory CD103+ MLN-DCs did 
not depend on Toll-like receptor signalling. Remarkably, RA itself could directly 
induce RALDH2 in both DCs and stromal cells in vitro. Furthermore, using vitamin 
A deficient mice, it was found that RA-mediated signalling was strongly reduced 
within the small intestines, and that RALDH2 mRNA expression in both migratory 
CD103+ MLN-DCs and MLN stromal cells was strongly diminished. Moreover, 
supply of vitamin A to vitamin A deficient mice restored RA-mediated signalling in 
the intestine and RALDH activity in migratory CD103+ MLN-DCs. Our results show 
that RA-dependent signalling within the intestine is indispensable for RALDH 
activity in  the draining MLN. 
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Introduction
Vitamin A has long been recognized for its role in immunity. It is currently estimated 
that 190 million preschool-aged children and 20 million pregnant women in 
developing countries are vitamin A deficient [1], leading to increased risk of night 
blindness and mortality [2,3]. Vitamin A deficiency compromises mucosal barriers 
of the respiratory and gastrointestinal tracts [4]. It has also been described that 
vitamin A deficiency affects the ability of macrophages and neutrophils to migrate 
to sites of infection, phagocytose and kill bacteria [4,5]. Vitamin A also plays a 
critical role in the development of adaptive immune responses in the intestines. 
Through expression of the vitamin A converting aldehyde dehydrogenase 1A 
(ALDH1A, also called retinaldehyde dehydrogenase (RALDH)) enzymes, dendritic 
cells (DCs) and stromal cells in gut-associated lymphoid organs, like Peyer’s 
patches (PP) and mesenteric lymph nodes (MLN), are able to produce the active 
metabolite retinoic acid (RA) necessary to induce gut-homing specificity on 
activated T cells [6-11], FoxP3-expressing regulatory T (Treg) cells [12-18] and 
IgA producing B cells [19-21], and to suppress the differentiation of Th17 cells 
[13,16,17]. Therefore, RA appears to be a key molecule that controls lymphocyte 
homing properties and mucosal immune responses. It is thus of importance to 
know how RALDH levels are regulated within the mucosal immune system.
The major pathway of RA synthesis depends on two steps. Vitamin A is first 
reversibly oxidized by alcohol dehydrogenases (ADH) to form retinaldehyde. 
These enzymes are expressed in most cells including DCs. Next, retinaldehyde is 
irreversibly metabolized to RA by three members of the aldehyde dehydrogenase 
gene family, ALDH1A1 (RALDH1, ALDH1A2 (RALDH2) and ALDH1A3 (RALDH3) 
[22-24]. RALDH expression is limited to certain cell types, like intestinal epithelial 
cells [7,25-27], nerve fibers [28] and MLN stromal cells as well as DCs in PPs, 
MLNs and intestinal lamina propria, while splenic or peripheral lymph node 
(PLN)-DCs display only very low expression levels of these enzymes [6,7,10,12]. 
The differential expression of RALDH enzymes by DCs associated with mucosal 
tissues, suggests a role for the mucosal environment in the induction of these 
enzymes. It has not been fully established how and when intestinal DCs acquire 
the RA-producing capacity. 
In MLNs, a distinct subset of DCs has been identified that express RALDH enzymes 
at high levels and are marked by the expression of CD103 [12]. These CD103+ 
DCs are better equipped to induce retinoic acid receptor (RAR) signalling in T 
cells [29], FoxP3+ Treg cell differentiation, and gut-homing receptor expression 
on activated T cells when compared to CD103– DCs [9,12]. CD103+ MLN-DCs 
represent a lamina propria-derived migratory population, which acquire the 
mucosal phenotype within the intestinal environment [9,18,30-33]. Indeed, we 
[34] and others [35] have shown that contact of bone marrow-derived (BM)-DCs 
with gut epithelial cells induced expression of RALDH enzymes and educated BM-
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DCs to induce gut-homing molecules on T cells in vitro. Similar data have been 
published for human DCs [36]. Factors involved in mucosal DC imprinting include 
RA, as well as GM-CSF, IL-13, TGFb, TSLP and IL-4 [33,35-37]. Of these factors, RA 
and GM-CSF plus IL-4 have been described to contribute to RALDH expression in 
DCs [37]. 
In addition to contact with intestinal epithelial cells, DCs are in contact with microbes 
present in the intestinal lumen via pattern recognition receptors which include 
Toll like receptors (TLRs) [38,39], C-type lectin receptors [40] and intracellular 
Nod-like receptors [41]. Recently it was described that RALDH2 expression in 
both BM-DCs and splenic DCs was induced upon zymosan stimulation [42]. It is 
therefore possible that also in the intestine, TLR-mediated signals contribute to 
RALDH expression in CD103+ lamina propria DCs.
It remains to be determined how RALDH expression is regulated in MLN stromal 
cells. However, RALDH expression by adult MLN stromal cells might represent an 
intrinsic capacity, since transplanted MLN retained expression of RALDH in a skin-
draining location [10]. Also, PLN transplanted into the mesenteries maintained 
low RALDH levels compared to MLN, irrespective of intestinal-derived factors 
draining to these transplanted LN [6].
Here we show that RALDH enzymes are postnatally induced in MLN-DCs and MLN 
stromal cells suggesting that external factors during postnatal development 
are involved in maturation of the RALDH-dependent intestinal immune system. 
We found that expression and activity of RALDH enzymes is independent of 
TLR signalling, because MLN-DCs from Trif mutant, MyD88-/- and C57BL/6 WT 
animals exhibit similar RALDH activity. Remarkably, dietary vitamin A appeared 
to be crucial for RALDH expression in MLN-DCs and MLN stromal cells and loss of 
RALDH activity in mice that were deficient for vitamin A could be quickly restored 
by vitamin A supplementation. These data point to an essential role of dietary 
vitamin A for a proper functioning of the mucosal immune system.
Materials and Methods
Mice
C57BL/6 mice aged 1 to 14 weeks, MyD88-/- mice [43] and Triflps2/lps2 mice aged 10-
14 weeks were bred at our own animal facilities and were housed under specific-
pathogen-free conditions (SPF). In Triflps2/lps2 mice, the Trif protein is modified by 
a single base-pair deletion resulting in a dysfunctional protein [44]. The Animal 
Experiments Committee of the VU Medical Center approved all of the experiments 
described in this study.
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Generation of Vitamin A-deficient, -control and –high mice
C57BL/6 mice obtained from Charles River (Charles River, Maastricht, The 
Netherlands) were mated and pregnant females either received a chemically 
defined diet that lacked vitamin A (the modified AIN-93M feed, MP Biomedical, 
Solon, Ohio, USA; vitamin A deficient (VAD)), contained vitamin A (2800 IU/kg in 
the modified AIN-93M feed, MP Biomedical; vitamin A control (VAC)) or contained 
double the amount of vitamin A (5600 IU/kg in the modified AIN-93M feed, MP 
Biomedical; vitamin A high (VAH)). These diets started at 8-9 days of gestation. 
The pups were weaned at 4 weeks of age and maintained on the same diet at least 
until 10 weeks of age before analysis was performed. All mice were housed under 
SPF conditions.
Cell sorting, ALDEFLUOR assay and flow cytometry
Single cell suspensions were made by cutting LNs with scissors, followed by 
digestion at 37ºC for 20 min, using 0.5 mg/ml Blendzyme 2 (Roche, Penzberg, 
Germany) and 0.2 mg/ml DNAse I (Roche) in PBS, while constantly stirring. Cell 
clumps were removed by pipetting the cells over a nylon mesh. LN cells were 
washed and resuspended in PBS with 2% NBCS. 
For sorting of DCs and stromal cells, cells were stained with biotin conjugated 
anti-MHC-II (clone M5/114), PE conjugated anti-CD11c (clone N418, eBioscience, 
Immunosource, Halle-Zoersel, Belgium), Alexa fluor 647 (Invitrogen, Breda, The 
Netherlands) conjugated anti-CD45 (clone MP33) and 7AAD (Molecular Probes, 
Invitrogen) to discriminate between live versus dead cells. CD45+ MHC-II+ CD11c+ 
DCs and CD45– MHC-II– CD11c– stromal cells were sorted using a MoFlo XDP cell 
sorter (Beckman Coulter, Woerden, The Netherlands). 
RALDH activity in individual cells was measured using ALDEFLUOR staining kits 
(StemCell Technologies, Grenoble, France), according to the manufacturer’s 
protocol with modifications. Briefly, cells suspended at 106 cells per ml in 
ALDEFLUOR assay buffer containing activated ALDEFLUOR substrate (365 nM) with 
or without the RALDH inhibitor diethylaminobenzaldehyde (DEAB, 7.5 µM) were 
incubated for 40 min at 37°C. For flow cytometric analysis of ALDEFLUOR-reacted 
cells, cells were subsequently stained with PE conjugated anti-CD11c (clone N418, 
eBioscience), biotin conjugated anti-CD103 (clone M290, BD Bioscience, Breda, 
The Netherlands), Alexa fluor 647 conjugated anti-MHC-II (clone M5/114) and with 
Sytox Blue (Invitrogen) to discriminate between live versus dead cells. Secondary 
antibody used was PERCP conjugated (BD Bioscience) or PE-Cy7 conjugated 
streptavidin (eBioscience). Cells were analyzed with a Cyan ADP flow cytometer 
(Beckman Coulter). 
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In vitro experiments 
Bone marrow was isolated from femurs and tibia using a mortar and cultured for 
one week in IMDM medium containing 10% FCS, 50 µM b-mercaptoethanol, 1% 
L-glutamine, 1% Penicillin-Streptomycin (IMDM complete medium) and 20 ng/ml 
GM-CSF (clone X63) to obtain bone marrow derived DCs (BM-DCs). 
1x105 BM-DCs were cultured in 96-wells plates (Greiner Bio One, Alphen aan den 
Rijn, The Netherlands) for 24 hours in a volume of 200 µl IMDM complete medium 
in presence or absence of 100 nM all-trans retinoic acid (RA, Sigma-Aldrich, 
Zwijndrecht, The Netherlands). 1x106 BM-DCs were cultured for 24 hours in a 
volume of 1 ml IMDM complete medium with anti CD40 antibody (8 µg/ml, clone 
1C10), imiquimod (5 µg/ml, Cayla InvivoGen, Toulouse, France), LPS (1µg/ml, 
Sigma-Aldrich), PAM3CSK4 (100 ng/ml, Cayla InvivoGen), Phorbol 12-myristate 
13-acetate (PMA, 100 ng/ml, Sigma-Aldrich), curdlan (33 µg/ml, Sigma-Aldrich), 
Polyinosinic–polycytidylic acid sodium salt (Poly I:C, 10 µg/ml, Sigma-Aldrich) or 
zymosan (5 µg/ml, Sigma-Aldrich). 
Stromal cells from PLNs and MLNs were cultured in 96-wells plates (Greiner Bio 
One) for 7 days as described earlier [10] and incubated with 5 nM all trans-RA, 
50 nM all trans-RA and 500 nM all trans-RA in a volume of 200 µl complete IMDM 
medium for 24 hours. Cells were lysed in RLT buffer from RNeasy kit (Qiagen 
Benelux, Venlo, The Netherlands) or lysis buffer from mRNA Capture kit (Roche, 
Woerden, The Netherlands) for RNA isolation and analysis with Real time PCR.
RNA isolation and real time PCR
RNA was isolated from sorted CD45+ MHC-II+CD11c+ DCs, CD45- MHC-II- CD11c- 
LN stromal cells and stimulated BM-DCs and LN stromal cells using RNeasy kit 
(Qiagen Benelux) or mRNA Capture kit (Roche) according to the manufacturer’s 
protocol. cDNA was synthesized using RevertAid First Strand cDNA Synthesis Kit 
(Fermentas Life Sciences, Burlington, Canada) or with the Reverse Transcription 
System (Promega Benelux, Leiden, The Netherlands), respectively. Primers for 
RALDH1 (Aldh1A1), RALDH2 (Aldh1A2), RALDH3 (Aldh1A3), RARb, GM-CSF (Csf2), 
IL-4 and TGF-b1 and for housekeeping genes ubiquitin C, hprt, and GAPDH 
(Isogen Life Science, De Meern, Netherlands; Invitrogen) were designed across 
exon-intron boundaries using Primer Express software (PE Applied Biosystems, 
Foster City, CA). Real time PCR was performed on an ABI Prism 7900HT Sequence 
Detection System (PE Applied Biosystems). Total volume of the reaction mixture 
was 10 ml, containing cDNA, 300 nM of each primer and SYBR Green Mastermix 
(PE Applied Biosystems). The comparative Ct method (∆Ct) was used to assess 
relative changes in mRNA levels between samples. 
Statistics
Results are given as the mean ± SD. Statistical analyses were perfomed using the 
2-tailed Student’s t test. 
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Figure 1. RALDH expression and activity in MLN-DCs is increased during postnatal development.
(A) CD45+ MHC-II+ CD11chigh DCs were FACS-sorted from MLN and PLN from female C57BL/6 mice aged 2-3 
weeks and aged 7-9 weeks. Sorted DCs were analyzed for expression of RALDH1, RALDH2 and RALDH3 by 
real-time PCR. Relative expression levels in young PLN-DCs was set at 1. Per group 3-6 animals were used 
for FACS-sorting. Experiment was performed two times. RALDH1 expression was not detectable in these LN, 
while RALDH3 expression was too low to give any consistent difference. Significant difference is indicated by * 
(p<0.01). (B) MLN cell suspensions from C57BL/6 mice aged 1, 3, or 9 weeks were analyzed for MHC-II, CD11c 
and CD103 expression. Data represent percentage ± SD of MHC-II+ CD11chigh DCs of total LN cells (top) and 
percentage of MHC-II+ CD11chigh DCs expressing CD103 (bottom). Per group 6-7 animals were used for analysis. 
(C) CD103+ MHC-II+ CD11chigh DCs in LN cell suspensions from C57BL/6 mice aged 1, 3, or 9 weeks were analyzed 
for RALDH activity using ALDEFLUOR assay. Representative FACS plots are shown for ALDEFLUOR signal and 
CD103 expression by MHC-II+ CD11chigh DCs in PLN and MLN. Box indicates CD103 gate for calculations of 
ALDEFLUOR MFI shown in D. (D) Data represent ALDEFLUOR MFI ± SD in CD103+ LN-DCs in absence (black 
bars) or presence (grey bars) of RALDH inhibitor DEAB. Per group 7 animals were used for analysis. Significant 
differences are indicated by * (p<0.01). MLN, mesenteric lymph node; PLN, peripheral lymph node.
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Results
RALDH expression and activity is increased during postnatal development.
The enzyme RALDH2 has been described to be the most abundantly expressed 
vitamin A converting enzyme in MLN-DCs and MLN stromal cells [6,10,12,37] and 
its expression is crucial for the induction of gut-homing T cells within adult MLNs. 
In order to determine how RALDH expression in these cells is controlled we first 
investigated at what point after birth MLN-DCs and MLN stromal cells started 
to express and showed functional activity of RALDH enzymes. Hereto, MHC-II+ 
CD11c+ DCs and CD45– MLN stromal cells were sorted from MLNs and PLNs from 
C57BL/6 mice, 2-3 weeks and 7-9 weeks of age and analyzed for RALDH2 mRNA 
expression. Remarkably, at an early age, MLN-DCs showed low expression levels 
of RALDH2 with levels that were similar as measured in PLN-DCs, while adult 
MLN-DCs highly expressed RALDH2 (Figure 1A). A similar age-related distribution 
was found for CD45– MLN stromal cells sorted from mice at the age of 2-3 weeks, 
which showed significantly lower expression of RALDH2 when compared to adult 
MLN stromal cells (Supplementary Figure 1). Notably, RALDH2 expression in PLN 
stromal cells was hardly detectable and expression of RALDH1 and RALDH3 mRNA 
was undetectable in all DC and stromal cell samples. In conclusion, RALDH2 
expression in MLN-DCs and MLN stromal cells is postnatally induced over the 
course of 2-7 weeks. 
Low expression of RALDH2 in MLN-DCs at the age of 2-3 weeks could simply be 
due to a failure of lamina propria-derived DCs to migrate to the draining MLN at 
this age. However, staining for CD103, which is now a well established marker for 
lamina propria-derived DCs [9,18,31], showed that already at 1 week after birth 
approximately 50% of MHC-II+ CD11c+ DCs expressed CD103 (Fig. 1B, bottom). 
Furthermore, the percentages of MHC-II+ CD11c+ DCs (Fig. 1B, top) and of CD103+-
expressing DCs (Fig. 1B, bottom) were not different between the different ages. 
This strongly suggests that already within the first week after birth lamina propria-
derived DCs are migrating to MLNs and that RALDH levels must be lower in these 
DCs in the first weeks after birth. 
To ensure that indeed mRNA for RALDH was translated into functional protein 
RALDH enzyme activity was analyzed in MLN cells from mice at different ages 
using the ALDEFLUOR assay. With this assay RALDH activity can be measured in 
individual cells by flow cytometry with a fluorescent substrate, specific for RALDH 
enzymes. Among MLN cells, RALDH activity was detected almost exclusively in 
CD103+ MHCII+ CD11c+ cells of MLNs (Fig. 1C, left), corroborating that CD103+ 
MLN-DCs have higher RALDH mRNA levels compared to CD103- DCs in MLNs 
[12]. Notably, we were not able to detect RALDH activity in MLN stromal cells, 
since the ALDEFLUOR assay was not suitable for stromal cell analysis. At 1 and 
3 weeks of age, CD103+ MLN-DCs showed significantly lower levels of RALDH 
activity than measured in adult CD103+ MLN-DCs (Figure 1D). In addition, CD103+ 
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PLN-DCs showed very low RALDH activity at all ages analyzed. In conclusion, not 
only RALDH expression, but also RALDH activity increased in MLN-DCs during 
postnatal development. 
RALDH enzyme activity is not dependent on TLR signalling.
Next, we questioned how the expression and activity of RALDH is regulated 
during postnatal development. Mice are essentially born germ-free, but soon after 
birth, mucosal surfaces are colonized with high numbers of bacteria [45,46]. It is 
therefore conceivable that the induction of RALDH in MLN-DCs and MLN stromal 
cells is linked to postnatal colonization of the intestine by commensal bacteria. 
Also, recently it was described that both bone marrow derived DCs (BM-DCs) and 
splenic DCs were induced to express RALDH2 upon zymosan stimulation [42]. 
Indeed, we confirmed that RALDH2 expression was induced in zymosan-treated 
BM-DCs (Figure 2A), but we also observed a significant induction upon stimulation 
with PAM3CSK4, PMA, curdlan and LPS (Figure 2A). Since we and others [42] found 
Figure 2. RALDH activity in MLN-DCs is independent of MyD88- and Trif-dependent signalling.
(A) BM-DCs from C57BL/6 mice were incubated with different TLR ligands for 24 hours. Relative mRNA 
expression levels of RALDH2 were measured by real time PCR. Relative expression in control BM-DCs (co) was 
set at 1. The experiment was performed 3 times. Significant differences are indicated by * (p<0.05) and ** 
(p<0.02).  (B,C) MHC-II+ CD11chigh DCs in MLN and PLN cell suspensions from 10-14 week old C57BL/6, MyD88-
/- mice and Trif mutant were analyzed for RALDH activity using ALDEFLUOR assay. Data represent ALDEFLUOR 
MFI ± SD in CD103+ MLN- and PLN-DCs in absence or presence of RALDH inhibitor DEAB for MyD88-/- animals 
(A) and Trif mutant animals (B) compared to C57BL/6. For each experiment 5 MyD88-/-, 6 Trif mutant mice and 
5 C57BL/6 mice were used. 
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TLR-induced upregulation of RALDH2 expression in DCs in vitro, we analyzed 
that RALDH enzyme activity in MLN-DCs from MyD88-/- and Trif mutant mice. 
Analysis of MLN-DCs from MyD88-/- (Figure 2B) and Trif mutant mice (Figure 2C) 
showed that normal RALDH enzyme activity could be measured in these DCs, 
substantiating that TLR signalling via these adaptor proteins is not mandatory for 
induction of RALDH in MLN-DCs in vivo [47]. 
RALDH enzyme activity was abrogated in vitamin A deficient mice.
Since it has been shown that intestinal epithelial factors, among which the vitamin 
A metabolite retinoic acid (RA), induce RALDH expression in BM-DCs [35], we 
decided to address whether dietary vitamin A is crucial for the postnatal induction 
of RALDH enzyme activity. C57BL/6 mice were raised on a vitamin A deficient 
(VAD) and compared with animals raised on vitamin A control diet (VAC) or vitamin 
A high diet (VAH, containing double the amount of vitamin A). Serum retinol levels 
in 10 week-old VAC and VAH mice were 1.30 ± 0.01 µM and 1.43 ± 0.17 µM 
respectively, while serum retinol levels in VAD mice were undetectable at this 
age (detection limit 0.10 µM). Within the MLN, the proportion of DCs expressing 
CD103 was comparable in all 3 groups, showing that lamina propria-derived 
DCs were normally present in the MLNs (Figure 3A). Remarkably, the absence 
of dietary vitamin A almost abrogated RALDH enzyme activity, since ALDEFLUOR 
levels measured in MLN-DCs from VAD mice were reduced by 94% when compared 
Figure 3. Dietary vitamin A regulates RALDH enzyme expression and activity in MLN-DCs. 
(A,B) MHC-II+ CD11chigh DCs in MLN from C57BL/6 mice on vitamin A deficient (VAD), vitamin A control (VAC) 
or vitamin A high (VAH) diet aged 10 weeks were analyzed for CD103 expression and RALDH activity using 
ALDEFLUOR assay. Per group 7 animals were used for analysis. (A) Data represent percentage ± SD of MHC-II+ 
CD11chigh DCs expressing CD103 in individual MLNs. (B) Graphs show ALDEFLUOR MFI ± SD in CD103+ MLN-DCs 
and PLN-DCs from VAD, VAC and VAH mice in absence (black bars) or presence (grey bars) of RALDH inhibitor 
DEAB. (C,D) CD45+ MHC-II+ CD11chigh MLN-DCs and CD45– MLN stromal cells were FACS-sorted from male VAD 
and VAC C57BL/6 mice, aged 11 weeks. Sorted cells were analyzed for expression of RALDH1, RALDH2 and 
RALDH3 by real-time PCR. Relative expression levels in VAC MLN-DCs (C) or in VAC MLN stromal cells (D) was 
set at 1. RALDH1 and RALDH3 expression were too low to give any consistent difference. Per group 6 animals 
were used for FACS-sorting. Experiment was performed two times. Significant differences are indicated by * 
(p=0.01), ** (p<0.001) and *** (p=0.05).
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to MLN-DCs from VAC and VAH mice and comparable to levels observed in PLN-
DCs (Figure 3B). In addition, RALDH enzyme activity in MLN-DCs from VAC and 
VAH mice was comparable, indicating that extra dietary vitamin A did not further 
increase RALDH enzyme activity in MLN-DCs (Figure 3B). 
To evaluate whether dietary vitamin A also influenced RALDH mRNA expression, 
both CD45– MLN stromal cells and MHC-II+ CD11c+ MLN-DCs were sorted from 
VAD and VAC mice and analyzed for RALDH2 mRNA expression. In agreement 
with our observation that RALDH enzyme activity in DCs required dietary vitamin 
A, RALDH2 mRNA expression levels in MLN-DCs from VAD mice were significantly 
reduced when compared to MLN-DCs from VAC mice (Figure 3C). In addition, 
CD45- MLN stromal cells sorted from VAD mice also showed significantly lower 
levels of RALDH2 mRNA when compared to VAC mice (Figure 3B). In conclusion, 
dietary vitamin A is crucial for RALDH2 mRNA expression in both MLN-DCs and 
MLN stromal cells. 
Figure 4. RALDH activity in VAD MLN-DCs is restored upon vitamin A supplementation. 
MHC-II+ CD11chigh DCs in MLN cell suspensions from C57BL/6 mice, aged 12 weeks, on vitamin A deficient (VAD), 
vitamin A high (VAH) diet or from VAD mice that received VAH diet for 7 days (VAD>VAH) were analyzed for 
CD103 expression and RALDH activity using ALDEFLUOR assay. (A) Shown are representative flow cytometry 
plots of ALDEFLUOR activity and CD103 expression of MHC-II+ CD11chigh DCs from PLN and MLN. Box indicates 
CD103 gate for calculations of ALDEFLUOR MFI shown in B. (B) Graphs show ALDEFLUOR MFI ± SD in MLN-DCs 
from VAH, VAD and VAD > VAH mice in absence (black bars) or presence (grey bars) of RALDH inhibitor DEAB. 
Per group 8 animals were used for analysis. Experiment was performed two times. (C) RNA was isolated from 
MLN suspensions from VAH, VAD and VAD > VAH mice and analyzed for RALDH2 expression with real time 
PCR. Per group 3 MLNs were used for analysis. RALDH1 and RALDH3 expression were undetectable in these 
samples. Significant differences are indicated by * (p=0.05) and ** (p<0.002). 
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Restoration of RALDH enzyme activity in MLN-DCs upon vitamin A 
supplementation.
As the lack of vitamin A in food abrogates RALDH activity in both MLN-DCs and 
MLN stromal cells, we questioned whether we could rescue this by feeding the 
VAD animals a vitamin A high (VAH) diet for 7 days (VAD>VAH). Surprisingly, 
supplementation with vitamin A resulted in a significant increase of ALDEFLUOR+ 
CD103+ MLN-DCs in these mice when compared to VAD animals (Figure 4A, B). 
Moreover, RALDH2 mRNA expression levels in total MLN, to which both DCs 
and stromal cells contribute, were increased upon vitamin A supplementation 
of VAD mice (Figure 4C). These results show that already after 7 days of vitamin 
A supplementation, the effects of vitamin A deficiency on RALDH enzymes were 
reverted and that MLN-DCs were able to quickly respond to nutritional status. 
Retinoic acid directly regulated RALDH enzyme expression in LN stromal 
cells and dendritic cells.
Our data suggest that RA, derived from vitamin A, is crucial for RALDH expression 
in MLN-DCs and MLN stromal cells and we hypothesized that RA itself may directly 
induce RALDH expression in these cells. Indeed, several of the genes involved in the 
metabolic pathway of vitamin A are positively induced by RA [48-51], thus creating 
a positive feedback loop. We therefore determined whether RALDH expression in 
LN stromal cells and BM-DCs could be induced by addition of increasing amounts 
of RA in vitro. Expression of RALDH2 was significantly induced in PLN stromal 
cells by addition of 50 nM RA (Figure 5A, left), while at high RA concentrations 
Figure 5. Regulation of RALDH expression in dendritic cells and LN stromal cells by RA. 
(A) PLN and MLN stromal cells were cultured for 7 days and subsequently stimulated with 5 nM, 50 nM or 500 
nM RA. After 24 hours, PLN stromal cells (A, left) and MLN stromal cells (A, right) were analyzed for RALDH2 
expression with real time PCR. Relative expression levels in unstimulated MLN stromal cells (control) was set 
at 1. Experiment was performed 3 times. (B) BM-DCs were cultured alone or in presence of 100 nM RA. After 
24 hours, BM-DCs were analyzed for expression of RALDH1, RALDH2 and RALDH3 by real-time PCR. Relative 
expression levels in control DCs (DC only) was set at 1 for each RALDH gene. Experiment was performed 4 
times. Significant differences are indicated by * (p<0.001), ** (p=0.01) and *** (p=0.05).
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Figure 6. Expression of RALDH enzymes in small intestines is not affected by dietary vitamin A 
deficiency. 
Expression of RALDH1, RALDH2, RALDH3 mRNA (A) and RARmRNA (B) were analyzed in small intestine 
samples from VAD and VAC mice by real time PCR. Expression of transcripts was normalized to Cyclophilin A 
and Ubiquitin C. Relative expression levels in VAC small intestines was set at 1.0 for each gene analyzed. Per 
group 3 animals were used. Significant differences are indicated by * (p=0.02) and ** (p=0.001). (C) Expression 
levels of RARmRNA were analyzed in small intestine samples from VAD, VAH and VAD mice supplemented 
with vitamin A (VAD>VAH) by real time PCR. Expression of transcripts was normalized to Cyclophilin A and 
Ubiquitin C. Relative expression levels in VAH small intestines was set at 1.0 for each gene analyzed. Per group 
5 animals were used. Significant differences are indicated by * (p=0.02) and ** (p<0.001). 
(500 nM), no induction of RALDH expression could be observed. Additionally, 
analysis of MLN stromal cells demonstrated a reduction of RALDH2 expression 
with increasing amounts of RA (Figure 5A, right). Furthermore, BM-DCs stimulated 
in vitro with 100 nM RA showed a 5-fold higher expression of RALDH2 mRNA, 
while induction of RALDH1 and RALDH3 enzymes was not significantly affected 
(Fig 5B). Since epithelial cells express RALDH1 enzymes and can thus produce 
RA [25-27,52], epithelial-derived RA might be an important imprinting factor for 
inducing RALDH2 expression in lamina propria-DCs. For MLN stromal cells the 
transport of vitamin A by the lymph may be of importance [53,54]. Overall, these 
data imply that RA can imprint both DCs and LN stromal cells in a dose dependent 
manner.
RALDH expression in small intestines is not affected by vitamin A deficiency.
Since RALDH expression in MLN-DCs and MLN stromal cells is dependent on vitamin 
A, we reasoned that the levels of RALDH expression in epithelial cells within the 
small intestine may also depend on dietary vitamin A. We tested small intestines 
from VAD and VAH mice for mRNA expression of RALDH1, RALDH2 and RALDH3 
enzymes using real time PCR. Remarkably, during vitamin A deficiency, RALDH1 
and RALDH2 mRNA expression levels were not altered and were comparable to 
levels observed in VAC small intestines (Figure 6A). RALDH3 expression was 
significantly increased during vitamin A deficiency, indicating the presence of a 
compensatory mechanism for RA production by increasing RALDH3 expression.
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RARβ is a nuclear receptor for RA and known to be a direct target gene of RA 
[48,50]. Expression levels of RARb mRNA can thus be viewed as an indicator of 
RA-mediated signalling within cells. Analysis of RARb showed that mRNA levels 
were indeed strongly reduced in VAD small intestine (Figure 6B), showing that RA-
mediated signalling is absent within the intestine of VAD mice. The absence of RA-
mediated signalling within the intestine could be restored by supplementation of 
VAD mice with dietary vitamin A for 7 days since RARb expression was significantly 
induced in the supplemented VAD mice (VAD>VAH) when compared to VAD 
animals (Figure 6C). From this we can conclude that vitamin A supplementation of 
VAD mice leads to its conversion to RA and induction of RA-mediated signalling, 
resulting in the induction of RALDH expression MLN-DCs and MLN stromal cells.
Discussion
We have demonstrated that during postnatal development RALDH enzymes are 
upregulated in MLN-DCs and MLN stromal cells, pointing to environmental factors 
involved in the induction. RALDH activity in MLN-DCs was not affected when 
microbial triggering via TLRs was diminished, as seen in mice defective in Trif- 
and MyD88-dependent signalling, while the intake of vitamin A turned out to be 
instrumental for RALDH activity within the mucosal immune system. Not only 
RALDH expression in DCs, but also in MLN stromal cells was critically dependent 
on vitamin A consumption. Notably, RALDH enzyme activity in MLN-DCs could 
quickly be restored in vitamin A deficient animals by vitamin A supplementation. 
These data give further insight in the mechanisms of how vitamin A affects the 
functioning of the mucosal immune system.
Mice are essentially born germ-free, but soon after birth, mucosal surfaces are 
colonized with high numbers of bacteria [45,46]. Germ-free mice show reduced 
numbers of lamina propria CD4+ T cells, IgA producing B cells and intra epithelial 
lymphocytes [55,56], and MLNs and spleens are smaller and less cellular [57]. 
This indicates that commensal bacteria play a crucial role in the maturation of the 
mucosal immune system during postnatal development. Therefore, we speculated 
that TLR triggering might be involved in the induction of RALDH expression, as 
suggested previously [37,42]. However, MLN-DCs from both MyD88-/- and Trif 
mutant animals had comparable levels of RALDH activity to WT animals in vivo. 
This suggests that the regulation of RALDH activity in MLN-DCs in vivo does 
not involve MyD88- and Trif-dependent TLR signalling, confirming the recent 
findings that MLN-DCs from mice deficient for both MyD88 and Trif still showed 
ALDELFUOR activity [47]. Nevertheless, it is conceivable that other pattern 
recognition receptor pathways may overcome the deficiency of Trif or MyD88 
proteins in vivo. The literature indicates however that DCs, which are exposed to 
intestinal factors, express lower TLR levels and are thus less well able to respond 
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to TLR ligands [12,32,32,58,59]. This could explain our finding that MyD88 and 
Trif are dispensable for RALDH expression in CD103+ MLN-DCs in vivo. In contrast, 
our data showed that vitamin A-derived RA is mandatory for RALDH expression 
and activity in MLN-DCs. Remarkably, in addition to the inhibitory effect of RA on 
TLR responsiveness in DCs, RA has been shown to increase intestinal epithelial 
barrier function [60,61]. Therefore, in case of vitamin A deficiency, the intestinal 
barrier might be compromised resulting in enhanced invasion of bacteria and 
enhanced exposure of DCs to TLR ligands. Despite potentially enhanced bacterial 
invasion and exposure, we could not observe RALDH enzyme activity in lamina 
propria-derived DCs during vitamin A deficiency. 
Intestinal epithelial cells produce a vast array of soluble factors which are thought 
to license lamina propria DCs to induce gut-homing T cells through the expression 
of RALDH enzymes [34,35]. Factors produced by epithelial cells include RA, as well 
as GM-CSF, IL13, TGFb, TSLP and IL-4. Of these factors, RA was shown to be crucial 
for the imprinting of the mucosal DCs phenotype (this paper and [35]). At first this 
seems to be contradicted by statements that RA could only weakly induce RALDH 
expression FLt3L derived BM-DCs [37], however the concentration used (1µM RA) 
was within the range at which we also fail to induce RALDH expression in BM-DCs. 
Both our data and data from others [35] showed that RA used at concentrations 
around 100 nM can significantly induce RALDH2 expression in BM-DCs while a 
further increase of RA seems to inhibit expression of RALDH2. Negative regulation 
of RALDH2 by RA has indeed been described to occur upon excessive RA 
administration during embryonic development [62]. Moreover, GM-CSF plus IL-4 
have been described to contribute to the expression of RALDH enzymes in Flt3L-
BM-DCs [37]. GM-CSF is produced in the intestines and MLNs by macrophages and 
granulocytes [37]. MLN-DCs from beta-c-/- animals, lacking the GM-CSF receptor, 
showed a reduction of approximately 50%, while the absence of dietary vitamin A 
resulted in a 94% reduction (Figure 3B). It is conceivable that GM-CSF within the 
small intestine is also controlled by RA and that VAD mice produce low levels of 
GM-CSF leading to lack of RALDH2 induction. We tested this hypothesis and found 
that, on the contrary, GM-CSF levels were not different in the small intestines and 
MLNs of VAD mice and VAC mice (Supplementary Figure 2). In addition to GM-
CSF, IL-4 and TGF-b1 were tested and, although TGF-b1 was significantly lower 
in MLNs from VAD mice, levels of IL-4 and TGF-b1 were found not to be different 
in the small intestines of VAD mice and VAC mice (Supplementary Figure 2). We 
therefore conclude that lack of RALDH2 in MLN-DCs does not correlate with the 
absence of GM-CSF, IL-4 and TGF-b1 in VAD mice.
It is intriguing that RALDH levels in MLN DCs and stromal cells are slowly induced 
after birth. Vitamin A-derived RA is crucial for embryonic development and is 
transplacentally delivered from the mother to the embryo. Embryos, however, do 
not store this vitamin A and embryos and newborn mice have very low levels of 
vitamin A in their livers compared to adult mice [63,64]. Postnatally, newborn mice 
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receive high amounts of vitamin A via breast milk allowing to build up vitamin A 
stores in the liver. Perhaps that first sufficient liver stores need to be generated 
before vitamin A, bound to its transporter protein RBP4, can be transported 
through the blood in sufficient amounts to other tissues like intestines and MLNs. 
During vitamin A deficiency, RALDH expression could still be detected in the small 
intestines, while RARb expression was virtually absent, indicating that RA-mediated 
signalling no longer occurred. Thus, although epithelial cells of VAD mice were 
still capable of converting vitamin A, lack of vitamin A resulted in the absence of 
RA and consequently in the failure to induce RALDH expression in lamina propria-
derived DCs and MLN stromal cells. These data showed that dietary vitamin A has 
a profound effect on RALDH enzymes in DCs and stromal cells, while it does not 
regulate RALDH expression in the small intestine. Other factors, possibly present 
in the intestinal lumen, may contribute to RALDH expression by epithelial cells. 
Since intestinal epithelial cells express RALDH1 and have been shown to be able 
to imprint DCs in a RA-dependent manner [7,26,35], these cells are most likely the 
providers of RA for induction of RALDH in lamina propria DCs. It will therefore be 
of importance to establish whether RALDH levels in the intestinal epithelial cells 
are constant or whether they are also controlled by environmental factors.
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Supplementary figure 1. RALDH expression in MLN stromal cells is increased during postnatal 
development.
RNA was isolated from FACS-sorted CD45- PLN and MLN stromal cells from young female C57BL/6 mice, 
aged 2-3 weeks, and from adult female C57BL/6 mice, aged 7-9 weeks. Cells were analyzed for relative 
expression levels of RALDH enzymes by real-time PCR. RALDH1 and RALDH3 expression were too low to give 
any consistent difference. Experiment was performed two times. Per group 3-6 animals were used for FACS-
sorting. Significant difference is indicated by * (p<0.001).
Supplementary figure 2. GM-CSF levels in small intestines and MLNs remain unchanged during 
vitamin A deficiency.
Expression levels of GM-CSF, IL-4 and TGF-β1 mRNA were analyzed in small intestines (A) and MLNs (B) from 
VAD and VAH by real time PCR. Expression of transcripts was normalized Ubiquitin C. Relative expression 
levels in VAH small intestines (A) and VAH MLNs (B) was set at 1.0. In this experiment small intestines from 
5 animals and MLNs from 3 animals were used for mRNA analysis. Significant difference is indicated by * 
(p=0.003).
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Abstract
The vitamin A metabolite retinoic acid (RA) has been reported to suppress Th1 
responses and enhance Th2 responses. Here we investigated whether differences 
in vitamin A metabolism could underlie the differences between C57BL/6 and 
BALB/c mice, which are reportedly seen as Th1 and Th2 responders, respectively. 
BALB/c mice were shown to have higher RALDH activity in MLN-DCs, increased 
ability to induce CCR9 expression on CD4+ T cells and more FoxP3 regulatory T 
cells. Within BALB/c small intestines, higher expression levels of RALDH enzymes, 
RA-mediated signalling and IgA secretion was observed, as well as increased 
accumulation of T cells and B cells in the small intestinal lamina propria. Therefore, 
the level of RA production and consequently the degree of RA-mediated signalling 
is crucial for the efficiency of the mucosal immune system.
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Introduction
Vitamin A has long been known for its role in immunity, especially since vitamin 
A deficiency ablates proper mucosal immune responses, leading to diarrhea, 
infections and early childhood mortality [1-3]. Vitamin A is a fat soluble vitamin 
and is absorbed from the gastrointestinal tract. It can be consumed preformed as 
retinyl esters, as found in animal source foods such as liver, egg, fish and whole 
fat dairy products [3]. Dietary vitamin A can also be obtained from provitamin 
A carotenoids as found in vegetables and fruits. Vitamin A is metabolized into 
the active metabolite retinoic acid (RA) in two oxidative steps. Vitamin A is first 
reversibly oxidized by alcohol dehydrogenases (ADH) to form retinaldehyde. 
Next, retinaldehyde is irreversibly metabolized to RA by three members of the 
aldehyde dehydrogenase gene family, ALDH1A1 (RALDH1), ALDH1A2 (RALDH2) 
and ALDH1A3 (RALDH3) [4-6]. The active metabolite RA binds to retinoic acid 
receptors (RARs) which in turn act as transcription factors that bind retinoic acid 
responsive elements within the promoter regions of target genes [7-9].
RALDH expression is associated with the mucosal immune system and reported 
to be functionally active within intestinal epithelial cells [10-12]. Also, dendritic 
cells (DCs) in Peyers’ patches (PPs), mesenteric lymph nodes (MLNs) and intestinal 
lamina propria express RALDH enzymes, while splenic or peripheral LN (PLN)-DCs 
display only very low expression [13-17]. Furthermore, stromal cells within MLNs 
express RALDH enzymes [14,16]. We have shown that RA itself directly regulates 
the level of RALDH expression in BM-DCs as well as LNstromal cells in vitro, and 
that RALDH expression within the mucosal immune system requires dietary intake 
of vitamin A (chapter 4). Generation of RA is crucial for the induction gut-homing 
molecules a4b7 and CCR9 on activated T cells [17]. Furthermore, the induction 
of FoxP3 regulatory T cells relies on RA, in combination with TGFb [13,18-23], 
while it suppresses the differentiation of Th17 cells [18,21,22]. Moreover, RA 
is reported to skew immunoglobulin class switching in B cells to an increased 
secretory IgA production [24-26], which protects the host against the vast array of 
microbes constantly present in the intestinal lumen. Therefore, RA appears to be 
a key molecule that controls mucosal immune responses. 
The genetic background of inbred mice was found to be a determing factor in 
the preferential induction of either a Th1 or Th2 immune response [27,28]. The 
subset of T cells termed Th1 cells, which produce interleukin-2 (IL-2), interferon-g 
(IFNg) and lymphotoxin, are important mostly for immunity against intracellular 
pathogens, such as Leishmania major. In contrast, Th2 cells produce IL-4, IL-
5, IL-10 and IL-13, which contributes to the direct enhancement of humoral-
mediated immunity. T cells from C57BL/6 mice preferentially produce Th1 
cytokines with high IFNg and low IL-4, whereas T cells from BALB/c mice favor 
Th2 cytokine production with low IFNg and high IL-4 when stimulated in vitro [27]. 
Interestingly, it has been shown that RA can suppress Th1 responses and enhance 
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Th2 responses [15]. In this study we therefore investigated whether C57BL/6 
and BALB/c mice differ in the metabolism of vitamin A and in mucosal immune 
functions that are RA-dependent. We demonstrate that MLN-DCs from BALB/c 
mice displayed higher RALDH activity, which correlated with increased induction 
of gut-homing molecules on CD4+ T cells and more FoxP3+ regulatory T cells. In 
addition, BALB/c mice showed higher expression levels of RALDH enzymes and 
RA-mediated signalling within the small intestines compared to C57BL/6 mice. 
Within the lamina propria of the small intestines, an increased accumulation of 
T cells and B cells was observed in BALB/c mice, with a concomitantly enhanced 
secretion of IgA into the intestinal lumen. In conclusion, enhanced RA production 
in BALB/c mice is associated with the development of a more efficient mucosal 
immune system. 
Materials and Methods
Mice
C57BL/6 mice and BALB/c mice aged 10-14 weeks were obtained from Charles 
River (Charles River, Maastricht, The Netherlands). DO11.10 transgenic mice and 
OT-II transgenic mice were bred at the animal facility of the VU Medical center 
and used at the age of 7 weeks. Both DO11.10 mice, generated on a BALB/c 
background, and OT-II mice, generated on a C57BL/6 background, have CD4 
T cells with a transgenic T cell receptor specific for the ovalbumin (OVA) 323-
339 peptide. All mice were kept under standard animal housing conditions. The 
Animal Experiments Committee of the VU Medical Center approved all of the 
experiments described in this study.
T cell enrichment, CFSE labelling, transfer and antigenic stimulation
Spleens and LNs from DO11.10 and OT-II mice were minced through a 100-mm 
gauze to obtain single cell suspensions. To deplete erythrocytes from spleen cell 
suspensions, cells were incubated for 2 minutes on ice in lysis buffer (150 mM NH4, 
1 mM NaHCO3, pH 7.4). CD4
+ cells were enriched using the CD4 negative selection 
kit (Dynal, Invitrogen, Breda, The Netherlands). Cells were labelled with 5 mM of 
5,6-carboxyfluorescein succinimidyl ester (CFSE; Molecular Probes, Invitrogen) at 
3x107 cells/ml for 10 min at 37˚ C, after which the cells were washed. BALB/c 
and C57BL/6 mice were injected with approximately 4x106 OVA-specific T cells 
and received 50 mg OVA (Sigma-Aldrich, Zwijndrecht, The Netherlands) in 200 ml 
saline 24 hours later by intragastric (i.g.) administration. Seventy-two hours after 
antigenic stimulation, MLNs were dissected and used as single cell suspensions 
for FACS analysis. 
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Flow cytometry and ALDEFLUOR assay
Single cell suspensions were made by cutting LNs with scissors, followed by 
digestion at 37ºC for 25 min while constantly stirring, using 0.5 mg/ml Blendzyme 
2 (Roche, Penzberg, Germany) and 0.2 mg/ml DNAse I (Roche) in PBS. Cell clumps 
were removed by pipetting the cells over a nylon mesh. The LN cells were washed 
and resuspended in PBS with 2% NBCS. 
RALDH activity in individual cells was measured using the ALDEFLUOR assay 
kit (StemCell Technologies, Grenoble, France), according to the manufacturer’s 
protocol with modifications. Briefly, cells resuspended at 106 cells per ml in 
ALDEFLUOR assay buffer containing activated ALDEFLUOR substrate (365 nM) with 
or without the RALDH inhibitor diethylaminobenzaldehyde (DEAB, 7.5 µM) were 
incubated for 40 min at 37°C. For flow cytometric analysis of ALDEFLUOR-reacted 
cells, cells were subsequently stained with PE conjugated anti-CD11c (clone 
N418, eBioscience, Immunosource, Halle-Zoersel, Belgium), biotin conjugated 
anti-CD103 (clone M290, BD Bioscience, Breda, The Netherlands) Alexa fluor 
(Invitrogen, Breda, The Netherlands) 647 conjugated anti-MHC-II (clone M5/114) 
and with Sytox Blue (Invitrogen) to discriminate between live versus dead cells. 
Secondary antibody used was Percp conjugated (BD Bioscience) or PE-Cy7 
conjugated streptavidin (eBioscience).
Upon OVA administration, MLNs were isolated from BALB/c and C57BL/6 
mice and single cell suspensions were made by digestion as described above. 
Subsequently, cells were stained with biotin conjugated anti-mouse DO11.10 
TCR (KJ1-26, Caltag Laboratories, Burlingame, CA) or PE conjugated anti-mouse 
Va2 TCR (clone B20.1, eBioscience) to identify OVA-specific T cells in BALB/c and 
C57BL/6 mice, respectively. To analyze expression of gut-homing molecules, 
cells were also stained with anti-a4b7integrin (clone DATK32, kindly provided 
by Dr. Alf Hamann, Charité Universitätsmedizin Berlin, Germany) and anti-CCR9 
(clone 7E7, kindly provided by Prof. Dr. Reinhold Förster, Hannover Medical 
School, Hannover, Germany), in combination with PE-Cy7 conjugated anti-CD4 
(clone GK1.5, eBioscience) and Sytox Blue (Invitrogen) to discriminate between 
live versus dead cells. Secondary antibody used was Alexa 647 conjugated anti-
rat antibody (Invitrogen). Cells were analyzed with a Cyan ADP flow cytometer 
(Beckman Coulter, Mijdrecht, The Netherlands). 
Intracellular FoxP3 staining 
Cell suspensions were prepared from C57BL/6 and BALB/c MLNs by digestion as 
described above. Cells were stained with Alexa 488 conjugated anti-CD4 (clone 
GK1.5) and biotin conjugated anti-CD25 (clone 7D4, BD Bioscience). Secondary 
antibody used was PE-Cy7 conjugated streptavidin (eBioscience). For Foxp3 
staining, cells were subsequently fixed in Fix/Perm buffer (eBioscience), followed 
by permeabilization and staining for Foxp3 with Alexa 647 conjugated anti-
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Foxp3 (clone FJK-16s, eBioscience) according to the manufacturer’s instructions 
(eBioscience). Cells were analyzed with a Cyan ADP flow cytometer (Beckman 
Coulter).
Enzyme-linked immunosorbent assay for secretory IgA
The faeces of the small intestines (SI) of C57BL/6 and BALB/c mice were collected 
in cold PBS buffer (faecal content of 33 cm SI in 2 ml PBS). Debris was removed by 
cold centrifugation for 20 min at 2000 rpm to harvest the supernatant for analysis 
of secretory IgA after an appropriate dilution. Secretory IgA was determined 
by sandwich-ELISA according to the manufacturer’s protocol (Gentaur Europe, 
Brussels, Belgium), in which the anti-mouse IgA capture antibody was coated on 
the plate and bound faecal IgA was detected with horseradish peroxidase labeled 
anti-mouse IgA detecting antibody. Samples were analyzed with a Fluostar Optima 
microplate reader (BMG Labtech, Isogen Lifescience, de Meern, The Netherlands). 
The concentration of secretory IgA was expressed as µg/ml PBS-dissolved faeces. 
RNA isolation and real time PCR
Small intestines were dissected from C57BL/6 and BALB/c mice, flushed with 
PBS and homogenized in TRIZOL (Gibco, Invitrogen). RNA was isolated by 
precipitation with isopropanol. The concentration of RNA was measured with the 
Nanodrop Spectrophotometer (Nanodrop Technologies, Wilmington, DE). cDNA 
was synthesized from total RNA using RevertAid First Strand cDNA Synthesis Kit 
(Fermentas Life Sciences, Burlington, Canada) according to the manufacturer’s 
protocol. 
Mesenteric lymph node cells from C57BL/6 and BALB/c were lysed and mRNA 
was isolated using the mRNA capture kit (Roche). cDNA was synthesized with the 
Reverse Transcriptase kit (Promega, Leiden, The Netherlands) according to the 
manufacturer’s protocol. 
Specific primers for CD45, CD3, CD19, Foxp3, Csf2 (GM-CSF), IL-4, IFNg, RARb, 
RALDH1 (Aldh1A1), RALDH2 (Aldh1A2), and RALDH3 (Aldh1A3) and primers for 
housekeeping genes Ubiquitin C and GAPDH (Isogen Life Science, De Meern, 
Netherlands; Invitrogen) were designed across exon-intron boundaries using 
Primer Express software (PE Applied Biosystems, Foster City, CA) and Vector NTI 
software (Invitrogen). Real time PCR analysis was performed on an ABI Prism 
7900HT Sequence Detection System (PE Applied Biosystems). Total volume of the 
reaction mixture was 10 ml, containing cDNA, 300 nM of each primer and SYBR 
Green Mastermix (PE Applied Biosystems).
Statistics
Results are given as the mean ± SD. Statistical analyses were perfomed using the 
2-tailed Student’s t test. 
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Results
BALB/c express higher levels of RALDH enzymes in small intestines compared 
to C57BL/6.
Since BALB/c mice are known as prototypical Th2-type mice and RA has been 
described to skew T cells towards the Th2-type profile upon activation, while 
inhibiting Th1 cytokine production [15,18], we hypothesized that the expression 
of RA-producing enzymes may be differentially expressed by BALB/c and C57BL/6 
mice. Since epithelial cells from the small intestines are known to express RALDH 
enzymes [10-12], we decided to compare RALDH mRNA levels in the small intestines 
of both mouse strains with real time PCR. Indeed, expression of RALDH1, -2, and 
-3 was significantly enhanced in BALB/c small intestines compared to C57BL/6 
(Figure 1A). The largest difference was observed for RALDH1, which is known 
to be highly expressed by epithelial cells lining the gut [17,29]. Remarkably, 
Figure 1. RALDH enzyme expression is increased in BALB/c small intestine.
Expression levels of RALDH1, RALDH2, RALDH3 mRNA (A), RARb mRNA (C) and GM-CSF (D) were analyzed 
in small intestine samples from C57BL/6 (black bars) and BALB/c (grey bars) by real time PCR. Expression of 
transcripts was normalized to Ubiquitin C. Relative expression levels in C57BL/6 small intestines was set at 
1.0 for each gene analyzed. Per group 5 animals were used. (B) Expression of RALDH1 mRNA was analyzed in 
proximal, middle and distal parts of the small intestine. Expression of transcripts was normalized to Ubiquitin 
C. Relative expression levels in the proximal C57BL/6 small intestine was set at 1.0. Five animals were used 
for analysis. (E) Expression levels of IFNg and IL-4 mRNA were analyzed in whole small intestine samples from 
C57BL/6 and BALB/c by real time PCR. Expression of transcripts was normalized to CD3 mRNA levels. Relative 
expression levels in C57BL/6 small intestines was set at 1.0 for both genes analyzed. Per group 5 animals were 
used. Significant differences are indicated by * (p<0.05), ** (p=0.02), or *** (p=0.001).
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when expression of RALDH1 was analyzed along the gut axis, starting at the 
stomach, we observed the highest expression in the proximal small intestine, 
while expression decreased towards the distal part of the small intestines (Figure 
1B). In all three parts analyzed, RALDH1 expression was significantly higher in 
BALB/c mice compared to C57BL/6 mice.
RARb is a retinoic acid receptor, known to be a direct target gene of RA [30,31]. 
Expression levels of RARb mRNA can therefore be viewed as an indicator of RA-
mediated signalling in cells. Analysis of RARb showed that mRNA levels were 
significantly increased in BALB/c small intestine compared to C57BL/6, indicating 
that within the small intestines of BALB/c mice more RA-mediated signalling is 
taking place (Figure 1C). Since a relation between GM-CSF-mediated signalling 
and RALDH expression in DCs has been suggested in literature [32] we also 
checked whether GM-CSF levels were different between the 2 mouse strains. No 
significant difference could be found (Figure 1D). As a control, we analyzed IFNg 
and IL-4 mRNA levels, corrected for CD3 mRNA expression, in small intestines as 
markers for Th1- and Th2-skewing, respectively. As expected, IFNg expression 
was significantly higher in C57BL/6 small intestines, while the expression of 
IL-4 mRNA was significantly higher in small intestine samples from BALB/c mice 
(Figure 1E). 
BALB/c MLN-DCs show higher RALDH activity than C57BL/6 MLN-DCs.
Studies have shown that CD103+ MLN-DCs represent a population of migratory DCs 
derived from the lamina propria, transporting orally derived Ag from the intestine 
to the MLN and inducing gut-tropic T cells and regulatory T cells [33,34]. It has 
been hypothesized that DC acquire the mucosal phenotype within the intestinal 
environment, which is created by the epithelial cells. Indeed, we and others have 
shown that contact of BM-derived DCs with gut epithelial cells induced expression 
of RALDH enzymes and educated BM-derived DCs to induce gut-homing T cells in 
vitro [35,36]. Furthermore, we have shown that RA directly induces RALDH enzyme 
expression levels in BM-DCs in vitro (chapter 4) and that in the absence of RA, 
RALDH expression is lacking in CD103+ DCs in MLNs. We therefore tested whether 
the increased RA-mediated signalling observed in small intestines of BALB/c mice 
could result in higher RALDH enzyme activity in CD103+ MLN-DCs when compared 
to C57BL/6 mice. RALDH activity was measured using the ALDEFLUOR assay, 
a flow cytometry-based assay with a fluorescent substrate which is specific for 
RALDH enzymes. Notably, the percentage of MHCII+ CD11c+ DCs was decreased 
(Fig. 2A, left), but the proportion of DCs expressing CD103 was higher in MLNs 
from BALB/c compared to C57BL/6 mice (Figure 2A, right). Flow cytometry plots 
of ALDEFLUOR and CD103 showed that most of the ALDEFLUOR signal could be 
observed in the CD103+ DC population of MLNs in both BALB/c and C57BL/6 mice 
(Figure 2B), confirming the report that CD103+ MLN-DCs express higher RALDH 
mRNA levels compared to CD103- DCs in MLNs [13]. In addition, calculations of 
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ALDEFLUOR MFI revealed that RALDH activity was significantly higher in BALB/c 
CD103+ MLN-DCs compared to C57BL/6. This activity was RALDH specific, since 
ALDEFLUOR MFI was highly decreased in presence of RALDH inhibitor DEAB and 
no difference between BALB/c and C57BL/6 could be observed (Figure 2C).
Induction of gut-homing T cells is enhanced in BALB/c MLNs.
Due to their highest RALDH2 expression, CD103+ MLN-DCs are now being 
recognized as the DC subset that is best equipped to induce RA-mediated 
signalling in T cells, leading to FoxP3 T cell differentiation, and the induction of 
gut homing molecules [13,37,38]. Since BALB/c mice displayed higher RALDH 
activity in MLN-DCs when compared to C57BL/6, we addressed whether the 
induction of gut-homing T cells was different in BALB/c mice when compared to 
C57BL/6 mice. Hereto, CFSE-labelled ovalbumin (OVA) specific transgenic CD4+ 
Va2+ T cells (OT-II cells) and OVA-specific CD4+ KJ1+ T cells (DO.11.10 T cells) were 
transferred to C57BL/6 and BALB/c mice, respectively. Twenty four hours later, 
mice received 50 mg ovalbumin intragastrically and at 72 hours after antigen 
Figure 2. RALDH activity is increased in 
MLN-DCs from BALB/c mice.
(A-C) MHC-II+ CD11chigh DCs in MLN cell suspensions 
from C57BL/6 and BALB/c mice were analyzed for 
CD103 expression and RALDH activity using the 
ALDEFLUOR assay. Data represent percentage 
MHC-II+ CD11chigh DCs of total LN cells in individual 
MLNs (A, left) and average percentage ± SD of 
MHC-II+ CD11chigh DCs expressing CD103 (A, right). 
(B) Representative FACS plots are shown for 
ALDEFLUOR signal and CD103 expression by MHC-
II+ CD11chigh DCs in PLN and MLN. Box indicates 
CD103+ gate for calculations of ALDEFLUOR MFI in 
C. (C) Graph shows average ALDEFLUOR MFI ± SD 
in CD103+ MHC-II+ CD11chigh MLN-DCs in absence 
or presence of RALDH inhibitor DEAB. Per group 
a total of 10 animals were used for analysis in two 
separate experiments. Significant differences are 
indicated by * (p=0.03), ** (p<0.001).
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Figure 3. Induction of gut-homing molecules is enhanced in BALB/c MLNs.
(A-D) C57BL/6 and BALB/c mice received 4x106 OVA-specific CD4+ OT-II or CD4+ DO11.10 T cells respectively. 
Activated OT-II cells and DO11.10 cells in MLNs were analyzed by flow cytometry 3 days after intragastric 
OVA administration. Shown are flow cytometry plots of cell proliferation and expression of a
4
b
7
 (A, top) and 
CCR9 (A, bottom) by proliferating OT-II cells in C57BL/6 MLNs and proliferating DO11.10 cells in BALB/c MLNs. 
(B) Data represent average fold induction ± SD of α
4
β
7
 and CCR9 expression on activated OVA-specific T cells 
compared to undivided T cells in C57BL/6 MLNs (black bars) and BALB/c MLNs (grey bars). (C, D) Data are 
calculated as average fold induction ± SD of a
4
b
7
 expression (C) and CCR9 expression (D) by activated OVA-
specific T cells per cell division in MLNs from C57BL/6 (black squares) and BALB/c (white squares). Per group 
a total of 10 animals were used for analysis in two separate experiments. Significant differences are indicated 
by * (p<0.003), ** (p=0.02).
administration, expression of mucosal homing molecules a4b7 and CCR9 was 
analyzed on proliferating OT-II and DO.11.10 T cells in MLNs by flow cytometry. 
No difference in a4b7 and CCR9 expression was visible on the CFSE-labeled non-
proliferating T cell populations in MLNs from both mouse strains, indicative of a 
uniform entry of injected cells in both BALB/c MLNs and C57BL/6 MLNs (Figure 3A). 
Flow cytometry plots also showed that in both BALB/c MLNs and C57BL/6 MLNs T 
cell activation is necessary for induction of gut-homing molecules a4b7 and CCR9 
(Fig. 3A). We observed that the fold induction of a4b7 expression by proliferating 
OVA-specific T cells in C57BL/6 MLNs is similar to the fold induction in BALB/c 
MLNs (Figure 3B, left). Moreover, the fold induction of this gut-homing molecule 
analyzed per cell division showed a similar pattern in both mouse strains (Figure 
3C, left). Surprisingly, the fold induction of CCR9 expression by proliferating OVA-
specific T cells in BALB/c MLNs was much higher when compared to C57BL/6 
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MLNs (Figure 3B, right). Examining the fold induction of CCR9 expression per cell 
division revealed that CCR9 was induced on OVA-specific T cells in C57BL/6 mice 
during the first cell divisions, but then reached levels similar to the undivided 
peak (Figure 3C). Lack of a significant induction of CCR9 is probably caused by 
the generation of both CCR9- and CCR9+ OVA-specific T cells in later cell divisions, 
which decreased the MFI of CCR9 expression of the entire dividing population 
(Figure 3A, left bottom). In BALB/c MLNs, however, CCR9 expression levels 
continued to increase with every cell division (Figure 3D). Unfortunately, we could 
not compare the induction of gut-homing molecules on CD8+ T cells, because 
no transgenic mouse strain that recognizes OVA in the context of MHC-I on the 
BALB/c background exists. In conclusion, the results strongly suggest that higher 
RALDH acitivity in BALB/c mice correlated with a more efficient induction of gut-
homing molecule CCR9 on T cells.
BALB/c mice display higher FoxP3 expression than C57BL/6 mice.
In addition to the essential role of RA in the induction of gut-homing molecules 
on T cells, RA also has been reported to be involved in the induction of FoxP3 
expressing CD4+ regulatory T cells [13,18-23]. We therefore tested FoxP3 mRNA 
levels in small intestine and MLN samples of both C57BL/6 and BALB/c mice with 
real time PCR. FoxP3 mRNA levels were significantly enhanced in both BALB/c 
MLN (Figure 4A) and BALB/c small intestines (Figure 4B) compared to the same 
tissues derived from C57BL/6. Moreover, FACS analysis of intracellular FoxP3 
expression by T cells showed that the percentage of CD25+ FoxP3+ T cells was 
significantly higher in MLNs from BALB/c mice compared to C57BL/6 mice (Figure 
4C). In conclusion, higher RALDH activity in BALB/c mice correlated with higher 
percentages of FoxP3+ T cells present in MLNs. 
Figure 4. FoxP3 expression is increased in BALB/c small intestines and MLNs.
(A, B) Expression of FoxP3 mRNA was analyzed in MLN (A) and small intestine (B) samples from C57BL/6 (black 
bars) and BALB/c mice (grey bars) by real time PCR. Expression of transcripts was normalized to Ubiquitin C 
for small intestine and to GAPDH and Ubiquitin C for MLN. Relative expression levels in small intestines and 
MLNs from C57BL/6 mice was set at 1.0. Per group 5 animals were used. (C) Single cell suspensions of MLNs 
from C57BL/6 (black bars) and BALB/c mice (grey bars) were stained for CD4 and Foxp3 and analyzed by FACS. 
Data represent average percentage ± SD of CD25+ FoxP3+ among CD4+ T cells. Per group 6 animals were used. 
Significant differences are indicated by * (p<0.003), ** (p<0.05).
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BALB/c mice display increased lymphocyte levels and IgA secretion in small 
intestines.
Since the induction of gut-homing T cells occurred with greater efficiency in BALB/c 
MLNs when compared to C57BL/6 MLNs, we questioned whether this would result 
in increased numbers of immune cells in the small intestinal lamina propria. With 
immunostainings we observed more hematopoietic cells in the lamina propria of 
small intestines of BALB/c mice when compared to C57BL/6 (data not shown). To 
quantify this, expression levels of CD45 (haematopoietic cells), CD3 (marker for 
T cells) and CD19 (marker for B cells) were analyzed in the small intestines from 
C57BL/6 and BALB/c mice with real time PCR. Data showed that the expression 
of CD45 mRNA in BALB/c small intestine was increased about 2-fold compared to 
C57BL/6 (Figure 4A). In addition, mRNA levels for CD3 and CD19 were significantly 
higher in BALB/c small intestines when compared to C57BL/6 small intestines. 
Since RA has been demonstrated to promote class switching of immunoglobulins 
to the IgA isotype in B cells [24-26], we wondered whether the secretion IgA into 
the intestinal lumen would differ between BALB/c and C57BL/6 mice. Faeces 
was collected from the small intestines of BALB/c and C57BL6 mice in which 
secretory IgA was measured by ELISA. We observed that the concentration of IgA 
within the faeces of BALB/c mice was remarkably higher compared to C57BL/6 
mice (p=2.96E-10, Figure 5B). This could be the result of increased RA-mediated 
signalling within BALB/c small intestines as well as of increased numbers of B cells 
present in the small intestines. In conclusion, enhanced RA-mediated signalling 
in BALB/c mice correlated with increased induction of gut-homing molecules, 
with enhanced migration of lymphocytes to the small intestines, as well as with 
elevated levels of secretory IgA within the intestinal lumen. 
Figure 5. Increased lymphocyte levels and IgA secretion in BALB/c small intestines. 
(A) Expression of CD45, CD3, and CD19 mRNA was analyzed in whole small intestine from C57BL/6 and BALB/c 
by real time PCR. Expression of transcripts was normalized to Ubiquitin C. Per group 5 animals were used. 
Relative expression levels in C57BL/6 small intestines was set at 1.0 for each gene analyzed. (B) Concentration 
of secretory IgA (mg/ml of PBS-dissolved faeces) in faeces from C57BL/6 mice (black bars) and BALB/c mice 
(grey bars) measured by ELISA. Per group 6 animals were used. Significant differences are indicated by * 
(p<0.05), ** (p=0.003), *** (p=2.96E-10).
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Discussion
In this study we demonstrated that C57BL/6 and BALB/c mice differ in the 
expression and activity of RALDH enzymes and consequently in RA-induced 
immune functions which are crucial for the mucosal immune system. BALB/c 
mice displayed enhanced vitamin A metabolism, since expression levels of RALDH 
enzymes and RA-mediated signalling in small intestines were increased, as well 
as RALDH activity in CD103+ MLN-DCs. Consequently, increased induction of 
CCR9 expression on CD4+ T cells was observed, suggesting that activated T cells 
from BALB/c MLNs are better equipped to migrate to the intestines. Indeed, we 
observed increased mRNA levels for T cells and B cells in the small intestines of 
these mice. In addition, higher levels of secretory IgA were found in the intestinal 
lumen of BALB/c mice when compared to C57BL/6 mice. Moreover, FoxP3 mRNA 
was increased in small intestines and MLNs of BALB/c mice. Although we observed 
a difference in percentage of FoxP3+ T cells in MLNs from BALB/c versus B6 mice, 
we did not discriminate between naturally occurring regulatory T cells, which 
are thymus derived, and regulatory T cells that differentiated in the periphery 
towards FoxP3 expressing T cells. Whether there is a role for RA in the induction 
of regulatory T cells in the thymus is not clear.
Since RA-mediated signalling is crucial in shaping the mucosal immune system, 
it becomes important what the underlying cause of the observed differences 
between BALB/c and C57BL/6 is. Notably, it has been published that GM-CSF is an 
important factor involved in imprinting of RALDH expression in mucosal DCs [32]. 
However, in contrast to the difference in RALDH levels, we observed no significant 
difference in GM-CSF mRNA levels in BALB/c and C57BL/6 small intestines (Figure 
1D). We therefore propose that GM-CSF is not directly involved in imprinting of 
intestinal DCs, but that it may contribute at another level to RALDH expression. 
What other factors are responsible for the difference in RA production and 
signalling in these mouse strains remains unknown. Cellular RA availability is 
regulated by the vitamin A nutritional status and the tightly regulated balance 
between RA synthesis and catabolism. Notably, BALB/c mice and C57BL/6 mice 
used in these studies were kept under similar housing conditions and nutritional 
status. Possibly, factors that regulate the balance between RA synthesis and 
catabolism are differentially expressed in BALB/c and C57BL/6. Polymorphisms 
and mutations have been reported to exist in some genes that encode these 
factors [39-46]. Future research is needed to establish whether these mutations 
or polymorphisms indeed affect the levels of RA synthesis. 
We propose that enhanced RA-mediated signalling seen in BALB/c mice when 
compared to C57BL/6 mice may lead to a more efficient mucosal immune system. 
Consequently, BALB/c may combat mucosa-associated pathology better. In fact, 
it has been shown that BALB/c mice are more resistant to developing colitis 
and require a higher dose of DSS compared to C57BL/6 to induce a comparable 
disease severity [47-49]. Even with the higher dose of DSS, BALB/c mice lose less 
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weight and recover more rapidly after withdrawal of DSS compared to C57BL/6 
mice. These differences are often attributed to a difference in Th1-Th2 balance 
in these mice, since BALB/c mice are known as prototypical Th2-type mice, while 
C57BL/6 mice show a more Th1-driven response. In addition, treatment with RA 
ameliorated human and murine colitis by increasing the number of Treg cells 
[50]. We propose here that variation in RA metabolism might determine disease 
susceptibility in these mice, since RA affects homing of T cells to the intestines as 
well as the generation of FoxP3+ regulatory T cells and isotype switching toward 
IgA. Moreover, RA availability determines epithelial integrity and increases the 
barrier function of the intestinal epithelial cells [51,52]. 
Although BALB/c mice are resistant to developing DSS-induced colitis, these 
mice are more susceptible when compared to C57BL/6 to infections that require 
a typical Th1 type response, such as Leishmania major infection in the skin. 
Resistant C57BL/6 T lymphocytes produce IFNg that activates macrophages to 
produce NO and kill the parasite, while susceptible BALB/c T lymphocytes instead 
produce more IL-4 that suppresses macrophages [53,54]. Therefore, BALB/c mice 
show enhanced mucosal immune system at the expense of the peripheral immune 
system.
An example of a typical Th17-driven immune disease is experimental autoimmune 
encephalomyelitis (EAE), an animal model for multiple sclerosis (MS) [55]. Strain 
specific differences have been reported to exist in C57BL/6 and BALB/c mice 
during EAE [56,57]. Disease onset in BALB/c mice was delayed when compared 
to C57BL/6 mice. Clinical signs of EAE rapidly decreased in BALB/c mice while 
C57BL/6 mice showed a slow decline of disease severity [56]. Given the fact that 
RA has been described to skew T cells upon their activation towards the Th2-type 
profile, while inhibiting Th1 and Th17 cytokine production [15,18], a number 
of research groups have investigated the effect of RA treatment on EAE disease 
progression and severity. RA was shown to strongly inhibit pathogenic Th17 and 
Th1 responses during EAE. Treatment with RA dramatically delayed disease onset 
and strongly decreased disease severity [58-61]. Other Th17-driven infectious 
diseases might therefore also benefit from RA treatment as was reported for the 
murine model for rheumatoid arthritis [62].
Since enhanced RA-mediated signalling may lead to a decreased Th1-Th2 balance, 
increased induction of Foxp3+ regulatory T cells and epithelial barrier function, 
modulation of RA availability would be beneficial to increase the mucosal immune 
response and resistance to infections and immune diseases. Studies in vitamin A–
deficient patients showed indeed a compromised Th2-type immune response and 
a cytokine imbalance skewed towards Th1 [63]. 
In conclusion, our data suggest that the enhanced RA synthesis in BALB/c mice 
when compared to C57BL/6 mice results in the development of a more efficient 
mucosal immune system. Control of RALDH levels may therefore be an attractive 
way to regulate the mucosal immune response.
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Abstract
Dextran sulphate sodium (DSS)-induced colitis is a widely used animal model for 
inflammatory bowel diseases. The BALB/c inbred strain of mice is more resistant to 
DSS-induced colitis than C57BL/6 mice; however, the mechanism underlying this 
phenomenon is largely unknown. In this paper, we show that BALB/c mice have 
more organized gut associated lymphoid tissue (GALT) in the colon compared 
to C57BL/6 mice. Furthermore, decreased susceptibility to colitis is paralleled 
by increased colonic expression of retinaldehyde dehydrogenase 1 (RALDH1) in 
BALB/c mice. RALDH1 is an enzyme responsible for the conversion of vitamin A 
to its active metabolite retinoic acid (RA), which is involved in the induction of 
FoxP3+ regulatory T cells and IgA producing B cells. As we show here, removal of 
vitamin A from the diet of C57BL/6 mice, which will decrease RA levels, gave rise 
to a more severe form of DSS-induced colitis. This illustrates the importance of 
vitamin A for the control of the disease. Higher levels of RA-mediated signalling in 
the colon may thus serve as an explanation as to why BALB/c mice are resistant to 
DSS colitis and highlights the role of vitamin A and its metabolite in inflammatory 
bowel disease.
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Introduction
Ulcerative colitis and Crohn’s disease, collectively referred to as inflammatory 
bowel disease (IBD), are characterized by chronic inflammation of the intestinal 
tract. A variety of animals models exists for IBD. Dextran sulphate sodium (DSS) 
is a chemical compound, which is thought to have toxic effects on the epithelial 
cells lining the intestines, resulting in altered gut permeability and superficial 
intestinal inflammation that resembles, to a certain extent, ulcerative colitis [1, 2]. 
It has been reported by various independent research groups that strain specific 
differences exist in susceptibility to DSS-induced colitis between C57BL/6 and 
BALB/c inbred strains of mice [3-5]. In short, it has been shown that BALB/c mice 
are more resistant to developing colitis and require a higher dose of DSS compared 
to C57BL/6 to induce a comparable severity of disease. Even with higher doses 
of DSS, BALB/c mice generally lose less weight and recover more quickly after 
withdrawal of DSS as than C57BL/6 mice.
Vitamin A (retinol) is a fat soluble vitamin which has a variety of effects on 
the immune system. Vitamin A is absorbed from the gastrointestinal tract and 
converted to its active form retinoic acid (RA) through two oxidative steps. Retinol 
is converted to retinaldehyde by alcohol dehyrogenase enzymes. Retinaldehyde is 
subsequently oxidized by retinaldehyde dehyrogenases (RALDH) to form RA, which 
is an irreversible process [6-12]. RA then binds to retinoic acid receptors (RARs) 
which act as transcription factors and bind retinoic acid responsive elements 
(RAREs) within the promoter region of their target gene, leading to a variety of 
downstream effects [13, 14].
Retinoic acid has numerous effects on the immune system. Iwata and colleagues 
have shown that RA can suppress Th1 response and enhance Th2 responses [15]. 
Furthermore, RA is described to have an effect on lymphocyte homing to the 
intestine by inducing expression of the gut homing molecules α4β7 and CCR9 on 
activated T cells [16, 17]. In combination with TGFβ, RA has also been shown to 
greatly enhance the differentiation, expansion and gut homing of T regulatory cells 
which serve to suppress immune responses [18-20]. RA not only affects T cells in 
the intestines but has also been reported to have numerous effects on B cells in 
the gut. RA aids in isotype class switching of immunoglobulins by B cells in gut-
associated lymphoid tissue (GALT) leading to an increase in IgA production [21]. 
IgA is the most abundant immunoglobulin present in the intestines and secretory 
IgA forms a protective layer which lines the intestines and protects the host against 
the vast array of microflora constantly present in the intestines [22, 23]. RA has also 
been shown to induce the expression of CXCL13 during lymph node development 
and upon vagus nerve stimulation in the intestine [24]. Upregulation of CXCL13 
in the intestine could lead to the attraction of more B cells to the intestine [25]. 
Thus RA has numerous beneficial effects on the mucosal immune system and an 
increase in RA-mediated signalling may aid the host in recovering from colitis.
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Interestingly, it has been shown that BALB/c mice tend to have a more Th2 skewed 
cytokine profile whereas C57BL/6 mice tend to have a more Th1 skewed cytokine 
profile [26-30]. Taken together with the data showing that RA can suppress Th1 
responses and enhance Th2 responses, this suggests that differences in RA 
production between these mouse strains may be responsible for the differences 
observed in colitis susceptibility. In this study we aimed to investigate this 
hypothesis by relating the expression levels of RALDH and RA-mediated signalling 
in the colon of C57BL/6 mice versus BALB/c to differences in DSS-induced colitis 
susceptibility.
Materials and Methods
Mice
Specific pathogen free (SPF) BALB/c, C57BL/6 female mice and C57BL/6 breeding 
pairs were obtained from Charles River (Charles River Laboratories, Maastricht, 
The Netherlands) and housed in the animal facility at the Vrije Universiteit 
(Amsterdam, The Netherlands). Animals were housed under standard laboratory 
conditions, only female mice were used in experiments. The starting age of the 
animals was 8-10 weeks with a weight range of 18-20 grams. 
Generation of vitamin A deficient and vitamin A control animals was based on a 
method previously described by Iwata et al [17]. In short, females were mated 
and pregnant females were switched to the relevant vitamin A diet at 7-10 days 
of gestation and kept on the relevant diet until the pups were weaned. The 
offspring was subsequently placed on the same diet throughout the duration of 
the experiment. Two different custom made diets were based on modified AIN-
93M diet (MP Biomedicals United States, Solon OH, United States): (1) vitamin A 
deficient diet containing no vitamin A and (2) vitamin A control diet containing 
2800 IU/kg vitamin A. Ethics committee approval for all animal experiments was 
obtained from the Vrije Universiteit Animal Ethics Committee.
Induction of DSS colitis
We made use of a previously described single dose DSS colitis model by Melgar et 
al [3]. As previously established by other research groups BALB/c mice are more 
resistant to DSS-induced colitis than C57BL/6 mice [3-5]. Thus in order to induce 
a comparable severity of disease in both mouse strains we administered 2% DSS 
in C57BL/6 mice and 5% in BALB/c mice. A DSS titration (2%, 3%, 4% and 5%) was 
performed in BALB/c mice to confirm that in our facility 5% DSS in drinking water 
did indeed give a comparable severity of disease in BALB/c when compared to 
C57BL/6 mice given 2% DSS in drinking water, as reported (Melgar et al). C57BL/6 
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mice were thus given 2% DSS and BALB/c mice were given 5% DSS in drinking 
water ad libitum which was changed on a daily basis. For the acute colitis time 
point, analyzed at day 7, mice were given DSS for 7 days prior to euthanasia. 
For the chronic colitis time point mice were given DSS for the first 5 days of the 
experiment and then changed to normal drinking water for a 30 day rest period 
and euthanized at day 35.
Immunofluorescence
Mice were euthanized, colons were removed and embedded in OCT compound 
(Sakura Finetek Europe) and stored at -80oC. Tissues were subsequently 
sectioned on the cryostat (7 microns), and either stained with hematoxylin and 
eosin (H&E staining) or acetone fixed after which immunofluorescence stainings 
were performed. For an overview, pictures of a representative length of colon 
were visualized making use of the stitch picture function of the DM6000 Leica 
Immunofluorescence Microscope Leica (Leica Microsystems) with a 20x objective. 
For higher magnification pictures use was made of the Leica TCS-SP2-AOBS 
Confocal Laser Scaninning Microscope (Leica Microsystems).
Antibodies
Anti-gp38 (clone 8.1.1, anti-podoplanin) and anti-CD3 (clone KT3) were used as 
supernatants and visualized by means of the appropriate secondary antibody 
labeled with Alexa-Flour 488, Alexa-Flour 546 or Alexa-Flour 647 (Invitrogen 
Life Technologies, Breda, The Netherlands). Anti-B220 (clone 6B2) antibodies 
were affinity purified from hybridoma cell culture supernatants with protein 
G-Sepharose (Pharmacia, Uppsala, Sweden) and labeled with Alexa-Fluor 488 
or Alexa-Fluor 647 (Invitrogen, Breda, The Netherlands). Anti-CXCL13-bio (R&D 
Systems, Minnneapolis, USA) was visualized using the TSA signal amplification 
Kit with HRP-streptavidin and Alexa Fluor 546 tyramide (Invitrogen). Anti IgA-
bio (Invitrogen, Breda, The Netherlands) was used in combination with Alexa-
Fluor-647 conjugated streptavidin (Invitrogen, Breda, The Netherlands) and 
Alexa-647 conjugated anti-FoxP3 was used (eBioscience, San Diego, CA, USA).
Real time PCR
Whole colons were removed and placed in TRIZOL (Gibco, Invitrogen Lifes 
Sciences,Breda, The Netherlands) and stored at –800 C. Entire colons were 
homogenized and RNA was isolated according to the manufacturer’s instruction. The 
concentration of RNA was assessed by means of the Nanodrop Spectrophotometer 
(Nanodrop Technologies, Wilmington, DE). cDNA was synthesized by making use 
of a reverse transcriptase reaction which was performed according to the MBI 
Fermentas cDNA synthesis kit (Vilnius, Lithuania), using both the oligo(dT)18 and 
the D(N)6 primers. 
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Quantitative real time PCR was performed on the ABI Prism 7900 Sequence 
Detection System (Applied Biosystems , Foster City, CA). The reactions were 
performed with 0.25ng cDNA in a total volume of 10 μl containing SYBR Green 
PCR Master Mix (Applied Biosystems, Foster City, CA) and 300nM of each primer 
according to the manufacturer’s instructions. Primers were designed using Primer 
Express Software (Applied Biosystems) according to the guidelines provided by the 
manufacturer. Data obtained by real-time PCR were normalized for the geometric 
mean of the two most stable house-keeping genes (cyclophilin, ubiquitin) as 
determined by analysis with geNorm method software (http://medgen.ugent.
be/~jvdesomp/genorm/).
Statistics
Data obtained for percentage of daily weight loss and/or weight gain was 
analyzed by means of repeated measurement statistics to assess effect of day 
and effect of group and an independent student t-test was performed (Advanced 
Statistics, SPSS 16). A two-tailed unpaired student’s t-test was used to analyze 
differences between groups with * significant, if p<0.05; ** significant, if p<0.01; 
*** significant, if p<0.001. 
Figure 1. Daily changes in body weight 
of DSS- induced colitis in C57BL/6 and 
BALB/c mice. 
Average of daily weight +/– SEM of control 
animals is indicated with circles and of 
animals with colitis with squares. C57BL/6 
mice are indicated with black circles and 
squares and BALB/c mice are indicated 
with white circles and squares. Daily weight 
graphs are shown for C57BL/6 control 
animals and C57BL/6 chronic colitis animals 
(A), BALB/c control and BALB/c chronic 
colitis animals (B), and for C57BL/6 chronic 
colitis mice compared to BALB/c chronic 
colitis mice (C). C57BL/6 chronic colitis 
mice received 2% DSS in drinking water 
for the first five days of the experiment 
followed by a thirty day period on normal 
drinking water. BALB/c chronic colitis mice 
received 5% DSS in drinking water for the 
first five days of the experiment followed 
by a 30 day rest period on normal drinking 
water. Both control groups included in the 
experiment received normal drinking water 
without DSS throughout the experiment.
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Results
BALB/c mice are more resistant to DSS-induced colitis than C57BL/6 mice.
To further investigate the differences observed in BALB/c mice versus C57BL/6 
mice in developing DSS-induced colitis we first needed to establish DSS-induced 
colitis in both mouse strains in our own facilities. C57BL/6 mice were given 2% 
DSS in drinking water for five days followed by a 30 day consecutive period on 
normal drinking water. Daily weight graphs showed that C57BL/6 mice started 
to lose weight on day 6 with a maximum weight loss of 7.6% on day 8, which 
was followed by a recovery phase (Figure 1A). DSS colitis in BALB/c mice was 
induced in a similar manner. However, due to the fact that BALB/c mice were 
more resistant to developing colitis, we used 5% DSS in drinking water for five 
days, after having established that upon administration of 2%, 3%, 4% or 5% DSS, 
5% DSS resulted in a disease score most comparable to C57BL/6 mice (data not 
shown). The kinetics of DSS-induced colitis was different in BALB/c mice compared 
to C57BL/6 mice. The daily weight graphs for BALB/c mice revealed that these 
mice started to lose weight on day 3 with a maximum weight loss of 3.8% which 
occurred on day 6 (Figure 1B). Thus, BALB/c mice tended to lose less weight 
at an earlier stage and recovered more quickly than C57BL/6 mice (Figure 1C). 
Macroscopic scoring of the colon revealed that, although BALB/c mice received a 
higher DSS % in the drinking water, C57BL/6 and BALB/c showed a comparable 
reduction in colon length during both acute colitis (day 7) and chronic colitis (day 
35) (Figure 2A). Both inflammatory and diarrhea scores revealed a comparable 
form of disease in C57BL/6 and BALB/c mice (Figure 2B and C). Comparable 
results have been obtained by two other independent research groups using the 
same DSS administration protocol for these two mouse strains [3, 5]. 
Figure 2. Macroscopic scores of DSS-induced colitis in C57BL/6 and BALB/c mice. 
(A) Graphs shows percentage of reduction in colon length, which is used as an indication for the severity of 
the disease. (B) Graph shows the inflammatory score (0-4) which is also used as an indication of the severity 
of disease along with (C) the diarrhea scores (0-4). C57BL/6 mice are indicated by black bars and BALB/c mice 
are indicated by white bars. Mice in the acute phase are analyzed at day 7 of DSS-induced colitis and mice in 
the chronic phase are analyzed at day 35 of DSS-induced colitis. Bars indicated are represented by an average 
+/- SEM of seven animals per group.
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BALB/c mice contain more colonic lymphoid tissue than C57BL/6 mice.
Since the observed differences in disease severity could be a result of a difference 
in the ability of the mucosal immune system to respond to tissue injury induced 
by DSS, we wanted to determine whether similar numbers of haematopietic cells 
were present within the colon. First, we determined the expression of CD45 
(haematopietic marker) within healthy control colons of C57BL/6 and BALB/c mice. 
BALB/c control colons contained significantly more mRNA for CD45 than C57BL/6 
control colons which indicated that more haematopietic cells were present within 
the non-inflamed BALB/c colon (Figure 3A). Further analysis of mRNA levels by 
real time PCR of the colons revealed an increased expression of both CD19 (B 
cells) and CD3 (T cells) in BALB/c control versus C57BL/6 control colons (Figure 
3B and C). While these cells can be found as single isolated cells within the colon, 
most cells are present in organized lymphoid structures. Cryptopatches and 
isolated lymphoid follicles, referred to as immature and mature solitary isolated 
lymphoid tissue (SILTs) respectively, along with colonic patches (CPs) make up 
the organized GALT of the colon, which provide a microenvironment for immune 
responses to occur in an efficient manner [31, 32]. It has previously been shown 
that adult BALB/c mice contain more SILTs than C57BL/6 mice [33]. The increased 
mRNA expression levels for CD45, CD19 and CD3 could indicate that BALB/c 
mice have more organized GALT structures, i.e. colonic patches and SILTs, than 
C57BL/6 mice. To quantify this, we counted the total number of SILTs and CPs 
Figure 3. BALB/c mice contain more organized GALT structures in the healthy colon compared 
to C57BL/6 mice. 
(A -C) Real time PCR analysis showing relative mRNA expression levels of (A) CD45, (B) CD19 and (C) CD3 
detected in whole colon of healthy control C57BL/6 and BALB/c mice. Data represent the average per group 
+/- SEM. Per group 5 mice were used. (D) Table shows the number of SILTs and colonic patches (CPs) present 
in healthy colon of C57BL/6 and BALB/c mice (n=2 per group). In all figures, results obtained for C57BL/6 mice 
and BALB/c mice are indicated in black bars and white bars, respectively. Significant differences are indicated 
by * (p<0.05), ** (p<0.01) and *** (p < 0.001). 
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Figure 4. Colonic patches and SILTs contain CXCL13 producing stromal cells and consist mainly 
of B cells. 
(A-D) Immunofluorescence analysis of control colons from BALB/c mice showing colonic patches (A and C) and 
SILTs (B and D). Representative overviews of colonic tissue taken with 20x magnification stitch picture function 
(A and B) and relevant area of interest (C and D). Pictures show organized GALT of the colon with stromal cells 
producing CXCL13 (B220 in green, CXCL13 in red and gp38 in blue, scale bars represent 250 μm). All pictures 
were taken on DM6000 Leica Immunofluorescence Microscope Leica (Leica Microsystems). (E) CXCL13 mRNA 
levels in colons of healthy BALB/c and C57BL/6 mice analyzed by real time PCR. C57BL/6 mice and BALB/c mice 
are indicated by black bars and white bars, respectively. Result represents the average per group +/- SEM. Per 
group 5 mice were used. Significant difference is indicated with * (p<0.05).
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present in C57BL/6 versus BALB/c control colons by sectioning through the 
entire colon and screening every 20th section for the presence of organized GALT 
structures. Indeed, BALB/c control colons contained more CPs (9) and SILTs (>31) 
than C57BL/6 animals that have 3 CPs and >25 SILTs (Figure 3D). 
Colonic patches and mature SILTs consist mainly of B cells, which cluster together 
to form follicles. The formation of these structures is principally controlled by 
stromal cells which express lymphotoxin β receptor (LTβR) [34-36]. The triggering 
of this receptor leads to the increased expression of a major B cell attracting 
chemokine, CXCL13, needed for SILT formation in the small intestine [37, 38]. The 
expression of CXCL13 might be restricted to mature SILTs and colonic patches 
and could serve as an additional measure for organized GALT within the colon. 
Indeed, upon analysis of CXCL13 expression within the tissue, we observed that 
CXCL13 colocalized with gp38+ stromal cells within B cell areas in mature SILTs 
and colonic patches (Figure 4A–D). To support our observation that more B cell 
follicles are present in BALB/c colons, we measured mRNA expression levels of 
CXCL13 in colons from healthy BALB/c and C57BL/6 mice with real time PCR. 
We detected higher expression levels of CXCL13 in BALB/c healthy colons when 
compared to C57BL/6, indicating that they express more CXCL13 needed for the 
formation of organized GALT present in the colons (Figure 4E).
Organized GALT structures contain IgA producing B cells and regulatory T 
cells.
The larger SILT structures in the small intestine have been shown to contain IgA+ 
B cells [33]. We have previously shown that SILTs and colonic patches in colons 
from healthy adult mice contain follicular dendritic cell networks with germinal 
centers, which should be capable to induce IgA isotype switching (Olivier et al. 
manuscript in preparation). We thus performed immunofluorescence stainings on 
colonic patches, which showed that colonic patches indeed consisted of distinct B 
cell follicles and T cell areas (Figure 5A). Within the B cell follicles, we could detect 
IgA+ B cells (Figure 5B). 
Stainings of the T cell areas in colonic patches showed that these structures 
contained FoxP3 expressing regulatory T cells (Figure 5C). Thus, an increase of 
organized GALT structures may be beneficial for the host with regards to IgA 
production and Treg cell generation, which is of importance for maintaining 
tolerance to the microflora and suppressing unwanted immune responses.
During inflammation, BALB/c colons contain more haematopietic cells than 
C57BL/6 colons.
In the healthy setting, BALB/c colons contain more T and B cells than C57BL/6 
colons, which may help to respond to DSS-induced colitis. We tested whether this 
difference was still present during inflammation at both the acute and chronic 
phase of the disease. 
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In the acute phase (day 7), real time PCR analysis revealed that also at this stage 
BALB/c mice have an increased mRNA expression of CD45, CD3 and CD19 when 
compared to C57BL/6 mice (Figure 6A–C). At this time point, BALB/c mice have 
already entered the recovery phase of colitis whereas C57BL/6 mice have not. 
Interestingly, during the chronic phase of inflammation, when both mouse strains 
are recovering from the disease, CD45 and CD3 mRNA analysis revealed no 
significant differences in expression levels in BALB/c and C57BL/6 mice. However, 
CD19 expression remained increased in BALB/c mice in the chronic phase of 
the disease. CXCL13, as a measure for B cells follicles present in the colon, also 
remained increased in both the acute and chronic phase in BALB/c mice (Figure 
6D). 
Another cell subset that is considered as protective for the intestinal integrity is 
formed by RORγt-expressing NKp46+ lymphoid tissue inducer (LTi) cells [25, 39, 
40]. In addition, RORγt is also expressed by Th17 cells, which were also shown to 
have a protective effect [41-43]. To assess if RORγt-expressing cells, which could 
be beneficial in dealing with colitis, were increased in BALB/c mice, we measured 
expression of RORγt in colons with real time PCR. Indeed, the results show an 
increased mRNA expression of RORγt in BALB/c mice compared to C57BL/6 mice 
in the healthy, acute and chronic inflammatory setting indicating that BALB/c mice 
have an increase in a variety of immune cells which can be of benefit in dealing 
with colitis (Figure 6E).
Figure 5. Organized GALT structures 
contain IgA producing B cells and 
regulatory T cells. 
(A) Representative picture of 
immunofluorescence analysis of a colonic 
patch in a BALB/c mouse with both T cell 
and B cell areas. B220 is shown in green 
and anti-CD3 in red (scale bars = 250 μm). 
(B) Magnification of a B cell follicle which 
contains IgA producing B cells (B220 in 
green and IgA in blue, scale bars = 50 μm). 
(C) Magnification of the T cell area which 
contains regulatory T cells (CD3 in red 
and FoxP3 in blue. Scale bars = 50 μm). 
All pictures were taken on DM6000 Leica 
Immunofluoresence Microscope Leica 
(Leica Microsystems). 
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BALB/c control colons have higher levels of RALDH enzymes and more RA-
mediated signalling.
The migration of lymphocytes to the intestine, along with the production of IgA 
and differentiation of regulatory T cells have all been shown to be under the 
influence of retinoic acid (RA), which is the active metabolite of vitamin A. The 
formation of RA is dependent on enzymes called retinaldehyde dehydrogenases 
(RALDH). Upon RA formation, RA binds nuclear retinoic acid receptors (RARs) which 
become active transcription factors that bind RAREs within the promoter region 
of their target genes. To see whether differences in RALDH expression between 
Figure 6. BALB/c colons contain more haematopoietic cells in both the acute and chronic 
inflammatory setting than C57BL/6 colons. 
(A-D) Real time PCR analysis of colons in the control, acute (day 7) and chronic (day 35) inflammatory setting. 
Graphs show mRNA expression levels of CD45 (A; haematopoietic cells), CD3 (B; T cells) CD19 (C; B cells), 
CXCL13 (D) and RORγt (E). In all figures results obtained for C57BL/6 mice are indicated in black bars and 
BALB/c mice are indicated in white bars. All averages +/– SEM are representative of 5 mice per group. 
Significant differences are indicated by * (p<0.05), ** (p<0.01) and *** (p < 0.001).
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Figure 7. BALB/c mice have more retinoic acid-mediated signalling than C57BL/6 mice.
Real time PCR analysis of C57BL/6 and BALB/c control colons showing mRNA expression levels of RALDH1 (A), 
RALDH2 (B), RALDH3 (C) and RARβ (D). In all figures, results obtained for C57BL/6 mice are indicated in black 
bars and BALB/c mice are indicated in white bars. All averages +/– SEM are representative of 5 mice per group. 
Significant differences are indicated by * (p<0.05).
the two mouse strains existed, we analyzed the expression of the 3 isoforms of 
the RA converting enzymes, i.e. RALDH-1, -2 and -3 by real time PCR in healthy 
colons of BALB/c and C57BL/6 mice. Analysis revealed a significant increase in 
the expression of RALDH1 in BALB/c colons compared to C57BL/6 colons (Figure 
7A). For the remaining two isoforms, i.e. RALDH-2 and -3, there was no significant 
difference observed (Figure 7B and C). To address whether indeed enhanced RA-
mediated signalling occurred within BALB/c colons, we addressed expression 
levels of RARβ, which is a direct target gene of RA and shown to be an indicator of 
the level of RA-mediated signalling both in vivo and in vitro [44]. Analysis of RARβ 
mRNA levels showed that expression levels for RARβ were significantly increased 
in control colons of BALB/c mice when compared to C57BL/6 mice, indicating that 
indeed more RA-mediated signalling takes place within the colon of BALB/c mice 
when compared to C57BL/6 (Figure 7D).
Vitamin A deficiency increases the severity of chronic colitis.
To assess if the level of RA synthesis indeed correlates with the severity of colitis, 
mice were raised either on a diet containing a normal vitamin A concentration or 
on a diet deficient in vitamin A. Subsequently, colitis was induced and their health 
status was monitored. Vitamin A deficient mice suffered from a more severe 
colitis than mice on a vitamin A control diet as indicated by the weight loss and 
diarrhea (Figure 8A and B). In fact, 5 of the 7 animals in these experiments had 
to be euthanized before the end of the experiment because of severe disease. 
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Figure 8. Vitamin A deficiency increases the severity of DSS-induced colitis. 
Daily weight graphs of animals on a vitamin A control diet (A) and a vitamin A deficient diet (B) given 2% DSS in 
drinking water for the first five days of the experiment followed by a 30 day period on normal drinking water. 
Number of organized GALT structures was counted by macroscopic scoring (C). Colons of vitamin A control (D, 
F) and vitamin A deficient (E, G) without or with DSS administration were analyzed by H&E stainings at 35 days 
after initiation of DSS administration.
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The remaining two animals only returned to their starting weight at the end of 
the experiment. Macroscopic inspection of the colons showed large lymphoid 
structures in vitamin A deficient control mice, which were not visible in control 
mice on vitamin A sufficient diet (Figure 8C). Upon histological examination these 
larger lymphoid structures in colons of vitamin A control mice were confirmed 
(Figure 8D and 8E). DSS administration resulted in histological signs of colitis in 
both vitamin A deficient and vitamin A control animals with more profound cellular 
infiltrates and bowel thickening in vitamin A deficient mice when compared to 
mice on vitamin A control diets (Figure 8F and G). These results suggested that 
vitamin A deficiency already leads to an enhanced cellular influx into the colon 
of untreated vitamin A deficient mice, while upon DSS treatment the animals get 
a more severe colitis than animals on a vitamin A control diet. This confirms our 
hypothesis that dietary intake of vitamin A is indeed needed for a protective effect 
on inflammatory disease within the colon.
Discussion
BALB/c mice suffer from less severe DSS-induced colitis compared to C57BL/6 
mice and tend to recover more quickly after the withdrawal of DSS. Here we show 
that in the healthy setting BALB/c mice have more organized GALT structures in 
the colon and this may be responsible for the less severe colitis and the quicker 
recovery observed in this mouse strain. It has been shown that inducible bronchus 
associated lymphoid tissue (iBALT) in the lung has a protective effect and helps 
animals clear influenza virus at an enhanced rate [45, 46]. It has also been shown 
that these iBALT structures contain germinal centers, which act as additional 
ectopic sites that promote immunoglobulin class switching and thus promote 
IgA production, which aids the host in clearing infection [45]. In the context of 
the intestine, Lorenz and Newberry have shown that larger SILTs containing B 
cells play a role in the production of antigen-specific IgA [47]. Peyers’ Patches of 
the small intestine have also been shown to be involved in antigen-specific IgA 
production [48] and in this paper we show that colonic patches, which are the 
counterpart of Peyers’ Patches, present in the colon also contain B cells which 
are capable of IgA production. Intriguingly, it has also been shown that RA is 
needed for immunoglobulin class switching by B cells to be able to produce IgA 
[21, 49]. RA has also been shown to aid in the differentiation of regulatory T cells, 
which are known to suppress inflammation, and the induction of gut homing 
molecules needed for these cells to return to the intestines [18-20]. In this paper 
we have shown that FoxP3+ regulatory T cells are largely present in colonic 
patches. Organized GALT structures, i.e. SILTs and colonic patches containing 
IgA-producing B cells and regulatory T cells, provide a micro environment in which 
numerous beneficial immune responses may occur, which may be responsible for 
the decreased severity of colitis in BALB/c mice. 
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RA is not only involved in the production of IgA by B cells and the differentiation 
and gut homing of regulatory T cells to the intestine but can also potentially play 
a role in the formation of organized GALT. It has been shown that RA can induce 
CXCL13 expression in stromal organizer cells, which is the initial event in the 
formation of peripheral lymph nodes during embryonic development [24]. In the 
context of the adult intestine, transgenic overexpression of CXCL13 in epithelial 
cells leads to an increase of both B cells and LTi cells and promotes the formation 
of SILTs [25]. Considering that adult BALB/c mice have more organized GALT in 
the healthy setting, in combination with higher RA-mediated signalling and higher 
levels of CXCL13, it is tempting to speculate that the higher levels of RA-mediated 
signalling in BALB/c mice is responsible for the observed increase in organized 
GALT in these animals. Interestingly, we show that in addition to more organized 
GALT structures containing T and B cells, BALB/c mice express higher levels of 
RORγt. RORγt is expressed by various cell subsets in the intestine i.e. LTi cells, 
NKp46+ cells and Th17 cells [41-43, 50]. All of these cell types have been shown 
to have beneficial or protective effects in helping the host cope with infection. It 
is likely that also the presence of these cells will further aid in the resistance that 
BALB/c mice show towards DSS-induced colitis. Whether RA-mediated signalling 
is involved in their existence within the intestine will need further study. It has 
been shown that RA can mediate the balance between pro- and anti-inflammatory 
responses [51]. In the context of TNBS colitis, it has been shown that the 
administration of RA ameliorates colitis by shifting the balance from a Th1 to 
a Th2 response [52]. Furthermore, there is evidence to support the fact that RA 
can shift the Treg/Th17 balance in both TNBS colitis and human ulcerative colitis 
[53]. Confirming the effects of vitamin A and RA in our study, we show that the 
removal of vitamin A from the diet, and thus a decrease in RA levels, gives rise 
to a more severe form of colitis. The fact that BALB/c mice express higher levels 
of RALDH enzymes and display higher RA-mediated signalling could serve as an 
explanation as to why BALB/c mice are more resistant to DSS-induced colitis than 
C57BL/6 mice.
Taken together, BALB/c mice have more organized GALT structures, containing 
more T cells, B cells and regulatory T cells, and display higher RA-mediated 
signalling when compared to C57BL/6 mice. It is tempting to speculate that 
inherent differences in RA-mediated signalling are responsible for this increase, 
and could explain why BALB/c mice suffer from less severe colitis and have a 
quicker recovery than C57BL/6 mice. Intriguingly, in the context of the human 
form of disease, it has been shown that IBD patients frequently suffer from 
vitamin A deficiency [54]. This raises the attractive hypothesis that administration 
of vitamin A and or RA to patients suffering from IBD could serve as an effective 
treatment or alleviation of disease in these patients. 
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Abstract
The vitamin A metabolite retinoic acid (RA) has been reported to have numerous 
effects on haematopoietic cells. Here we demonstrate that RA promoted 
differentiation of haematopoietic LTi cells during embryonic development. Both 
addition of RA to embryonic cells in vitro as well as supplementing pregnant 
mice with RA in vivo, mediated the differentiation of haematopoietic precursors 
from CD4– IL-7Ra+ to CD4+ IL-7Ra+ mature LTi cells. On the contrary, withdrawal 
of vitamin A from pregnant mice resulted in a significant decrease of mature LTi 
cells. Furthermore, mice with enhanced vitamin A metabolism displayed more 
mature LTi cells and larger mucosal lymphoid organs. Therefore, our data showed 
that RA mediates local differentiation of LTi cells and that the availability of RA 
has a measurable effect on haematopoietic differentiation during embryonic 
development. 
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Introduction
Development of secondary lymphoid organs like Peyers’ patches (PPs) and 
mesenteric lymph nodes (MLNs) involves clustering of haematopoietic lymphoid 
tissue–inducer (LTi) cells, characterized as CD45+ CD4+ CD3– IL-7Ra+ RORgt+, with 
VCAM+ mesenchymal stromal organizer cells [1-3]. At specific locations in the 
embryo, LTi cells expressing membrane bound lymphotoxin-ab, cluster together 
and interact with the lymphotoxin-b receptor (LTbR) on stromal organizer cells 
[4]. LTbR triggering causes stromal organizer cells to synthesize chemokines 
and adhesion molecules that attract and retain more LTi cells [5]. This initiates a 
chain of events that involves further accumulation and signalling of LTi cells and 
organization of the cell clusters into complete lymph nodes. 
A number of factors are crucial for lymph node development by promoting the 
differentiation and survival of LTi cells. Mice deficient in the retinoic orphan receptor 
RORgt or the inhibitor of transcription Id2 lack LTi cells and consequently, the 
development of lymph nodes is disturbed [6-8]. In addition, deletion or inhibition 
of the interleukin-7 receptor a (IL-7Ra) also affected lymph node development [6, 
9], while enhanced expression of IL-7 promoted the survival and accumulation of 
LTi cells and resulted in the formation of larger lymph nodes as well as ectopic 
lymph nodes [10]. Furthermore, TRANCE deficient mice showed defective lymph 
node formation and reduced numbers of LTi cells which both could be rescued 
by transgenic overexpression of TRANCE [11]. Therefore, the formation of both 
normal and ectopic lymphoid organs can be regulated by controlling LTi cell 
numbers.
IL-7Ra and CD4 are expressed at the final differentiation stages of the LTi lineage 
[4], but not all LTi cells present within the lymph node anlagen are CD4+ [5, 6, 12, 
13]. This suggests that CD45+ IL-7Ra+ CD4– CD3– LTi cells form the precursors of 
mature CD45+ IL-7Ra+ CD4+ CD3– LTi cells and probably differentiate locally into 
mature LTi cells [5, 13, 14].
Vitamin A plays a critical role in the development and function of the immune 
system. Previously, we have shown that the initiation of embryonic lymph node 
development is controlled by the vitamin A metabolite retinoic acid (RA). RA 
induced expression of CXCL13, which is necessary for the first clustering of 
LTi cells [12]. Nerve fibers adjacent to the location of lymph node development 
expressed RALDH enzymes necessary for conversion of vitamin A into RA [12] and 
are therefore most likely the source for RA and responsible for CXCL13 induction 
in stromal organizer cells. Furthermore, in the adult, differentiation of mucosal 
DCs in the intestinal lamina propria has been shown to involve RA (Chapter 4 
and [15, 16]). Moreover, RA coordinates the function of lymphocytes within 
the mucosal immune system at multiple levels, such as regulating gut-homing 
molecule expression on T and B cells [17, 18] and the balance between regulatory 
T cells and Th17 cells [19-21]. 
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These studies demonstrate that RA is of vital importance during embryonic 
development of the immune system as well as proper functioning of the immune 
system in the adult by affecting the differentiation and function of multiple 
haematopoietic cell subsets. Since LTi-like cells are also identified in adult intestines 
and thus associated with a retinoic acid-rich environment [22, 23], we hypothesized 
that RA may influence haematopoietic LTi differentiation in the embryo. Here we 
demonstrate that RA promoted the differentiation of LTi cells from CD4– IL-7Ra+ 
to CD4+ IL-7Ra+ LTi cells both in vivo and in vitro. Supplementation of pregnant 
mice with RA skewed the differentiation of haematopoietic precursors towards 
the mature LTi phenotype in the embryo. On the contrary, embryos from mothers 
that received vitamin A deficient diet showed a reduced LTi cell differentiation 
towards the mature LTi phenotype. We could correlate differences in vitamin A 
metabolism between mouse strains with the presence of more mature LTi cells 
and larger mucosal lymphoid organs. Therefore, our data supports the hypothesis 
that RA regulates local differentiation of LTi cells, suggesting that the level of RA 
production during pregnancy can affect the formation of lymphoid tissue in the 
offspring.
Materials and methods
Animals
C57BL/6 mice and BALB/c mice aged 10-14 weeks were obtained from Charles 
River (Charles River, Maastricht, The Netherlands) and kept at our own facilities 
under standard animal housing conditions. The Animal Experiments Committee 
of the VU Medical Center approved all of the experiments described in this study.
To obtain vitamin A deficient (VAD) and vitamin A control (VAC) embryos, pregnant 
C57BL/6 mice either received a chemically defined diet that lacked vitamin A 
(the modified AIN-93M feed, MP Biomedical, Solon, Ohio, USA), or that contained 
vitamin A (2800 IU/kg in the modified AIN-93M feed, MP Biomedical) from E8.5 
until sacrifice at E18.5. 
To generate RA supplemented embryos, pregnant C57BL/6 mice were provided 
with 250µg retinoic acid/g food (RA; Sigma-Aldrich, Zwijndrecht, The Netherlands) 
from E10.5 until sacrifice at E13.5 [24, 25]. RA was dissolved in 100% ethanol at 
5 mg/ml. Either 250 µg/g chow was made by diluting 8 ml stock to 100 ml with 
water to which 60 g of ground chow was added. Food was refreshed every day 
until sacrifice.
In vitro retinoic acid stimulation
For in vitro stimulation, embryonic cells were harvested as described before [12]. 
In short, E13.5 C57BL/6 embryos were used and all extremities including the 
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head above the eyes and internal organs including haematopoietic cell containing 
organs and mesenteric lymph nodes (MLNs) were removed. The tissue was digested 
with 0.5 mg/ml Blendzyme 2 (Roche, Penzberg, Germany), 0.2 mg/ml DNase-I 
(Roche) in PBS for 15 min at 37°C while constantly stirring. Cell suspensions were 
washed with RPMI (Invitrogen, Breda, The Netherlands), supplemented with 2% 
heat-inactivated FCS, 100 U/ml penicillin, and 100 µg/ml streptomycin. Cells were 
allowed to adhere for 2 hours at 37°C. For RA stimulation experiments, all-trans 
retinoic acid (RA, Sigma-Aldrich, Zwijndrecht, The Netherlands, dissolved as 10 
mM in 100% ethanol) was added at 100 nM. After incubation for 24 hours at 37°C 
and 5% CO2, cells were analyzed by flow cytometry.
Flow cytometry 
MLNs were isolated from VAD and VAC embryos at E18.5, or from C57BL/6 
and BALB/c embryos at E18.5. Embryos from RA supplemented mothers were 
collected at E13.5 and dissected as described above. Single cell suspensions 
were made by cutting tissues with scissors, followed by digestion at 37ºC for 
20 min, using 0.5 mg/ml Blendzyme 2 (Roche) and 0.2 mg/ml DNase-I (Roche) 
in PBS while constantly stirring. Cell clumps were removed by pipetting the cells 
over a nylon mesh. Lymph node cells were washed and resuspended in PBS with 
2% NBCS. Subsequently, cells were stained with anti-IL-7R antibody (anti-CD127, 
clone A7R34, eBioscience, Immunosource, Halle-Zoersel, Belgium), Alexa fluor 
488 (Invitrogen, Breda, the Netherlands) conjugated anti-CD45 (clone MP33), 
Alexa fluor 488 conjugated anti-CD4 (clone GK1.5), Alexa fluor 488 conjugated 
anti-CD3 (clone 145-2C11, eBioscience), PE conjugated anti-CD4 (clone GK1.5, 
eBioscience), PE-Cy7 conjugated anti-CD45 (clone 30-F11, eBioscience) and with 
Sytox Blue (Invitrogen) to discriminate between live versus dead cells. Secondary 
antibody used was Alexa fluor 647 conjugated goat anti-rat antibody (Invitrogen). 
Cells were analyzed with a Cyan ADP flow cytometer (Beckman Coulter, Woerden, 
The Netherlands). 
Macroscopic analyis of lymph nodes and Peyer’s Patches
MLNs were carefully dissected from 10-14 week old BALB/c and C57BL/6 mice and 
the length of the mesenteric lymph node string was measured. Peyer’s patches 
(PPs) were excised and the number of PPs per small intestine were counted. The 
weight of MLNs and PPs was determined.
Statistics
The data shown in figure 1B and 1C were analyzed with a paired Student’s t-test. 
A two-tailed unpaired Student’s t-test was used for all other analyses. 
RA promotes LTi cell differentiation during embryonic development142
7
Results
Retinoic acid influences differentiation of haematopoietic LTi cells.
Since RA is involved in haematopoietic differentiation [15, 18, 20, 26, 27] and 
important for the induction of CXCL13 in mesenchymal cells of lymph node 
anlagen [12], we hypothesized that RA could also influence haematopoietic LTi 
differentiation in developing lymph nodes. To test this, we made cell suspensions 
from embryonic tissues enriched for peripheral lymph node anlagen [12]. After 
adherence of mesenchymal cells, RA was added to these cultures and 24 hours 
later the percentages of precursor LTi and mature LTi cells were analyzed by flow 
cytometry. Representative flow cytometry plots show gating for CD45+ cells and 
expression of CD4 and IL-7Ra (Figure 1A). Since CD45+ CD3– IL-7Ra+ CD4– LTi 
Figure 1. RA promotes differentiation of precursor LTi cells to mature LTi cells.
(A) Shown are representative flow cytometry plots of CD45, CD4 and IL-7Ra expression by PLN enriched 
embryonic cells from E13.5 C57BL/6 embryos. Boxes indicates CD45+ gate and CD4+ and CD4– gate for 
calculations of LTi ratios shown in B, C and D. (B) In vitro cultures of PLN enriched embryonic cells from 
E13.5 C57BL/6 embryos stimulated with 100 nM RA for 24 hours. 3 individual experiments with n=7. (C) 
PLN enriched embryonic cells (E13.5 C57BL/6) from pregnant mice supplemented with 250 µg RA/g food. 2 
individual experiments with n=9. (D) MLN suspensions from vitamin A deficient (VAD) and vitamin A control 
(VAC) embryos at E18.5. 2 individual experiments with n=10. Cells were analyzed for expression of CD45, 
CD3, IL-7Ra, and CD4. The ratio of the percentage of CD45+ CD3– IL-7Ra+ CD4+ cells over CD45+ CD3– IL-7Ra+ 
CD4– cells was calculated. Data represent average ratio ± SEM. Significant differences are indicated as * 
(p=3.25E-08) or ** (p=0.02).
RA promotes LTi cell differentiation during embryonic development 143
7
cells represent immature LTi cells and form the precursors to CD45+ CD3– IL-7Ra 
+ CD4+ mature LTi cells [5, 13, 14], we calculated the ratio of CD45+ IL-7Ra+ CD4+ 
mature LTi cells over CD45+ IL-7Ra+ CD4– precursor LTi cells. Upon RA stimulation, 
the ratio of mature LTi cells versus precursor LTi cells was significantly skewed 
towards the mature CD4+ population (Figure 1B). To confirm in vivo that indeed 
RA can mediate the differentiation of LTi cells, we provided pregnant mice with 
RA in their food, starting at E10.5 [24, 25], 3 days before sacrifice at E13.5. After 
isolating peripheral lymph node anlagen enriched embryonic tissue, cells were 
analyzed by flow cytometry for LTi cells and their precursors. We observed that 
in vivo supplementation of RA dramatically increased the mature CD4+ population 
(Figure 1C). Therefore, we conclude that RA can mediate the differentiation of 
immature CD45+ CD3– IL-7Ra+ CD4– LTi cells towards mature CD45+ CD3– IL-7Ra+ 
CD4+ LTi cells. 
Absence of vitamin A in diet of pregnant mice affects LTi cell differentiation 
in the offspring.
Since we observed that RA supplementation to pregnant females increased the 
differentiation of LTi cells during embryonic development, we reasoned that 
reducing the availability of RA should result in decreased embryonic LTi cell 
differentiation. To test this hypothesis, we provided vitamin A, from which RA 
is metabolized, deficient food (VAD) to pregnant mice at E8.5 and isolated the 
mesenteric lymph nodes (MLNs) at E18.5. VAD diet gradually depletes liver 
stores of pregnant mothers and thus reduces RA availability during embryonic 
development. FACS analysis on digested E18.5 MLNs indeed showed that deprival 
of vitamin A led to a significant decrease of CD45+ IL-7Ra+ CD4+ mature LTi cells 
(Figure 1D). 
Differentiation towards mature LTi cells is enhanced in BALB/c mice.
Since we have observed that BALB/c and C57BL/6 mice differ in vitamin A 
metabolism and RA-mediated signalling (Chapter 5)and that RA increases the 
amount of mature LTi cells, we reasoned that the amount of mature LTi cells 
might be different in BALB/c versus C57BL/6 mice. Therefore, the developmental 
stage of LTi cells in E18.5 MLNs derived from either BALB/c or C57BL/6 embryos 
was determined by flow cytometry. The percentage of CD45+ haematopoietic cells 
in these MLNs was similar in both mouse strains (Figure 2A). At this age, few B 
cells and hardly any T cells were present within MLNs (4.4% ± 1.4 and 3.0% ± 0.6 
of CD45+ cells in C57BL/6 and BALB/c, respectively) and therefore nearly all of 
the CD45+ cells were LTi cells. Next, we analyzed the developmental stage of LTi 
cells by measuring CD4 expression on CD45+ CD3– IL-7Ra+ LTi cells. C57BL/6 
mice contained more immature CD4– IL-7Ra+ LTi cells (Figure 2B, left) and less 
mature CD4+ IL-7Ra+ LTi cells (Figure 2B, right) in MLNs when compared to BALB/c 
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mice. As a result, the ratio of mature CD4+ IL-7Ra+ LTi cells over precursor CD4– 
IL-7Ra+ LTi cells was significantly lower in C57BL/6 MLNs than in BALB/c MLNs. 
And thus, enhanced vitamin A metabolism and RA-mediated signalling in BALB/c 
mice correlated with enhanced LTi differentiation towards more mature LTi cells 
(Figure 2C). 
Transgenic overexpression of IL-7 has been shown to lead to increased numbers 
of LTi cells resulting in enlarged Peyers Patches (PPs) and MLNs and ectopic lymph 
nodes [10]. We described in chapter 6 that the colon of BALB/c mice contained 
much more isolated lymphoid follicles and cryptopatches than C57BL/6 mice. In 
addition, we observed that PPs and MLNs in BALB/c mice were larger than those 
in C57BL/6 mice. To quantify this we investigated the size of mucosal secondary 
lymphoid organs in both mouse strains by measuring length and weight of both 
MLNs and PPs. Representative pictures show PPs on small intestines of C57BL/6 
and BALB/c mice (Figure 3A) and dissected MLNs from both mouse strains (Figure 
3B). Upon measurement, MLNs from BALB/c mice were significantly larger than 
from C57BL/6 mice and by weight BALB/c MLNs were significantly heavier when 
compared to C57BL/6 MLNs (Figure 3C). We could detect slightly more PPs in BALB/c 
small intestines than in C57BL/6 small intestine (Figure 3D, left). Moreover, the 
weight of pooled PPs per BALB/c mouse was increased more than 2-fold compared 
to C57BL/6 PPs (Figure 3D, right). These data indicate that the generation of 
higher numbers of mature LTi cells in BALB/c mice may consequently not only 
lead to the formation of larger lymphoid tissues but also to more lymphoid tissues 
within the mucosal immune system.
Figure 2. Differentiation of LTi cells is increased in BALB/c mice.
MLNs were isolated from C57BL/6 and BALB/c mice at day of birth. MLN cell suspensions were analyzed for 
expression of CD45, CD3, IL7Ra, and CD4. (A) Data represent the average percentage ± SD of CD45+ cells in 
C57BL/6 and BALB/c MLNs. (B) Shown is the average percentage of CD45+ cells that are IL7Rα+ CD4– (left), and 
are IL7Ra+ CD4+ (right) of individual MLNs. (C) The ratio of the percentage of IL7Ra+ CD4+ cells over IL7Ra+ CD4– 
cells of individual animals was calculated (right). A total of 15 C57BL/6 derived from 3 different litters and 12 
BALB/c mice derived from 2 different litters were used for analysis in two separate experiments. Significant 
differences are indicated by * (p<0.0001).
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Discussion
The vitamin A metabolite RA has numerous effects on haematopoietic cells, such as 
the migration of lymphocytes towards the intestines [17, 18] and the development 
of regulatory T cells [19-21]. Here we have shown that increased RA availability 
results in enhanced LTi differentiation and the development of more mucosal 
lymphoid tissue. By using several approaches, we showed that RA stimulation 
resulted in more mature LTi cells, defined as IL-7Ra+ CD4+, at the expense of the 
IL-7Ra+ CD4– precursor population. This differentiation was affected by withdrawal 
of vitamin A from pregnant females, resulting in a significant decrease of mature 
LTi cells. Moreover, by studying mouse strains that differ in vitamin A metabolism 
we discovered that differentiation of LTi cells is enhanced in mice with higher 
RALDH expression and RA-mediated signalling (Chapter 5). This increased RA-
mediated signalling is most likely responsible for increased mature LTi numbers 
in the BALB/c mice. In conclusion, RA is important for the differentiation of the 
progenitor LTi cells towards their final phenotype and is therefore essential for 
embryonic lymph node development.
Figure 3. BALB/c mice have larger secondary 
lymphoid organs.
Representative pictures for PPs (A) and MLNs 
(B) from 14 week old C57BL/6 and BALB/c mice. 
(C) Data represent average length ± SD (left) and 
weight of individual MLNs (right). (D) Results 
show average number ± SD of PPs per animal 
(left) and weight of pooled PPs from individual 
animals (right). Per group 10 animals were used for 
analysis in two separate experiments. Significant 
differences are indicated by * (p=0.02),** 
(p<0.0001). Peyers’ patches, PP; mesenteric lymph 
node, MLN.
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Previously, we have shown that nerve fibers adjacent to lymph node anlagen 
express RA-metabolizing RALDH2 enzymes and are likely producers of RA leading 
to the induction of CXCL13 expression in mesenchymal cells [12]. RA-induced 
CXCL13 attracts CXCR5 expressing LTi progenitor cells towards the anlagen. 
Additionally, LTi differentiation towards the mature LTi phenotype might also be 
promoted directly by RA derived from adjacent nerve fibers. In that case, nerve-
derived RA will not only affect LTi cell attraction to lymph node anlagen, but 
will also promote LTi cell differentiation and survival. Alternatively, in addition 
to CXCL13 induction, nerve-derived RA might induce RALDH expression in 
mesenchymal stromal organizer cells within the lymph node anlagen. We have 
shown that RALDH enzyme expression was induced in RA stimulated adult stromal 
cells in vitro (Chapter 4). Within lymph node anlagen, stromal organizer cells and 
LTi cells are in close contact and stromal organizer cells might provide LTi cells 
with RA for their differentiation upon RALDH induction. 
Multiple factors are required for LTi cell differentiation like RORgt, TRANCE, and 
Id2 [6, 8, 11]. It remains unknown how RA is involved in LTi cell differentiation. 
Possibly RA affects LTi differentiation by regulating the expression levels of one or 
more of these factors. A good candidate is the helix-loop-helix repressor protein 
Id2. Id2 is an early regulator of LTi cell differentiation [8]. It inhibits T and B cell 
development [28] and promotes the differentiation of haematopoietic precursors 
into NK cells and LTi cells [29]. It has been shown that Id2 is a RA-responsive 
gene [30], thus RA might control LTi cell differentiation by positively regulating 
expression levels of Id2 proteins during lymph node development.  
BALB/c mice showed enhanced LTi differentiation and displayed larger mucosal 
lymphoid tissues when compared to C57BL/6 mice. Others have reported that the 
number of LTi cells correlated with the amount of lymphoid tissue [10]. This allows 
for the hypothesis that maternal vitamin A metabolism may promote mucosal 
lymphoid tissue development in the fetus. Therefore, the amount of RA produced 
and the level of RA-mediated signalling may be instrumental for the development 
of the mucosal immune system during embryonic development. Since the 
production of RA is mostly dependent on conversion by RALDH enzymes, the 
levels of RALDH expression will determine the efficiency of LTi cell differentiation. 
It is therefore of importance to know why BALB/c and C57BL/6 mice differ in 
RALDH enzymes levels, and thus to dissect what controls RALDH expression levels 
within the developing embryo and pregnant mothers. This could potentially lead 
to therapeutic applications to stimulate the development of the mucosal immune 
system in the unborn child. 
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Summary
Mucosal immune system
The mucosal immune system protects us from harmful pathogens and at the same 
time maintains tolerance to harmless food antigens and commensal bacteria. The 
vitamin A metabolite retinoic acid (RA) is crucial for the mucosal immune system 
in maintaining this balance. In studies described in this thesis, several beneficial 
effects of RA have been investigated. We demonstrated that intestinal epithelial 
cells are involved in educating dendritic cells (DCs) to acquire a mucosal phenotype 
by upregulating RALDH enzyme expression. By omission of vitamin A from the diet 
we showed that dietary vitamin A is mandatory for RALDH expression in mucosal 
DCs and mesenteric lymph node (MLN) stromal cells. We subsequently showed 
that RA can directly regulate RALDH expression in DCs and stromal cells and we 
propose that intestinal epithelial cells are most likely the providers of RA for DCs. 
And thus, these intestinal epithelial cells provide an instructive environment that 
licenses DCs to transfer information about their tissue of origin and their site of 
antigen capture to the T cells. In addition, these imprinted DCs are crucial for 
other aspects of the mucosal immune system like the induction of regulatory T 
cells and IgA-producing B cells.
Developing immune system
Not only is dietary vitamin A of importance for the mucosal immune system, 
we also showed that it is affecting the formation of secondary lymphoid organs 
during ontogeny. We showed that RA was involved in embryonic lymph node 
development by promoting differentiation of lymphoid tissue inducer (LTi) cells. 
RA-supplemented mothers displayed increased numbers of mature LTi cells. 
Consistently, deprival of vitamin A led to a significant decrease of LTi differentiation 
status in developing LN of the embryos of vitamin A deficient (VAD) mothers.
Different levels of vitamin A converting RALDH enzymes
Differences in vitamin A metabolism will most likely result in altered functioning 
of the mucosal immune system. Inbred mouse strains show differences in RALDH 
activity. In the BALB/c mice, showing a higher RALDH activity when compared to 
C57BL/6 mice, a correlation was found between increased RALDH activity and 
enhanced induction of gut-homing molecule expression on CD4+ T cells, higher 
FoxP3 levels in intestines and MLNs, increased IgA production, enhanced LTi 
differentiation, and larger MLNs and Peyers’ patches (PPs). Moreover, in a disease 
setting, BALB/c mice showed an increased capacity to form tertiary lymphoid 
tissue that could contribute to IgA production and increased differentiation of 
regulatory T cells. Taken together, these data demonstrate that vitamin A is 
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of vital importance for proper functioning of the mucosal immune system and 
vitamin A status might be a determinant in disease susceptibility and severity. 
Paracrine retinoic acid-mediated signalling
We have suggested that during embryonic lymph node development expression 
of CXCL13 by mesenchymal stromal organizer cells is induced by RA provided 
by adjacent nerves [1]. Also, many other examples of a paracrine function for RA 
come from studies regarding embryonic organogenesis (reviewed in [2]), while 
no genetic support for autocrine RA signalling exists. In addition, increasing 
numbers of examples of a paracrine mode of action for RA are described in the 
adult mouse. Intestinal epithelial cells are now thought to be the providers of 
RA during the differentiation and imprinting of mucosal DCs [3-5]. Moreover, we 
(chapter 2 and [6]) and others [7-10] have shown that the induction of gut-homing 
T cells depends on RA presented by DCs and MLN stromal cells. Since DCs are in 
close contact with T cells during T cell activation for presentation of antigen, we 
hypothesized that RA is transferred to and presented by DCs to T cells through 
the immunological synapse formed between T cells and DCs. Compatible with this 
idea are the reported observations that uptake and presentation of RA to T cells 
can occur by DCs upon pre-incubation with RA which did not involve newly formed 
RA [11]. However, it remains unknown how RA is secreted and transferred from 
one cell to another. 
For transfer from DCs to T cells RA will have to be transported over both cell 
membranes. Molecules described to be especially equipped to perform such a 
function are ATP-binding cassette (ABC) transporters. ABC transporters are known 
to be expressed by a variety of immune cells like macrophages, DCs and T cells 
[12-17] and are thought to transport a wide variety of substrates across cellular 
membranes, including inflammatory molecules such as cytokines as well as 
lipids and drugs. Since RA is a lipid-soluble vitamin metabolite, ABC transporters 
might be good candidates for RA secretion. Indeed, overexpression of the 
ABC transporter MRP1 has been shown to block neuritogenic effects of RA in a 
neuroblastoma cell line, showing that MRP1 might have acted as an efflux pump 
for RA [18]. In addition, RA has been shown to regulate the expression of multiple 
ABC transporters, like P-glycoprotein (P-gp) [19, 20] or ABCA1 [21]. In this way, RA 
might regulate its own secretion. Similarly, expression of ABC transporters on T 
cells might be necessary for uptake of RA into the cell. Future research is needed 
to identify whether ABC transporters are involved in secretion and presentation of 
RA to neighboring T cells. Increasing the expression of ABC transporters on DCs, 
thereby enhancing RA secretion and presentation, may be beneficial to enhance 
the mucosal immune response necessary to overcome intestinal inflammation. 
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Modification of retinoic acid levels in the small intestine
Since RALDH expression in DCs is crucial for the mucosal immune system, it is of 
importance that we understand how RALDH levels in DCs are controlled. We have 
demonstrated in chapter 4 that after birth RALDH enzyme levels are upregulated 
in MLN-DCs and MLN stromal cells. This suggested to us that external factors are 
involved in inducing RALDH expression by these cells. Soon after birth, mucosal 
surfaces are colonized with high numbers of bacteria [22, 23], that play a crucial 
role in the maturation of the mucosal immune system [24-26]. Also, during the 
first week of life pups are solely fed with maternal milk, which is rich in vitamin A. 
In chapter 4, the role of these factors in regulating RALDH levels in mucosal DCs 
was investigated. We discovered that Toll-like receptor signalling was not crucial 
for RALDH enzyme expression since MLN-DCs from both MyD88-/- and Trif mutant 
animals had comparable levels of RALDH activity to WT animals, confirming the 
recent findings that MLN-DCs from MyD88-/- Trif-/- double knock-out mice still 
showed RALDH activity [27]. Remarkably, the intake of dietary vitamin A turned 
out to be mandatory for RALDH expression and enzyme activity within the 
mucosal immune system. Surprisingly, while RALDH mRNA levels in both MLN-
DCs and MLN stromal cells were affected by the lack of vitamin A absorption, 
RALDH expression levels within the small intestine remained unchanged. This 
indicates that RALDH expression in mucosal DCs and intestinal epithelial cells 
is regulated differently. However, factors regulating RALDH levels within the 
intestinal epithelial cells are still unidentified. Since we did not observe an effect 
of the absence of MyD88- or Trif-dependent TLR signalling on epithelial-mediated 
imprinting of RALDH expression in mucosal DCs, we suspect that also in epithelial 
cells RALDH levels are not regulated by TLR-dependent signals. It is plausible that 
other pattern recognition receptor pathways or that secreted bacterial products 
are involved in regulation of RALDH enzymes in intestinal epithelial cells. 
Being able to modify RALDH levels might be a beneficial tool to enhance RA 
production in the intestines, thereby promoting epithelial barrier function [28, 
29], mucosal DC imprinting and mucosal tolerance induction. Moreover, adjusting 
vitamin A levels and RA production in pregnant mothers will likely have a 
significant effect on the development of the mucosal immune system of newborns. 
In chapter 7, we demonstrated that RA is involved in local differentiation of LTi 
cells during LN development. Increased intake of RA by pregnant mice correlated 
with higher numbers of mature LTi cells in the developing embryos, while LTi 
differentiation in developing embryos was reduced when vitamin A was omitted 
from the diet of the mothers. Because the numbers of LTi cells is associated with 
size and number of LNs ([30] and chapter 7), we expect that increased RA levels 
in pregnant mothers will promote the development of larger LNs in newborns. 
Additionally, after birth, LTi cells are thought to give rise to NKp46 mucosal cells, 
a cell type that has recently been described to enhance the antimicrobial response 
and epithelial barrier function by inducing anti-bacterial peptide production by 
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intestinal epithelial cells [31-33]. Modification of RA levels in pregnant mothers 
might therefore be beneficial to improve the mucosal immune system of their 
children.
Clinical implications
To demonstrate the significance of having increased RA-mediated signalling 
within the intestines, BALB/c and C57BL/6 mice were compared in chapter 5 and 
6. These two mouse strains differ in RALDH activity and RA production in MLNs 
and small intestines. From these studies we can learn that increased RA-mediated 
signalling affected the mucosal immune system at multiple levels. The induction 
of gut-homing molecules and differentiation of regulatory T cells was enhanced in 
MLNs from BALB/c mice when compared to C57BL/6 mice. In addition, BALB/c mice 
displayed the accumulation of more T cells, FoxP3+ Treg cells and IgA secreting B 
cells in the lamina propria of the small intestine. In addition, the presence of more 
mature LTi cells in BALB/c mice correlated with the formation of more secondary 
lymphoid tissue and the development of tertiary lymphoid structures during 
colitis when compared to C57BL/6. Taken together, enhanced RA production, and 
concomitant RA-mediated signalling, is associated with a more efficient mucosal 
immune system in BALB/c mice. 
Cellular RA availability is regulated by the vitamin A nutritional status and the 
tightly regulated balance between RA synthesis and catabolism. Genetic variation 
(polymorphisms, SNPs and mutations) has been reported for a number of factors 
involved in maintaining this balance [34-39] like Cyp26A1 [37] or RALDH2 
[36] and this may result in higher or lower RA synthesis. Variation in RA levels 
caused by mutations or polymorphisms in the genes encoding these factors 
in humans might determine the efficacy of the mucosal immune system and 
susceptibility for infectious disease. Possibly, factors like these are differentially 
expressed in BALB/c and C57BL/6, like RALDH enzymes shown in chapter 5 and 
6. Consequently, BALB/c may have a better defense against mucosal infection and 
this might explain why these mice suffer from less severe colitis and recover more 
quickly than C57BL/6 mice. 
This raises the attractive hypothesis that administration of RA to patients could 
serve as an effective treatment or alleviation of disease. A number of research 
groups have investigated the effect of RA treatment on several inflammatory 
diseases like colitis, experimental autoimmune encephalomyelitis (EAE), collagen-
induced arthritis (CIA), psoriasis and acne [40-47]. Indeed, RA downregulated 
inflammatory responses in colon biopsies cultured from patients with ulcerative 
colitis in vitro and in mice suffering from colitis in vivo by increasing the number 
of regulatory T cells [40]. EAE, an experimental model for multiple sclerosis, is 
an example of a typical Th17-driven immune disease in which RA was shown to 
strongly inhibit pathogenic Th17 responses during the disease. Treatment with RA 
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dramatically delayed disease onset but also strongly decreased disease severity 
[41, 42, 44, 45]. Also, RA treatment markedly ameliorated CIA, an experimental 
model for rheumatoid arthritis, in mice [43]. Disease onset was delayed and RA 
improved the clinical course by reducing the production of inflammatory cytokines, 
immunoglobulin, and chemokines. Taken together, these results support the 
hypothesis that RA could serve as a new therapeutic agent in the treatment of 
human inflammatory diseases. 
Notably, the modification of RA availability must be approached with great 
carefulness. Because of the Th1-inhibiting effect of RA, Th1-driven immune 
responses like Leishmania major infection might be impaired. Also, excessive 
levels of RA may lead to disturbed embryonic development and birth defects. 
Recently involvement of RA in allergic responses has been described, where it 
is suggested that vitamin A deficiency or a high vitamin A intake may contribute 
to a lower or higher prevalence of allergic diseases, respectively [48-50]. In 
addition, as discussed in the introduction of this thesis, typical symptoms that are 
associated with high RA levels are weight loss, osteoporosis, liver damage, kidney 
damage, or loss of hair [51-57]. Therefore, when using RA as a therapeutic agent 
in patients, careful monitoring of adverse reactions must be pursued. Perhaps a 
more biological approach would be to modulate the levels of vitamin A converting 
RALDH enzymes within the intestines, since this may result in a more specific 
regulation of the amount of RA available to regulate the mucosal immune system. 
Future studies are needed to investigate how enzyme expression in the intestines 
can be modulated.
Concluding remarks
Based on the data presented in this thesis, we can conclude that vitamin A is of 
vital importance for mucosal immune homeostasis and vitamin A status in man 
might determine disease susceptibility and severity. In conclusion, the beneficial 
effect of RA on inflammatory disease in experimental models raises the attractive 
hypothesis that administration of RA to or enhanced intestinal RALDH expression 
in patients could serve as an effective treatment of inflammatory disease. 
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Nederlandse samenvatting
Het mucosale immuunsysteem
De taak van ons afweersysteem is om ziekmakende bacteriën en virussen die ons 
lichaam binnendringen, op te ruimen en te verwijderen. In ons maag-darmstelsel 
wordt dit principe echter veel subtieler toegepast. Hierin leven miljoenen bacteriën, 
de darmflora. Veel van deze bacteriën zijn niet ziekmakend, maar juist gunstig 
omdat deze bacteriën noodzakelijk zijn voor de vertering van voedsel dat ons eigen 
lichaam niet kan afbreken. Echter, wanneer schadelijke bacteriën binnenkomen, 
kunnen zij infecties veroorzaken. Een goed functionerend afweersysteem in het 
maag-darmstelstel (vanaf nu het mucosale afweersysteem genoemd) zal dus 
tegen schadelijke bacteriën in onze darm een afweerreactie opwekken om zo het 
lichaam te beschermen tegen infecties en ziekten, maar zal tegelijkertijd tolerant 
zijn voor de onmisbare bacteriën die daar continu aanwezig zijn. 
Het mechanisme waarmee ons afweersysteem onderscheid maakt tussen 
schadelijke en onschadelijke bacteriën is nog niet geheel duidelijk. Toch is het wel 
duidelijk dat een goede balans van het afweersysteem in de darmen zeer belangrijk 
is voor onze gezondheid, omdat verstoring van deze balans kan resulteren in 
chronische darmontstekingen zoals ulceratieve colitis en de ziekte van Crohn. Een 
beter begrip van deze balans is van groot belang voor de ontwikkeling van nieuwe 
therapieën voor de behandeling van dit soort ziekten.
Vitamine A is zeer belangrijk voor onze gezondheid. Het is essentieel voor veel 
processen zoals de embryonale ontwikkeling, voortplanting, groei, zicht en het 
mucosale afweersysteem. Ontoereikende consumptie van voedsel met vitamine 
A in ontwikkelingslanden resulteert in vitamine A deficiëntie dat voornamelijk 
voorkomt bij kinderen en zwangere vrouwen. Vitamine A deficiëntie leidt tot o.a. 
blindheid en groeistoornissen. Vitamine A deficiëntie ook tot een verslechterd 
afweersysteem waardoor diarree en darmontstekingen verhoogd en in ernstigere 
vorm voorkomen. Hierdoor overlijden jaarlijks meer dan een miljoen kinderen. Om 
vitamine A deficiëntie te voorkomen en te verhelpen heeft de Wereldgezondheidsraad 
programma’s opgezet om kinderen in ontwikkelingslanden twee tot drie keer 
per jaar vitamine A toe te dienen. Dit heeft tot gevolg gehad dat kindersterfte is 
gedaald met 20-50%. 
Vitamine A kan niet door ons lichaam geproduceerd worden en is een micronutriënt 
dat in de darmen wordt geabsorbeerd uit groente, fruit (wortels, pompoen, 
spinazie, boerenkool), dierlijk voedsel (lever, eieren) en zuivel. Vitamine A wordt 
in het lichaam omgezet tot retinolzuur. Retinolzuur is de werkzame stof die de 
hierboven beschreven processen beinvloeden. Voor de omzetting van vitamine A 
naar retinolzuur zijn enzymen nodig. Deze enzymen worden retinal dehydrogenase 
(afgekort RALDH) genoemd.
Dendritische cellen zijn belangrijke cellen van het afweersysteem die in de huid, 
longen en darmen continu op zoek zijn naar ziekteverwekkers waartegen ons 
immuunsysteem moet optreden. Wanneer deze zijn waargenomen, dan wordt de 
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informatie over de locatie en type gevaar door dendritische cellen gepresenteerd 
aan andere cellen van het immuunsysteem die de specifieke afweer moeten leveren. 
Dit zijn de T- en B-lymfocyten. De plek waar dit met grote efficiëntie gebeurd 
zijn de lymfoïde organen zoals de lymfeklieren en de milt. Wanneer lymfocyten 
in deze lymfoide organen de eiwitten afkomstig van de ziekteverwekkers 
kunnen herkennen, raken ze geactiveerd, waarna ze in staat zijn om tegen de 
ziekteverwekkers op te treden. 
Wanneer lymfocyten in de darm drainerende lymfeklieren worden geactiveerd 
krijgen ze vervolgens specifieke eiwitten op hun cel oppervlak, waarmee ze 
uitermate goed naar de darmen kunnen migreren. Dit is belangrijk omdat hier 
de ziekteverwekkers zijn binnengedrongen en vervolgens onschadelijk gemaakt 
moeten worden. Wanneer ziekteverwekkers via de huid binnendringen, dan gaan 
de lymfocyten die geactiveerd worden in de huid drainerende lymfeklieren juist 
moleculen tot expressie brengen waardoor ze naar de huid kunnen migreren.  
Vitamine A, in de vorm van de biologisch actieve metaboliet retinolzuur, reguleert 
de expressie van de moleculen die lymfocyten nodig hebben om naar de darm 
te migreren, de zogenaamde darmspecifieke homingsreceptoren. De benodigde 
RALDH enzymen voor de synthese van retinolzuur uit vitamine A worden specifiek 
door dendritische cellen van de darmen en in de darm drainerende lymfeklieren 
(mucosale dendritische cellen) tot expressie gebracht, terwijl de dendritische 
cellen buiten de darm en andere mucosa niet beschikken over deze enzymen. 
Naast de inductie van darmspecifieke homingsreceptoren is retinolzuur ook 
belangrijk voor de productie van het type A antilichamen (IgA). Antilichamen 
worden door B lymfocyten geproduceerd en IgA wordt voornamelijk in mucosale 
weefsels, zoals de darm, geproduceerd om bescherming te bieden tegen de 
bacteriën die aanwezig zijn in de darm. Retinolzuur is zeer belangrijk voor de 
productie van IgA door B cellen.
Kort samengevat, vitamine A is zeer belangrijk voor het functioneren van het 
mucosale afweersysteem, omdat verschillende immunologische processen 
beïnvloedt worden door de biologische werkzame metaboliet retinolzuur. Toch 
is er nog veel onbekend over de specifieke mechanismes waarmee vitamine A 
de gezondheid en het afweersysteem bevorderd en de ontwikkeling van infecties 
verlaagd. 
In dit proefschrift worden studies beschreven waarin we de rol van vitamine A 
in verschillende onderdelen van het afweersysteem hebben onderzocht. Onze 
resultaten dragen bij aan een beter inzicht in de beschermende rol van vitamine 
A in het mucosale immuunsysteem. 
Samenvatting van het proefschrift
In hoofdstuk 2 laten wij zien dat naast mucosale dendritische cellen ook stromale 
cellen (of steuncellen) in mesenteriale lymfeklieren RALDH enzymen produceren. 
Dit betekent dat stromale cellen ook retinolzuur kunnen produceren en T en B 
lymfocyten kunnen beïnvloeden. Om dit te onderzoeken hebben we mesenteriale 
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lymfeklieren getransplanteerd naar een gebied buiten de mucosa, namelijk de 
knieholte van de muis. Vervolgens hebben we onderzocht of T cellen in deze 
lymfeklieren worden gestimuleerd om darmspecifieke eiwitten tot expressie 
te brengen. De lymfeklier in de knieholte draineert de huid en  en hier worden 
normaal gesproken alleen de huidspecifieke homingsreceptoren geinduceerd 
op geactiveerde lymfocyten. Na transplantatie verdwijnen de afweercellen uit de 
getransplanteerde lymfeklier verdwijnen en hiermee dus ook de mucosale RALDH-
positieve dendritische cellen. De stromale cellen blijven achter en zijn dan het enige 
celtype verantwoordelijk voor de productie van retinolzuur. Wanneer lymfocyten in 
de getransplanteerde mesenteriale lymfeklier worden geactiveerd dan resulteert 
dit in de expressie van een deel van de darmspecifieke homingsreceptoren, terwijl 
een ander deel afhankelijk bleek te zijn van de mucosale dendritische cellen. 
Onze experimenten tonen dus aan dat dendritische cellen en stromale cellen in 
mesenteriale lymfeklieren beide T cellen kunnen instrueren om darmspecificieke 
eiwitten tot expressie te brengen en om zo efficient mogelijk T cellen naar de 
juiste weefsels te sturen. 
In hoofdstuk 3 hebben we onderzocht hoe darmepitheelcellen de ontwikkeling 
van mucosale DCs beïnvloeden. We hebben laten zien dat de darmepitheel cellen 
de dendritische cellen aanzetten om de vitamine A metaboliserende enzymen 
RALDH tot expressie te brengen. Deze dendritische cellen stimuleerden vervolgens 
T cellen om de darm-specifieke homingsreceptoren tot expressie te brengen. 
Retinolzuur, afkomstig uit de darm epitheel cellen, bleek in dit proces een cruciale 
factor te zijn. Daarentegen werden dendritische cellen door steuncellen uit de 
huid juist zo beinvloed, dat zij lymfocyten stimuleerden om de huid-specifieke 
homingsreceptoren tot expressie te brengen. 
In hoofdstuk 4 hebben we onderzocht hoe de expressie van RALDH enzymen in 
dendritische cellen en stromale cellen wordt gereguleerd. Onze resultaten lieten 
zien dat vlak na de geboorte zowel dendritische cellen als stromale cellen zeer 
lage expressie van RALDH enzymen vertoonden en dat tijdens de ontwikkeling na 
de geboorte de expressieniveaus in beiden celtypen verder omhoog gingen. 
Parallel aan de verhoging van de RALDH expressie vindt na de geboorte ook de 
bacteriële kolonisatie van de darmen plaats, waarbij allerlei immunologische 
veranderingen in de darm plaatsvinden. Daarom hebben wij onderzocht of er 
een verband is tussen bacteriële activatie van dendritische cellen en de inductie 
van RALDH enzymen. Stimulatie van dendritische cellen in kweekschaaltjes met 
verschillende bacteriële componenten leidde in een aantal gevallen inderdaad tot 
het aanzetten van RALDH expressie in de dendritische cellen. Echter, in een levende 
muis (in vivo) lijkt bacteriële signalering minder belangrijk voor de inductie van 
RALDH enzymen. Dit bleek uit experimenten met mucosale dendritische cellen uit 
transgene muizen waarin bacteriële signalering is platgelegd. Hierdoor worden 
de dendritische cellen niet door bacteriën geactiveerd, maar deze vertoonden 
desondanks nog steeds actieve RALDH enzymen. 
Omdat we in hoofdstuk 3 hadden gevonden dat epitheelcellen dendritische 
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cellen kunnen stimuleren om RALDH tot expressie te brengen  en dat dit proces 
afhankelijk was van retinolzuur, hebben wij vervolgens onderzocht of vitamine 
A de RALDH expressie in dendritische cellen kan beïnvloeden. Om dit te 
onderzoeken hebben we vitamine A deficiënte muizen gegenereerd door muizen 
op een vitamine A-vrij dieet te zetten. Als controle werden ook muizen op diëten 
met verschillende hoeveelheden vitamine A gegenereerd. Tot onze verbazing 
vertoonden de mucosale dendritische cellen uit de vitamine A deficiënte muizen 
helemaal geen RALDH activiteit meer, terwijl deze cellen uit de controle dieren wel 
beschikten over actieve RALDH enzymen. Dit fenomeen was te herstellen door de 
vitamine A deficiënte dieren voor een periode van 7 dagen op vitamine A controle 
voer te zetten. Deze resultaten laten zien dat de expressie van RALDH enzymen 
in mucosale dendritische cellen volledig afhankelijk is van de aanwezigheid van 
vitamine A in het voer. 
In hoofdstuk 5 hebben we het vitamine A metabolisme van twee verschillende 
muizenstammen vergeleken, namelijk BALB/c en C57BL/6 muizen. De BALB/c 
muizen hadden hogere expressie niveaus van RALDH enzymen in zowel darmen 
als mesenteriale lymfeklieren. Hierdoor zijn BALB/c muizen in staat zijn om 
meer retinolzuur te produceren in de darmen en de mesenteriale lymfeklieren 
dan C57BL/6 muizen. Als gevolg hiervan is de inductie van de darmspecifieke 
homingsreceptoren hoger in BALB/c muizen in vergelijking met C57BL/6 muizen. 
De consequentie hiervan is dat er meer lymfocyten aanwezig zijn in de darmen 
van BALB/c muizen in vergelijking met C57BL/6 muizen Door de verhoogde 
retinolzuur productie lijken BALB/c muizen dus te beschikken over een beter 
functionerend mucosaal afweersysteem dan C57BL/6 muizen. 
Dit laatste blijkt ook uit onze colitis studie, welke is beschreven in hoofdstuk 
6. Hierin hebben we de BALB/c muizen en C57BL/6 muizen opnieuw met elkaar 
vergeleken in een model waarin colitis werd geinduceerd. Colitis is een chronische 
ontsteking van de darmen en wordt in onze muismodellen geinduceerd door aan 
drinkwater het stofje dextraan sulfaat sodium (DSS) toe te voegen, waardoor 
een beschadiging van het darm epitheel ontstaat, welke leidt tot een tijdelijke 
ontsteking. BALB/c en C57BL/6 muizen verschilden in gevoeligheid voor de 
ontwikkeling van deze ziekte. Het bleek dat BALB/c muizen een hogere dosis van 
DSS nodig hadden om een vergelijkbaar ziektebeeld te ontwikkelen als C57BL/6 
muizen. Daarnaast herstelden BALB/c muizen sneller van colitis wanneer DSS uit 
het drinkwater werd verwijderd, zelfs na toediening van de hoge dosis DSS. We 
toonden aan dat BALB/c muizen tijdens colitis meer lymfoide structuren in de 
dikke darm ontwikkelden dan C57BL/6 muizen en dat deze lymfoide structuren 
veel IgA producerende B lymfocyten  en en beschermende T lymfocyten bevatten. 
Om te bewijzen dat vitamine A daadwerkelijk belangrijk is voor bescherming 
tegen colitis hebben we colitis geïnduceerd in vitamine A deficiënte dieren en deze 
vergeleken met vitamine A controle dieren. Beide groepen ontwikkelden colitis, 
echter het ziektebeeld in de vitamine A deficiënte dieren was vele malen slechter 
dan in de vitamine A controle dieren. Deze resultaten tonen aan dat vitamine A een 
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beschermende invloed heeft op colitis en dat een hogere retinolzuurproductie, 
zoals in BALB/c muizen, correleert met een lagere gevoeligheid voor de 
ontwikkeling van colitis en dus bijdraagt aan een beter functionerend mucosaal 
afweersysteem. 
In hoofdstuk 7 van mijn proefschrift wordt besproken hoe retinolzuur de 
embryonale ontwikkeling van lymfeklieren beïnvloedt. Voor de embryonale 
ontwikkeling van lymfeklieren zijn lymphoid tissue inducer (LTi) cellen en stromale 
organizer cellen nodig. Wij toonden in vitro aan dat de differentiatie van precursor 
LTi cellen tot volledig uitgerijpte LTi cellen werd bevorderd door de aanwezigheid 
van retinolzuur. Wanneer retinolzuur werd toegediend aan het voer van zwangere 
muizen leidde dit tot de ontwikkeling van meer uitgerijpte LTi cellen in het embryo. 
Echter, wanneer een zwangere muis op vitamine A deficiënt voer werd gezet, 
nam het aantal uitgerijpte LTi cellen in het embryo af. Ook in de BALB/c muizen 
die meer retinolzuur kunnen produceren waren meer uitgerijpte LTi cellen in de 
embryo’s aanwezig dan in C57BL/6 embryo’s. Het aantal uitgerijpte LTi cellen 
correleerde met de grootte van lymfeklieren na de geboorte. Uit deze analyses 
komt zeer duidelijk naar voren dat BALB/c muizen meer lymfoide structuren in de 
darmen hebben en grotere Peyerse platen en mesenteriale lymfeklieren hebben 
dan C57BL/6 muizen. Dit impliceert dat de vitamine A status (retinolzuurproductie 
en bloedspiegel) van de moeder invloed kan hebben op de ontwikkeling van het 
mucosale afweersysteem van haar kind. 
Conclusie
De studies beschreven in dit proefschrift laten zien dat vitamine A zeer belangrijk 
is voor het functioneren van ons mucosale afweersysteem vanwege de positieve 
invloed van het vitamine A metaboliet retinolzuur op verschillende onderdelen 
van het mucosale afweersysteem. Onvoldoende inname van vitamine A kan leiden 
tot een verstoorde balans van het mucosale afweersysteem wat de ontwikkeling 
van darmontstekingen en infecties tot gevolg kan hebben. Dit impliceert dat de 
effectiviteit van het mucosale afweersysteem en de gevoeligheid voor darminfecties 
en ontstekingen in mensen mede bepaald wordt door de inname en omzetting van 
vitamine A. Daarom kan de toediening van retinolzuur of mogelijkheid om RALDH 
niveaus te reguleren in patiënten een effectieve methode zijn om retinolzuur 
niveaus in de darmen te verhogen en zo het mucosale afweersysteem te versterken 
tijdens de behandeling van chronische darmontstekingen zoals ulceratieve colitis 
of de ziekte van Crohn. 
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Dankwoord
Na 4,5 jaar is het dan zover: mijn promotieonderzoek is afgerond en mijn 
proefschrift is geschreven! Uiteraard hoort daar ook het dankwoord bij, want dit is 
de gelegenheid om een aantal mensen persoonlijk te bedanken voor hun bijdrage 
aan mijn promotieonderzoek. 
Mijn promoter prof.dr. R.E. Mebius, beste Reina, allereerst wil ik je bedanken voor 
de mogelijkheid om in jouw groep te promoveren. Door jouw enthousiasme voor 
dit vak en persoonlijke manier van begeleiden heb ik heel veel van je geleerd. 
Bedankt voor alle werkbesprekingen waarin we samen heerlijk hebben zitten 
discussiëren en fantaseren over wat vitamine A allemaal doet in die darmen. Want 
wij weten wel hoe het zit, de rest van de wereld alleen nog niet! 
Mijn tweede promoter prof.dr. G. Kraal, beste Georg, bedankt voor alles wat ik van 
je heb geleerd. Jouw stimulerende ideeën en kritische blik op het onderzoek hebben 
sterk bijgedragen aan de kwaliteit en de totstandkoming van dit proefschrift. 
De leden van de leescommissie wil ik bedanken voor hun tijd en aandacht die ze 
hebben besteed aan het beoordelen van mijn proefschrift. 
Uiteraard gaat mijn dank ook uit naar de (oud-)collega’s uit groep Reina. 
Mascha, jij hebt me in het begin van mijn promotieonderzoek op sleeptouw 
genomen. Samen hebben we hele mooie transplantatie-experimenten gedaan en 
daarnaast hebben we als een van de eersten uitgezocht hoe we met dat nieuwe 
FACS apparaat, de Cyan, konden werken. Ik heb toen ontzettend veel van je geleerd 
en waardeer je hulp enorm. Veel succes met verdere carrière en ik vertrouw erop 
dat je heel succesvol zal worden in de fotografie. 
Marlene, de Nederlandse Duitse. Nadat ik jou geholpen heb om een DEC protocol 
in het Nederlands te schrijven besloot je dat Nederlands helemaal niet zo moeilijk 
is en sprak je vanaf die dag vloeiend Nederlands. Je bent twee jaar lang als post-
doc werkzaam geweest in groep Reina en we hebben intensief samengewerkt 
tijdens vele vitamine A experimenten. Ik ben erg blij dat je mijn paranimf wilt zijn 
op mijn promotie. Veel succes met je vervolg-carrière buiten de wetenschap. Ik 
heb gehoord dat je nu na zo’n korte tijd al een zeer gewaardeerde collega bent 
bij Elsevier.
Mijn andere paranimf Gera, jij kwam groep Reina versterken als analist. Samen 
met Marlene en Brenda hebben we een aantal zware en lange dagen meegemaakt 
tijdens de vitamine A studies. Gelukkig maakten we er altijd wat gezelligs van 
door met z’n allen in de koffiekamer een kleine maaltijd in elkaar te draaien 
(met af en toe een glaasje bubbels) om zo die lange experimentdagen een beetje 
dragelijk te maken. Daarnaast heb je me erg veel geholpen met de vele PCRs en 
coupekleuringen die in mijn proefschrift terug te vinden zijn. Ik vind het ontzettend 
leuk dat je hebt besloten om ook te gaan promoveren en ik ben ervan overtuigd 
dat dat je erg goed af zal gaan. Je hebt nu al veel meegekregen hoe het is om AIO 
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te zijn en straks kan je alvast meemaken hoe het is om op dat podium te staan. 
Heel veel succes tijdens je promotieonderzoek en bedankt voor al je hulp!
Brenda, you already started before I joined the Reina-group and learned me a lot 
about intestines, DSS experiments and digestions. I really enjoyed working with 
you on the BALB/c versus C57/BL6 stories and I also appreciate that we worked 
together on the vitamin A breeding and experiments. Thanks for all the fun at 
the lab and also at the cheese fondues together with Mascha, Marlene and Gera. 
Good luck with finalizing your PhD. We definitely have to drink some bubbles to 
celebrate our PhDs! 
Ook alle andere (oud-)collega’s van groep Reina, bedankt voor jullie hulp, 
wetenschappelijke input, discussies en samenwerkingen. Jasper, veel succes 
met jouw laatste loodjes als AIO. Ramon, bedankt voor je hulp bij de laatste 
transplantatie-experimenten. Succes met je nieuwe carrière bij Crucell. Serge, 
leuk dat ik nu ook wat heb gedaan met LTi cellen. We zullen er een mooi artikel 
van maken! Anna, ondanks de korte tijd dat je bij ons hebt gewerkt vond ik het 
erg gezellig om met jou samen te werken en te proberen om die lastige stromale 
cellen te kunnen sorteren. Veel succes met je verdere carrière. Antonio, good luck 
with your PhD project. Don’t forget to also spend some time to enjoy the city of 
Amsterdam!
Verder de (oud-)collega’s uit groep Geel, waar groep Reina onderdeel van 
is; Joke, Ida, Marieke, Tanja, Henrike, Kyra, Aram, Joost, Tom, Petros, Toon, 
Ronald, Erik, Ellen, Timo, Alice en Arnold. Bedankt voor wetenschappelijke 
discussies en hulp bij praktische zaken, maar ook voor de gezelligheid tijdens de 
vrijdagochtendbesprekingen en de gele groep uitjes. Ik vind het erg leuk om bij 
groep Geel te horen!
Naast de gele groep bevat de afdeling nog meer werkgroepen in verschillende 
kleuren. Ik wil iedereen van de afdeling MCBI bedanken voor hun stimulerende en 
kritische commentaren tijdens werkbesprekingen en voor alle gezelligheid op het 
lab maar ook tijdens de afdelingsuitjes, borrels en kerstfeesten.
Zeker niet onbelangrijk voor het slagen van mijn experimenten zijn de 
mensen die mij hebben geholpen met het proefdierwerk; Erwin, Carla, en 
Eelco. Eelco, ontzettend bedankt voor je hulp bij een aantal in vivo proeven en 
voor het beantwoorden van al mijn vragen over DEC protocollen, procedures, 
muizenbestellingen etc, etc. Erwin en Carla, enorm bedankt voor jullie hulp bij het 
opzetten en bijhouden van de vitamine A fok. 
Buiten de afdeling heb ik samengewerkt met Stefan Martin en Fanny Edele. Dear 
Stefan, thanks for working together on epithelial-DC imprinting project and for 
the nice paper we published. Hopefully we will continue our collaboration in the 
future. Dear Fanny, good luck with your post-doc in Toronto. I hope you’ll have a 
great time in Canada.
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In mijn periode als AIO heb ik met vele mensen een werkkamer mogen delen. 
Ten eerste H-269 waar ik tegelijk met Elly op de kabouterkamer terecht kwam bij 
Ronald, Erik en later Margot. Bedankt voor de gezelligheid, alle kabouterborrels 
en de heerlijke frituurlucht die vervolgens nog een week rond je computer bleef 
hangen. 
Mijn tweede AIO-kamer, J-283, mocht ik delen met Gijs, Nuray, Lydia, Ida, Jasper, 
Ellen en natuurlijk onze eigen rivierkreeft Ricardo (†) met zijn guppy familie. 
Bedankt voor de gezellige tijd, de heerlijke koekjes en tips tijdens het afronden 
van mijn promotieonderzoek. 
Inmiddels ben ik terecht gekomen op de post-doc kamer J-290, waar ik warm ben 
onthaald door Renate en Jack en inmiddels ben versterkt door Henrike. Ik ben 
erg blij dat jullie alle promotiestress die Henrike en ik af en toe meebrachten vol 
begrip hebben aangehoord. Gelukkig was er ook voldoende tijd voor thee-(oh 
nee, jullie drinken alleen maar koffie!)-leuten en verhalen over kokkerellen, luxe 
dinertjes en steeds groter wordende karpers met de geluiden van “Veronica top 
1000 Allertijden” op de achtergrond.
Tenslotte wil ik mijn familie en schoonfamilie bedanken. Mijn schoonfamilie Paul, 
Ronnie en Ralph, bedankt voor jullie continue belangstelling en interesse voor mijn 
promotieonderzoek. De jaarlijkse wintersportvakantie heeft zeker bijgedragen 
aan de totstandkoming van mijn proefschrift!
Mijn ouders en broers, lieve papa en Sandra, lieve mama en Hans en mijn beide 
broers Jur en Maurice, bedankt voor jullie onvoorwaardelijke steun, liefde en 
vertrouwen. Ik ben trots op jullie! 
En tenslotte, lieve Jules, inmiddels weet je hoe het is om met een AIO getrouwd 
te zijn. Bedankt voor het aanhoren van mijn frustraties, voor je onvoorwaardelijke 
steun maar ook voor het samen kunnen vieren van successen en je spontane 
verrassingen. Zonder jou was dit boekje er niet geweest, je stond altijd achter me. 
Je bent geweldig!
Rosalie
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Curriculum Vitae
Rosalie Molenaar werd op 1 december 1981 geboren te Alkmaar. Zij behaalde haar 
VWO diploma in 2000 aan het Petrus Canisius College te Alkmaar, waarna zij in 
september van dat jaar begon met de opleiding Biomedische Wetenschappen aan 
de Vrije Universiteit te Amsterdam. Tijdens deze opleiding verrichte zij haar eerste 
wetenschappelijke stage op de afdeling Moleculaire Celbiologie en Immunologie 
van het VU Medisch Centrum te Amsterdam onder begeleiding van dr. Janneke 
Samsom, waar zij heeft meegewerkt aan het onderzoek naar regulatoire T cellen. 
Tijdens de master-fase van de opleiding Biomedische Wetenschappen heeft Rosalie 
zich gespecialiseerd in de immunologie. Tijdens deze fase heeft zij als stagiaire 
onderzoek gedaan naar de functie en detectie van granzyme B en proteinase 
inhibitor 9 in serum tijdens transplantatie afstotingsreacties in nierpatienten. Dit 
onderzoek werd uitgevoerd op de afdeling Experimentele Immunologie op het 
Academisch Medisch Centrum te Amsterdam onder supervisie van prof.dr. Ineke 
ten Berge en dr. Ajda Rowshani en op de afdeling Plasma Eiwitten van Sanquin 
Research onder begeleiding van prof. dr. Erik Hack. De afrondende stage heeft 
Rosalie gedaan op het Nederlands Kanker Instituut op de afdeling Moleculaire 
Genetica, onder supervisie van dr. Jacqueline Jacobs en prof.dr. Anton Berns, 
waar onderzoek werd verricht naar factoren die de telomeren van chromosomen 
beschermen. In september 2005 heeft Rosalie haar master diploma Biomedische 
Wetenschappen behaald en is zij vervolgens in december van hetzelfde jaar 
gestart met haar promotieonderzoek bij de afdeling Moleculaire Celbiologie en 
Immunologie van het VU Medisch Centrum te Amsterdam onder begeleiding 
van promoteren prof.dr. R.E. Mebius en prof.dr. G. Kraal. De resultaten van dit 
onderzoek staan beschreven in dit proefschrift met de titel: Control of mucosal 
immune responses by vitamin A. Sinds 1 april 2010 is Rosalie als post-doc 
werkzaam op de afdeling Moleculaire Celbiologie en Immunologie van het VU 
Medisch Centrum te Amsterdam om het onderzoek wat is opgezet tijdens haar 
promotie voort te zetten.
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